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Executive Summary
1.1—Rationale
A Public Health Evaluation (PHE) was commissioned 
to examine PEPFAR-funded care and support. Phase 2 
of this PHE aimed to evaluate how PEPFAR care and 
support programme components and costs are related 
to health outcomes in Kenya.
1.2—Methods
Phase 2 was completed using three methods: a longi-
tudinal quantitative observational study of patient care 
and health outcomes over three months; qualitative 
interviews with patients, informal carers and staff; and 
a costing study to estimate facility-level costs of provid-
ing care and support. Six facilities receiving PEPFAR 
Care and Support funding were selected from those 
which had completed Phase 1. In the longitudinal study, 
self-reported health outcomes were measured using the 
MOS-HIV and the APCA African POS, and patient 
care using a modified Client Services Receipt Inventory.
1.3—Main Findings of Longitudinal Quantitative 
Study
1.3.1—Facility Characteristics
The facilities (numbered 155–160) were all HIV outpa-
tient clinics. Four were based in public hospitals, one in 
an NGO hospital, and one was a health centre.
1.3.2—Participant Characteristics
Six hundred ninety-six people were recruited to the 
study, and interviewed at a mean of 30.2 day intervals 
for four months. One hundred four participants did not 
complete all four interviews; nine died, thirty left the 
facility, three were unable to continue, and sixty-two 
did not identify a reason. Participants were aged 18–69 
(mean 35), 31% were male and 97% had some primary 
education. Median time from HIV diagnosis to recruit-
ment was 36 days and their median CD4 count was 
276 at the beginning of the study. At baseline 12% were 
accompanied by an informal carer.
1.3.3—Care Delivery
Of 52 components of care and support included in the 
questionnaire, participants received a mean of 12 per 
month and 20 altogether during the study. The most 
commonly provided were adherence counselling, pre-
vention with positives and CTX, each received by over 
90% of participants. Of the five categories of PEPFAR 
Care & Support (clinical, psychological, spiritual, social 
and preventive), 99% of participants received clinical 
care and 94% prevention. Psychological care was the 
least commonly delivered (58%). 
In general participants received clinical care from 
the facility, social and spiritual care from other sources. 
Symptom management was obtained both from the 
facility and from elsewhere. During the study 76% of 
participants received ART at least once. Receipt of 
CTX increased over time, until by the end of the study 
period 85% were receiving daily CTX and 95% had 
taken it the previous day. 
Forty-one percent of participants were recruited 
to the study within two weeks of their HIV diagnosis. 
The care they most commonly received was, in order 
from the highest prevalence, pre- and post-test counsel-
ling, adherence counselling, prevention with positives, 
CTX, multivitamines, and nutritional advice. During 
the study 56% received family VCT information, 67% 
improved drinking water supplies, 47% an ITN, 65% 
condoms and 92% CTX. These are the components of 
the preventive care package. Participants who had been 
diagnosed more than two weeks before recruitment 
received the preventive care package components with 
similar frequency. 
1.3.4—Physical and Mental Health and 
Palliative Care Related Problems
At baseline, participants had a mean self-reported 
physical health score of 46.1 and mean mental health 
score of 48.1 as measured using the MOS-HIV, with 
100 being the best possible health and 0 the worst. 
Their lowest scores on the multidimensional care scale 
1
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(APCA African POS) were for not being able to share 
their feelings with anyone, and not having enough help 
and advice for the family to cope.
1.3.5—Differences between Facilities
Facilities differed in the relative wealth of their partici-
pants and in the proportion who were newly diagnosed 
(defined as within 14 days of recruitment). Facility 157 
had 64% new participants while facility 156 had 13%. 
The facilities with poorest participants were 155 and 
160. Median CD4 count ranged from 332 at facility 
156 to 221 at facility 158. Provision of clinical care was 
high at all facilities, and provision of social care was 
always low, but the proportion to receive pain manage-
ment, nursing care or spiritual care varied widely.
1.3.6—Participant Characteristics and Health
Older people, and poorer people, reported lower physi-
cal health at baseline, but mental health was not associ-
ated with age or relative wealth. There was no difference 
in mental or physical health between men and women, 
or between those with different levels of education. Par-
ticipants with a low CD4 count reported lower physi-
cal health and, as a consequence, lower mental health. 
Whether participants were receiving ART at baseline 
was not associated with health outcomes. Participants 
taking ART had similar physical and mental health 
to those not prescribed ART (and probably with less 
advanced disease).
1.3.7—Changes in Health Over Time
Over time participants’ mean physical and mental 
health improved and care needs decreased, after ac-
counting for the bias that people with lower health 
were more likely to drop out of the study. Those with 
the lowest scores also experienced improvement. Facil-
ity 156 showed much less improvement in physical 
score than average; early gains in physical health then 
stabilised after the end of the first month. Older partic-
ipants experienced less gain in health than younger, and 
wealthier participants experienced more than poorer. 
Gender, education, and ART status were not associated 
with change. Participants receiving TB treatment had 
the same gains in mental health as those not receiving 
TB treatment, but less improvement in physical health. 
1.4—Main Findings of Qualitative Interviews
Patients reported feeling pain, fatigue and anxiety; in-
visible, chronic problems. Their main worries and those 
of carers centred on poverty, realised in difficulty paying 
for food, transport, drug costs and school fees. They 
made great efforts to find fruit and vegetables but there 
was often not enough for the family. 
Patients greatly appreciated the quality of care they 
received and, in most cases, the courteous behaviour of 
staff. They objected to waiting for a long time to see a 
health care worker, with opportunity costs and risk of 
infection in the waiting bay. Staff reported that increas-
ing patient numbers were difficult to manage and that 
the quality of care was perceived to decline when they 
were overloaded. Patients gave each other social and 
spiritual support, which usually did not come from the 
facility. There were schemes such as travel reimburse-
ment and provision of soap for home care, sometimes 
carried out by the facility and sometimes by the individ-
ual health worker. Family carers received little support. 
Care focused on clinical problems, and standard 
assessment and monitoring forms included only clini-
cal measures, not emotional wellbeing. Patients were 
advised not to have too many thoughts, as they reported 
worry and many thoughts burdening them. They were 
encouraged to participate in social life and to discipline 
themselves against feelings of isolation and ostracism. 
1.5—Main Findings of Costing Study
There was wide variation in costs per patient per year, 
ranging from $77 at Facility 157 to $1160 at Facil-
ity 159. Facility 159 was much more expensive than 
the others; the next largest cost was $418. The largest 
contribution to costs was staff salaries at three facilities, 
ART at two and lab costs at one. Clinical staff contrib-
uted much more to costs than did non-clinical staff. 
Patient loads were extremely high for non-clinical staff. 
There were economies of scale, so that facilities with 
more patients had lower costs per patient.
1.6—Recommendations
1.6.1—For Health Professionals
 » People with HIV have physical and mental health 
needs throughout the trajectory of illness, and 
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mental health in particular is not related to HIV 
progression but can be a problem at any stage. All 
patients referred with HIV should be assessed for 
psychological need on a regular basis. Emotional 
wellbeing should be a core component of patient 
assessment in HIV monitoring upon registration 
and throughout patient care
 » The needs of carers should be included in the 
patient care encounter. Including carers early on 
the care trajectory would demonstrate the value of 
the carer role in the eyes of facilities, improve social 
care for patients and could help to identify patient 
needs that are not acknowledged by the patients 
themselves. 
 » Participants established on ART were able to fur-
ther improve their physical and mental health over 
three months.  Care and support, complementary 
to ART, can help to optimise health. 
1.6.2—For Health Facility Managers
 » Health facilities should have a clear policy regard-
ing delivery of social care, food support and finan-
cial refunds, so that the burden of decision making 
and payment does not fall on health delivery staff.
 » Staff need to be supported and protected from risk 
of burnout to maintain valuable skills in health care 
and reduce turnover
 » There should be sufficient numbers of non-clinical 
staff to ensure a manageable patient load for coun-
sellors, nutritionists, social workers and community 
health workers, and high quality patient care. The 
areas addressed by these professions are a severe 
cause of need for people with HIV. 
 » Sufficient space is essential to providing confiden-
tial counselling services and meeting patient needs 
1.6.3—For Policymakers
 » Many participants were initiated onto ART within 
weeks of their HIV diagnosis, showing that they 
could have benefited from treatment at an earlier 
stage. Testing needs further encouragement so that 
people with HIV are identified as early as possible 
in the disease trajectory and gain the maximum 
benefit from care and support services including 
ART.
 » No problems were reported with the supply of 
ARVs but supplies of other drugs were frequently 
unreliable, causing expense to patients and delays 
to care. Supply chain systems should adopt the best 
practices of the ART delivery system.
 » Chronic hunger is not adequately managed by 
short-term interventions. Food shortage caused 
by poverty is a significant problem which inhibits 
delivery of HIV care. Health facilities should work 
towards sustainable, adequate food supply for all 
patients to help maintain health and adherence.
 » Policy makers should advocate for increased use of 
appropriate analgesics, including opioids, to man-
age chronic pain.
1.6.4—For Researchers
 » The evaluation model used here could be replicated 
in other countries.
 » Facility staff who had hosted research projects for 
years expressed a wish to learn skills and conduct 
their own research. Future research programmes 
should include building of knowledge and capacity 
in host settings.
 » A study of care and outcomes for children should 
be undertaken to explore the multidimensional 
problems of this important population, particularly 
the expanding group of HIV positive older children 
for whom optimal care is still being developed.
 » Shortage of non-ART drugs delayed patient care 
and was a common complaint, but the cause of 
these shortages is unclear. Examination of the bar-
riers to drug delivery and a more detailed investiga-
tion of how drugs are supplied would be beneficial 
in terms of care delivery and patient satisfaction. 
 » A longer follow-up period would be beneficial to 
explore whether care and outcomes are maintained 
over a period greater than three months.
 » A study of how different staff working in care and 
support of HIV patients spend their working hours 
would enable an examination of how care costs 
relate to patient outcomes.
 » Further study of referral networks from individual 
facilities would help understand where, as well as 
why, patients obtain care that is not provided at the 
principal facility of study.
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Introduction
In 2003 the United States government (USG) autho-
rised a five-year, $15 billion initiative to combat the 
global HIV/AIDS epidemic: the President’s Emergency 
Plan for AIDS Relief (PEPFAR). The money was allo-
cated approximately as follows: provision of antiretrovi-
ral (ARV) treatment for people living with HIV/AIDS 
(55%), programmes to prevent HIV (20%), assisting 
orphans and vulnerable children (10%) and provision of 
palliative care services for individuals with HIV/AIDS 
(15%). PEPFAR has commissioned PHEs in these 
areas to evaluate funded programmes. Palliative care was 
subsequently redefined as care and support by OGAC.
2.1—Aim
The aims of the evaluation were to (a) describe the 
nature and scope of HIV care and support provi-
sion supported by PEPFAR in two African countries, 
including the types of facilities available, clients seen, 
and availability of specific components of care (Phase 
1); and (b) evaluate how PEPFAR care and support 
programme components and costs are related to health 
outcomes (Phase 2). By meeting these aims, this study 
was designed to provide detailed descriptions of the 
care and support services that have been delivered 
through PEPFAR funding and identify the effective 
components and costs of the services, to improve the 
health of patients with HIV. Dissemination of the find-
ings is planned, in conjunction with country teams, to 
inform effective care and support provision within the 
two PHE target countries and beyond, where lessons 
can be transferred to other PEPFAR countries. 
2.2—Objectives
To address these aims, the study objectives were to:
 » undertake a cross-sectional survey of service con-
figuration and activity by visiting 10% of the facili-
ties being funded by PEPFAR to provide HIV care 
and support in Kenya and Uganda;
 » undertake a longitudinal prospective study of 600 
patients newly diagnosed with HIV or who pre-
sented with a new problem attending PEPFAR 
care and support services. Data collected included 
self-reported quality of life, core palliative out-
comes, and components of care received;
 » conduct qualitative interviews with staff, patients, 
and carers in order to explore and understand ser-
vice issues and care provision in more depth; and
 » undertake a cost comparison of care provided, in-
cluding staff, overhead and laboratory costs.
2.3—Study overview
The evaluation design, an observational study in Kenya 
and Uganda, was comprised of two sequential periods 
of data collection using mixed methodologies. Phase 1 
(2007) was a cross-sectional survey of 10% of facilities 
providing care and support services and documented 
facility configuration and activities using quantitative 
and qualitative descriptive data.
Phase 2 (2008) was a longitudinal evaluation of 
care and support services focusing on patient outcomes 
using validated outcome tools. Qualitative interviews 
with staff, patients and carers provided in-depth under-
standing of key issues. An additional cost analysis com-
ponent in this phase compared patient/family outcomes 
with their associated costs. Patient data collection took 
place between January and September 2008, with data 
collection for the costing component being completed 
in January 2009. This report focuses on Phase 2 of the 
evaluation in Kenya. Reports for Phase 1 in Kenya (1) 
and Uganda (2) have been published separately. 
This evaluation of PEPFAR-funded care and sup-
port for HIV was led by King’s College London (KCL, 
Principal Investigator) in collaboration with MEA-
SURE Evaluation at the University of North Carolina 
(UNC) and the African Palliative Care Association 
(APCA). The aims, methods and implementation of 
the evaluation were planned and agreed in consultation 
with the members of USG Care and Support Technical 
Working Group, USG Country Teams, and representa-
tives of the Ministries of Health in Kenya and Uganda.
2
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Phase 2 Methods
3.1—Study Design 
Phase 2 of the care and support PHE was a mixed 
method prospective evaluation of PEPFAR-funded 
care and support services. The main component was a 
longitudinal study of how care components potentially 
related to HIV patient palliative and general health 
outcomes over time. In-depth interviews with staff, 
patients and carers explored in-depth service issues. 
Descriptive cost data were collected to compare patient 
outcomes with cost of providing services. There were 
three parts to Phase 2 of this evaluation, including (a) 
a quantitative longitudinal study; (b) patient and staff 
interviews; and (c) a costing survey.
3.2—Rationale for the Study Design
The aim of the study was to evaluate how PEPFAR 
Care and Support programme components and costs 
are related to health outcomes. The PEPFAR pro-
gramme was country-wide and had been implemented 
for several years before the evaluation was commis-
sioned. Therefore it was not possible to conduct a 
before-and-after study. One option was to compare 
outcomes at facilities receiving PEPFAR funding with 
those which did not, but this design would have been 
difficult as there are few large facilities in the target 
countries which have never received PEPFAR fund-
ing. Little information exists regarding the quality of 
life of Kenyan populations, which could have been 
used as a comparison sample. Facilities did not have 
stated targets against which their performance could be 
compared.
A cross-sectional study would only be able to 
identify differences between facilities, which might be 
caused by population factors as well as variations in 
care and support delivery. A longitudinal cohort study 
design was selected to allow the effect of care over time 
to be examined. This design offered the best option for 
evaluation of outcomes, although it was not possible to 
remove the effects of previous contact with PEPFAR 
Care and Support. 
Patient self-reported health was selected as the out-
come of interest because care and support aims to im-
prove quality of life, and could not be properly assessed 
without measuring this outcome. A mixed-methods 
design incorporating both quantitative and qualitative 
methods allowed triangulation and greater understand-
ing of the data and its context.
3.3—Protocol Development
The protocol was developed by a multidisciplinary 
team, including medical professionals, HIV specialists 
and clinical and academic researchers, with review and 
comment from the USG Care and Support Techni-
cal Working Group and the country teams in Kenya 
and Uganda. All tools were piloted in one facility in 
Uganda. Following piloting, the wording and structure 
of the tools were modified and clarified. The tools are 
presented in Appendices A–D, and described below.
3.3.1—Longitudinal Quantitative Study
The data collection tools for the longitudinal study were 
four questionnaires, one of them (demography) used 
only once per person and the others used four times 
at monthly intervals. The time points, each one month 
apart, were designated T0 (entry to the study), T1, T2 
and T3. A “patient pack” was created for data collec-
tion, consisting of all the tools bound in the order they 
should be used, with the pages colour coded by time 
point, and preceded by a log page to complete the dates 
of interviews and a front cover with the participant’s 
ID number. For each facility, questionnaire packs were 
prepared in two languages; English and a common local 
language. All the documents were translated into local 
languages from the English versions twice, indepen-
dently, by two local researchers. Each of these versions 
was translated back to English by a third researcher, 
with any discrepancies discussed amongst the group 
and an agreed translation decided.
Demographic and medical questionnaire (Appendix A): 
Basic demographic and medical details were collected 
3
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using a brief questionnaire administered at T0 (recruit-
ment to study). In addition, four clinical questions were 
asked at T1: WHO stage, date and result of most recent 
CD4 test, and date of beginning ART. 
The African APCA Palliative Outcome Scale (POS) 
and Eastern Co-operative Global Performance Scale 
(ECOG) (Appendix B): The APCA African POS is an 
adapted version of the original POS, which was devel-
oped at KCL to address the multidimensional problems 
of patients with incurable progressive disease and sub-
sequently adapted around the world (3;4). The APCA 
African POS was validated in ten centres in six Sub-
Saharan African countries in 2006 (5). Its ten items 
address the primary physical, emotional and spiritual 
concerns of patients and families and employs scoring 
methods appropriate for a range of literacy skills. It 
was administered at each of the four time points. The 
validation study demonstrated its properties included 
sensitivity to change, and it has high levels of patient 
and clinician acceptability. 
The ECOG is a clinician-rated single item measure 
of physical performance, with no psychosocial indices 
of quality of life, also at administered at all four time 
points (6). Scores range from 0 (normal activity) to 
4 (unable to get out of bed). The ECOG is the most 
widely used performance measure (7).
Medical Outcome Scale-HIV (MOS-HIV) (Appen-
dix C): The MOS-HIV is a very widely used quality 
of life measure and has been culturally adapted to the 
East African HIV setting (8, 9). The 35 items, asked at 
all four time points, address the domains of role func-
tion, pain, physical functioning, cognitive functioning, 
overall health perception, mental health, and vitality. 
The weighted subscores in these domains are then 
combined to produce two summary scores measuring 
physical health and mental health.
Client Service Receipt Inventory (Appendix D): 
This tool was a version of the Client Services Receipt 
Inventory (CSRI) (10) adapted for the aims of this 
study and the HIV setting in Africa in order to collect 
information about services received by patients in the 
study. Every month the CSRI recorded receipt of 52 
components of physical, psychological, spiritual, social 
and preventive care, and whether they were received at 
the facility or from elsewhere.
3.3.2—Qualitative Interviews
Interview schedules (Appendices E, F and G) were de-
signed to gain greater understanding of service use and 
provision from the views of the patients, their carers 
and the staff. The principal themes for patients and car-
ers were experience of facility care, choice of facility, the 
nature and content of clinical encounters, and principal 
needs. Interviews addressed medical, psychological, 
spiritual and social domains. Initial interview tran-
scripts were reviewed and question wording amended 
where needed to improve clarity of questions and fully 
explore key issues. The interview schedules, information 
sheets and consent forms were translated into local lan-
guages from the English versions twice, independently, 
by two local researchers. Each of these versions was 
translated back to English by a third researcher, with 
any discrepancies discussed amongst the group and an 
agreed translation decided.
3.3.3—Costing Study
Because the provision of care is such a complex area 
there are potentially a number of cost components that 
could be accounted for. Due to funding constraints 
on this study only the following key cost elements 
were examined: (a) labour—by staff type, staff salaries; 
(b) medicines—ARVs, pain medicines, antibiotics, 
CTX, other—and their inventories—buffer stock; (c) 
laboratory items—supplies and equipment; (d) build-
ings—rent per month or estimated rental value—and 
utilities; and (e) capital inputs—high end equipment 
and vehicles. 
Because only the major cost drivers were included, 
the costs in this report are likely to be an underestimate 
of the real costs of providing care. Cost elements that 
may be significant, but which were not accounted for 
include: costs of developing training and HMIS sys-
tems, training of health providers, supervision, monitor-
ing and evaluation including HMIS systems, clinic ad-
ministrative costs, drug and commodities management 
and maintenance and depreciation on capital assets.
As HIV care and support is provided in a clinical 
setting in which other non-HIV services are provided, 
it was necessary to estimate the proportion of some cost 
elements which are measured for all clinical services 
and attribute a share for care and support. This is a 
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common issue with the costing of services that are 
provided in an environment where several medical spe-
cialities are simultaneously provided separately at one 
facility. For labour costs, only staff who were involved 
in providing care and support services were included so 
there was no allocation difficulty with staff costs.
To estimate non-ARV drug costs, facilities reported 
the use of their three most common analgesics, of 
strong and weak opioids, CTX, the three most com-
monly prescribed antibiotics for OIs, and TB treatment. 
The cost of these was divided by the proportion of facil-
ity patients who were HIV positive, as a proxy for drug 
use. Similarly, capital and building costs were allocated 
to HIV care and support using the proportion of all 
patients accounted for by HIV patients. Tools were 
piloted and revised to maximise validity of the data col-
lected and ease of data provision for facilities.
3.4—Ethical Approval and Data Storage
Ethical approval to undertake the study in Kenya was 
received from the Kenya Medical Research Institute 
(Ref KEMRI/RES/7/3/1) and the College Research 
Ethics Committee at KCL (Ref CREC/06/07-140). 
Subsequent tool changes following piloting were also 
approved.
During longitudinal data collection all question-
naires were stored separately from consent forms, in a 
locked filing cabinet at the facility. Upon completion 
of the study, anonymised questionnaires were taken 
from the facility to Nairobi for storage in locked filing 
cabinets. These arrangements were in line with ethical 
guidance and the Data Protection Act.
3.5—Selection and Recruitment
3.5.1—Health Facilities
In Phase 1, the approximately 600 facilities receiving 
PEPFAR Care and Support funding in Kenya were di-
vided into three strata based on the number of patients 
treated in the past year, and 20 facilities were selected at 
random from each stratum. From these 60 facilities, the 
largest six were selected to participate in Phase 2. The 
inclusion criteria for Phase 2—which applied in addi-
tion to those for Phase 1—were that facilities recruited 
at least 30 new HIV patients a month, had sufficient 
staff with essential skills to conduct data collection, 
offered ongoing care and support to enable longitudinal 
data collection, and had sufficient capacity to engage in 
the study. The six largest facilities were selected because 
they were the most likely to meet the inclusion criteria 
listed above. 
3.5.2—Participants
Longitudinal quantitative study: Consecutive patients 
who met all of the following criteria were approached 
for participation in the longitudinal study: (a) patients 
were 18 years of age or over; (b) patients were diag-
nosed HIV positive; (c) patients knew of their diagno-
sis; (d) patients had sufficient cognitive ability (estimat-
ed by health care workers) to answer the questions for 
the study; and (e) patients were either new to service or 
presenting with a new problem (social, psychological, 
spiritual or physical).
Participants gave informed consent to partici-
pate following provision of an information sheet and 
consent form. These documents were translated into 
local languages, and were read aloud by the health care 
worker if the patient was nonliterate. Participants were 
reimbursed travel expenses to the facility of US$5 per 
visit. Each facility recruited about 100 participants for a 
total of 600.
Qualitative interviews: Any staff member working 
at the facility who was involved in the care of patients 
was eligible to participate in the staff interviews. A 
purposive sampling strategy was undertaken in order to 
interview a variety of staff designations. The aim was to 
complete seven patient interviews, three carer inter-
views and five staff interviews per facility. 
Eligible participants for the patient qualitative 
interviews were patients of the facility who had already 
been diagnosed as HIV positive, over 18 years of age, 
had been under care for at least six weeks, and were not 
involved in the longitudinal study (so as to minimise 
study burden). These patient participants were asked for 
consent to approach an identified adult informal carer 
(i.e., family member or friend who provides assistance/
support) in order to undertake a separate qualitative 
interview. 
Patient, carer and staff participants gave informed 
consent to participate following provision of an infor-
Phase 2 Kenya 8
Phase 2 methods 8
mation sheet and consent form, which was read aloud 
to the interviewee by the health care worker if the 
interviewee was nonliterate.
3.6—Data Collection
Facilities were informed of the planned survey through 
the MOH in each country. 
3.6.1—Longitudinal Quantitative Study
Data collection took place between January and Sep-
tember 2008, with recruitment to the longitudinal 
quantitative study ending in June to allow all the in-
terviews to be completed. With the exception of CD4 
counts, data for the longitudinal quantitative study were 
self-reported by the participants, and recorded in the 
questionnaire packs provided by health care workers 
(HCWs) already employed at each facility. 
HCWs recruited patients and completed question-
naires in the course of their regular duties. Funding 
was provided to the facility directors to support data 
collection, including purchase of a computer. HCWs 
were trained by APCA staff in the process of seeking 
informed consent and the completion of the question-
naires. A researcher maintained contact with each facil-
ity through regular visits which would include observ-
ing data collection, checking the use of appointment 
diaries and regular data entry, and delivering additional 
training as necessary. 
Data collection was conducted at recruitment (T0) 
and at three subsequent interviews about one month 
apart, which coincided with clinical appointments 
where possible. Once participants had completed the 
longitudinal study, CD4 counts were extracted from 
patient records by the HCWs, or by the researchers 
themselves under the supervision of HCWs.
Early in data collection it became apparent that 
participants could not always remember the date and 
result of their last CD4 count. Less than 50% of par-
ticipants were able to provide a CD4 count and it ap-
peared that these were biased towards people who were 
more ill or concerned about their health. Accordingly, 
permission was granted by the ethics board overseeing 
the study to search patients’ records for CD4 counts. 
Researchers visited each facility after the longitudinal 
quantitative study data collection had been completed, 
and copied CD4 counts for the study participants into 
a specially designed form which preserved anonym-
ity while allowing records to be linked to participants. 
CD4 count was the only piece of information obtained 
in this way. The decision to refer to patient records was 
taken because the researchers knew the information 
was collected by facilities, and participants had been 
informed of their result, but simply could not remem-
ber the information. 
One questionnaire pack contained all the data for 
one individual. The pages were colour-coded to indicate 
time points. The front cover of the pack was blank apart 
from the participant’s name. When the final time point 
was complete, this page was torn out, making the data 
unidentifiable. The second page included metadata log-
ging the progress of data collection and management at 
each timepoint. 
3.6.2—Qualitative Interviews
The interviews took place between February and Sep-
tember 2008. Single qualitative interviews with staff 
members, patients and informal carers were conducted 
by trained APCA staff and were digitally recorded. In-
terviews were carried out in several languages including 
English, Swahili and Luo. Interviews were conducted in 
private, usually in consulting rooms at the care facility.
Most participants were not accompanied by a carer 
and the few who were accompanied were often very 
ill, needing the carer’s constant presence. As a result, 
recruitment of sufficient carers for qualitative inter-
views was difficult. Researchers identified family carers 
through community outreach teams operating from 
the care facilities, where available. In this way, a more 
representative sample of carers of patients at all disease 
stages could be interviewed. 
3.6.3—Costing Study
A data collection instrument (Appendix H) was 
designed and tested to capture the identified cost 
elements in each of the Phase 2 facilities in which 
participants were being followed. Facility level data 
included number of patients seen by staff category in 
a typical day, hours spent with HIV patients per week 
and hours worked per week by staff category; number 
of staff by category involved in HIV care; quantities of 
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medications dispensed in the last three months by kind 
of drug; numbers of laboratory tests conducted in the 
last three months; information on physical buildings 
such as space and an equivalent in rental value of the 
space; utility costs per month including water, electric-
ity, generator fuel, communications, waste disposal 
etc.; transport costs, fuel, costs of drivers, maintenance; 
clinical consumable costs per month, including gloves, 
syringes, cotton wool swabs, plasters, soap, sterilizing 
solution etc.; amount spent on volunteer staff includ-
ing training, travel reimbursements, payment in kind in 
past 3 months.
Researchers gathered the information required for 
the instrument with information provided by key infor-
mants at each facility. Key informants varied by facility 
but generally included the HIV clinic director, hospital 
administrator or manager, the accountant, clinicians, 
nurses and pharmacists. In some cases, more than one 
site visit was required in order to interview all relevant 
respondents and to complete the questionnaire.
Unit costs were required for some cost elements. 
These included staff (i.e., full salaries including allow-
ances), prices of medicines and unit costs of labora-
tory tests. Salary data were obtained from the Kenyan 
Ministry of Health and from some of the facilities as 
well as from one of the USAID projects that supports 
some of the facilities. Drug costs were largely obtained 
from international sources such as the WHO and the 
International Drug Price Indicator Guide while labora-
tory test costs were obtained from ATC.
3.7—Data Management and Entry 
3.7.1—Longitudinal Quantitative Study
Immediately after collection, data were entered into a 
pre-designed EpiData v3.1 database with conditional 
checks for internal consistency. Data entry was con-
ducted at the health care facility by an administrative 
staff member who had been trained in the use of the 
tools and the database. When participants had com-
pleted the study, the completed data collection tools 
were transferred to the KEHPCA office. There research 
staff conducted a second round of all data entry and 
validation of the two rounds. Discrepancies identified 
were corrected by manual checking of questionnaires 
and results were revalidated until the two datasets were 
identical. The CD4 information from patient records 
was entered into a separate EpiData database and 
merged into the main dataset.
3.7.2—Qualitative Interviews
Interview recordings were transcribed verbatim into 
MS Word 2003 in the language in which they were 
conducted. If the interview was not conducted in 
English, two independent translations into English 
were then performed, either by the researchers or by 
identified native-speaker health professionals. A team 
of three then reconciled the two independent transla-
tions, referring back to the taped interview if necessary, 
and agreed upon a final version. After the final transla-
tion had been agreed, the tapes were destroyed. A table 
containing background information on the participant 
was added to the beginning of each transcript. These 
data were extracted from interviews and entered into 
Excel tables.
3.7.3—Costing Study
The data were entered into predesigned Excel spread-
sheets. Analysis, including creation of graphs and linear 
regression, was conducted in Excel workbooks with 
data drawn together from the different sheets. Clinical 
staff were defined as doctors, nurses and clinical officers.
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An analysis plan was developed and circulated to all 
contributors for comment after data collection was 
completed. The three main sources of data (longitudinal 
quantitative study, qualitative interviews and costing) 
were analysed separately. Analysis plans are outlined 
below, with the research questions in boxed text. 
Following the implementation of the analysis plans, 
the results were integrated. The six participating facili-
ties are designated by numbers in this report to preserve 
anonymity. The same identifying numbers were used 
in the Phase 1 report so that reference can be made 
between the two.
4.1—Longitudinal Quantitative Study
Analysis was conducted using Stata v10. 
4.1.1—Outcome Measures
The main outcome measures were the MOS-HIV 
(health related quality of life) and APCA African POS 
(palliative care related problems). In order to reduce 
multiple significance testing, for the purposes of this 
evaluation the MOS-HIV was used as the primary out-
come measure, owing to its previous use in longitudinal 
HIV research in Africa (11).
MOS-HIV: The 35 MOS-HIV items contribute to 
eight multi-item subscales (health perceptions, physi-
cal function, role function, cognitive function, pain, 
mental health, energy/fatigue, and health distress) and 
two single-item subscales (social function and quality of 
life). Subscales were computed by summation of indi-
vidual item scores and conversion to a score out of 100, 
with 0 indicating the poorest health and 100 indicating 
the best health. Two summary scores for physical health 
and mental health were calculated by weighting each 
subscale score with standard coefficients, then aggregat-
ing the weighted scores across subscales, which were 
also scored out of 100 (12). These summary scores were 
the principal outcomes used from the MOS-HIV. 
The physical health score comprises the physical 
function, pain, role function and social function sub-
scales, with a smaller component from the energy and 
general health perceptions subscales. The mental health 
score comprises mostly mental health, health distress, 
quality of life, cognitive function and energy subscales, 
with smaller contributions from social function and 
general health perception subscales. Both scores are 
standardised so that the mean is 50 and the standard 
deviation is ten (12). Point differences of three to five 
are considered clinically significant (11). 
APCA African POS: For the APCA African POS, 
the scores for the first three items (pain, symptoms and 
worry) were reversed so that for all items, zero repre-
sented the worst situation and five the best. Three items 
are addressed to the main carer of the patient. The POS 
is designed to be a multidimensional scale for progres-
sive disease (13) and it is unlikely that all the items form 
a single factor. The POS items are commonly used sepa-
rately for clinical audit (5). In this study, data from the 
instrument were used to give more detailed information 
on the problems of participants attending care facilities, 
and a total score was created using the seven patient 
items, but because of its limitations as a single scale it 
was not used as one of the main outcome variables.
4.1.2—Section A: Cross-Sectional Descriptive 
Analysis
Facility Characteristics
1. What are the six facilities like in terms of infrastructure and care offered?
Information from the cross-sectional survey in 
Phase 1 of the evaluation was used to provide a sum-
mary of facility characteristics for the six Phase 2 
facilities. The location, number of patients per year, type 
and referral system for inpatients, number and type of 
fulltime, part-time and volunteer staff at each facil-
ity, and the components of care offered were detailed. 
This information was self-reported by a small group of 
senior staff at each facility. 
4
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Participants and Interview Numbers
2. How many people were there in the study? 
3. How far apart were the interviews?
4. How many people dropped out and why did they leave?
Time points were designated T0 (study entry or 
baseline), T1, T2 and T3. Ideally these would each be 
one month apart but any data collection within two 
weeks either side of that point was acceptable, in order 
to minimise the burden of additional travel for par-
ticipants. Some recoding of timepoints took place. If 
a participant was recorded to have completed T0, T2 
and T3 but missed T1, then T1 was deleted from the 
record and T2 and T3 were renumbered T1 and T2, to 
obtain a continuous series of three points. Compressing 
timepoints in this way made the most efficient use of 
the data. 
An alternative would have been to consider that 
timepoint was defined by time elapsed since T0, rather 
than by number of interviews completed. However, 
as explained above, the time between interviews was 
not precisely one month and in some cases was con-
siderably more. Using exact time as the definition of a 
timepoint would have necessitated either renumbering 
some interviews to T4, T5 and so forth, or dropping 
them from analysis. 
The median, maximum, minimum and inter-quar-
tile range for time between interviews was calculated. A 
flowchart was produced indicating the loss to followup 
at each data collection point. The number of people 
recruited, completion rate and mean time between 
interviews was tabulated by facility.
Participant Characteristics
5. What kind of patients come to these six facilities for PEPFAR Care &  
Support services?
6. How long have they known they were HIV-positive?
7. Why do they come?
8. How advanced is their HIV disease?
The study group was described in terms of age, 
gender, number of dependants, and reason for attend-
ing the facility. The length of time between the date 
of HIV test result and the beginning of the study was 
calculated. 
The variables from the demography questionnaire 
which related to socioeconomic status were incorpo-
rated into a principal components analysis to generate a 
single factor. This factor was then split into five quin-
tiles of equal size, to create a categorical variables for 
relative wealth (14). The socioeconomic variables were 
presented by wealth quintile to portray the characteris-
tics of each level of relative wealth.
The variables included were those used in the 
DHS surveys: (a) material used to make the walls/roof/
floor of the house; (b) type of toilet; (c) main source 
of drinking water; (d) fuel used for cooking; and (e) 
household ownership of car/bicycle/refrigerator/televi-
sion/mobile phone/radio.
Reason for attending the facility was a closed 
question in the demography questionnaire. Individuals 
whose HIV test date was in the 14 day period prior to 
joining the study were recoded so that their reason for 
attending was ‘new HIV test result’. A free text option 
was provided for those who reported they came because 
of referral, a new illness or for another reason. The 
answers in the free text boxes were used to recode some 
responses. In particular, those who reported that they 
had been referred from VCT were recoded as having an 
HIV test result. Reason for joining were tabulated and 
presented by percentage.
CD4 count is the best measure of the progression 
of HIV disease commonly in use. CD4 count was used 
for two purposes: to establish a baseline measure of 
HIV disease severity at the time of the study, and to 
observe change in CD4 count over the course of three 
months. During data collection it was discovered that 
very few participants had two CD4 counts so close 
together to enable the examination of change over the 
course of the study. The first purpose of CD4 count 
(i.e., measure of disease severity) accordingly came to 
be the main one. 
Available CD4 count data was categorised by time. 
CD4 T1 was fixed within the range from one year prior 
to the beginning of the study (T0) to the time of the 
second interview, designated T1. CD4 T3 was in the 
range from the third interview (T2) to three months 
after T3. These time ranges were set after consulta-
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tion with clinicians as to the rate at which CD4 count 
changed over time and assessment of the data available 
in patient records. It was important to get a valid count 
from as many people as possible. If the time period was 
too short not enough counts would be included, and if 
it was too long the result would no longer be valid. To 
balance these competing demands, one year before T1 
was agreed as the boundary. 
For those individuals who had two CD4 counts to 
compare, change in CD4 counts from T1 to T3 was 
analysed using a paired t-test. The two other measures 
of illness severity, WHO stage and ECOG physical 
function score, were also analysed. ECOG at the begin-
ning of the study was tabulated and WHO stage at 
each timepoint was presented by facility.
Care Participants Received
9. What kinds of Care & Support do people receive?
10. What kind of care do they get from the PEPFAR-funded health facility 
and what do they get from other places?
11. What are the five categories of PEPFAR Care & Support?
12. Which of these five categories are people most likely to get?
13. What care do people get immediately after being diagnosed HIV 
positive?
14. What is the Preventive Care Package and how many people get it?
The frequency of ever receiving each of the 52 care 
components listed in the CSRI was calculated. People 
who responded “don’t know” when asked whether they 
received a component of care were grouped in the “no” 
category. Care receipt was reported separately for com-
ponents received at the study facility and those received 
elsewhere. The main figures presented were proportion 
receiving a care component at a particular time point 
(as a percentage of those completing the timepoint), 
and proportion ever receiving the care component (de-
fined as receiving it at least once and up to four times, 
calculated as a percentage of all study participants).
PEPFAR Care & Support services consist of five 
categories: clinical, psychological, spiritual, social and 
preventive care. The 52 components were ordered into 
these categories based on existing guidelines (15) and 
the percentage of people receiving each category was 
calculated. 
The 267 participants (of 696) whose positive HIV 
test took place in the two weeks before entering the 
study were analysed separately in order to explore the 
care which newly diagnosed people received. 
PEPFAR encourages the development of a coun-
try-specific Preventive Care Package (PCP) of prophy-
lactic items such as ITNs, water filters and multivita-
mins. In Uganda a five-item PCP has been evaluated 
and is being rolled out across the country. Kenya has 
not produced a definitive list of PCP items, so the 
Uganda PCP was used in this study. The five elements 
of the Uganda Preventive Care Package were examined, 
for newly registered patients (who should be assessed 
for need of each component) and existing patients.
Care Themes
15. What kind of problems do care components address?
16. What are the themes and patterns of care provision? 
17. How many people get antiretroviral therapy and how regularly do they 
get it?
18. How many people get CTX and do they take it every day?
Care components were grouped into themes ac-
cording to the issues they addressed and the way in 
which they were provided. This approach allowed more 
detailed analysis of the relationships between care com-
ponents. The care themes were also used in later analy-
sis as an average of the number of people receiving care 
by facility. For this section, components of care which 
were very rare (received by fewer than 10% of par-
ticipants at any time) were removed from the themes, 
because as outliers they could have unwarranted effects 
on the results. Each care theme was tabulated. Further 
analysis is described below by care theme.
Spiritual: Involves a visit by a religious leader, 
prayer with patients, and contact with traditional healer. 
Spiritual care is a distinct aspect of PEPFAR Care & 
Support. Staff praying with patients and a visit from a 
religious leader are the most common types of spiritual 
care provided through health facilities in Kenya. Many 
people with HIV visit traditional healers (16) and the 
care delivered by them fits the PEPFAR definition of 
spiritual care being sensitive to individual and commu-
nity culture (15).
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Counselling and Advice: Involves pre-and post-
test counselling, adherence counselling, family plan-
ning counselling, patient HIV support groups, family 
counselling and psychiatric therapy. This theme com-
prises all “talking therapies.” It is sometimes difficult to 
distinguish counselling as listening and responding to 
the patient’s worries and concerns from counselling as 
didactic imparting of information. VCT, for example, 
is a strategy of both prevention and care, assessed for 
its efficacy in reducing risk behaviour and HIV trans-
mission (17). While these are valuable goals, they are a 
departure from the usual purpose of counselling which 
is improved health for the individual.
Nursing: Involves wound care and other nursing 
care. Nursing is a specific discipline and its status may 
vary between facilities. 
Pain Management: Is an assessment of pain and 
provision of strong and weak opioids or non-opioid 
analgesics and treatment for neuropathic pain. Pain 
is a common symptom in HIV (18) and all five com-
ponents in this theme are necessary for its relief. The 
WHO pain ladder (19) outlines the need for non-opi-
oid and opioid analgesics until pain has been controlled. 
Neuropathic pain, which is particularly common in 
HIV (20) is caused by damage to nerves and does not 
respond to traditional, non-opioid and opioid analgesic 
pain medication. 
Symptom Management: Involves treatment for 
anxiety/depression, nausea/vomiting, skin rash/itching, 
diarrhoea, laxatives, thrush, oral candidiasis, cryptococ-
cus, other fungal infections, herpes, malaria and other 
opportunistic infections. 
The components in this theme were usually defined by 
the symptom treated, rather than the underlying cause 
or pathogen, because the cause of a symptom is often 
not known in HIV disease (21). All these physical 
symptoms and conditions are common in HIV (21, 22).
Nutrition: Includes food, multivitamins, nutritional 
advice, safe drinking water, therapeutic feeding for mal-
nutrition. As part of Phase 1 of the evaluation, patient 
focus group discussions revealed that food was one of 
the most commonly requested components of care. Poor 
nutrition comprises two problems: lack of macronu-
trients (wasting, malnutrition) and lack of micronutri-
ents (vitamins and minerals). Both of these predispose 
individuals with HIV to infections and ill health. Lack 
of food is the most fundamental level of poverty.
Social: Involves employment training/income 
generation activity (IGA), home help, household items, 
legal services, memory book work, loans/microfinance. 
The social theme components were selected after advice 
from USG country mission teams. Phase 1 qualitative 
data indicated that the purpose of IGA and microfi-
nance programmes was not only to increase income for 
families, but to reverse the myth that people with HIV 
are incapable of acting for themselves. Memory book 
work was allocated to the social care theme because it 
aims to reduce internalised stigma and improve rela-
tions between family members.
Prevention: Involves prevention with positives, con-
doms, ITNs, infection control training, isoniazid for TB 
prophylaxis. This theme includes both components to 
protect the person with HIV from other infections, and 
components to prevent them from infecting others with 
HIV. Prevention with positives is the general name 
for a package of care designed to encourage behaviour 
change (condom use, reduction of partners, and reveal-
ing HIV status). Condoms prevent further infection 
and also protect the individual from other strains of 
HIV and from other STIs such as herpes. Insecticide-
treated nets protect against malaria, which is more 
common and more aggressive in people with HIV (23), 
and the TB drug isoniazid can be used as a prophylactic 
for those at high risk of TB. 
ART: Involves ARVs and assessment of ARV 
treatment. Antiretroviral therapy consists of more 
than ARVs. It includes regular assessment to observe 
signs of developing resistance, toxicity and side effects. 
Receipt of antiretroviral therapy was tracked over time 
using a decision tree. Receipt of ARVs and of assess-
ment was compared by facility and timepoint. 
CTX: CTX is a broad-spectrum antibiotic proven 
to reduce morbidity and mortality in people with HIV 
(24, 25). At each interview participants were asked 
whether they had taken CTX on the previous day and 
whether they had been given daily prophylactic CTX 
in the last month. These answers were compared to test 
adherence.
TB: TB treatment was listed separately from 
treatment for other symptoms and infection, for two 
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reasons. Firstly, it is the leading cause of death for 
people with HIV in Africa (26). Secondly, the course 
of treatment lasts for four to six months, long after 
symptoms have resolved. The full course of treatment 
must be completed to prevent resistance and recurrence. 
TB testing was not included as it would not, in itself, 
improve outcomes. 
Health at the Beginning of the Study
19. What level of physical and mental health do people have at the 
beginning of the study?
20. What kinds of multidimensional problems do people have?
21. What needs do informal caregivers and family members have?
Physical and mental health summary scores were 
calculated from the MOS-HIV as described above. 
The summary scores at the beginning of the study were 
grouped into blocks of 50 to present as histograms, and 
analysed for mean, median and standard deviation. 
Multidimensional problems were collected in 
the APCA African POS. Each of the seven patient-
completed items was graphed individually and all items 
were analysed for median and inter-quartile range. 
These were used rather than the mean and standard de-
viation because scores were not expected to be paramet-
ric. The scores of the seven patient items were added 
together to create an APCA African POS total score, 
which was presented as a histogram.
How Participants Differ by Facility
22. Do the six facilities care for different kinds of people?
23. Are the people at some facilities more ill than at others?
24. Do people at different facilities get different kinds of care?
25. Do people at different facilities get all the five categories of PEPFAR Care 
& Support?
26. Are people at some facilities more likely to get care from elsewhere? 
27. How do physical health and mental health vary by facility?
The demographic characteristics of participants 
were compared according to the facility with which 
they were registered. Gender split, mean age, median 
number of dependants and median time to travel to 
the facility were compared visually. Relative wealth and 
reason for attending were tabulated by facility. Illness 
severity was explored by tabulating ECOG scores and 
mean CD4 count by facility.
The mean, standard deviation, minimum and 
maximum number of care components received by in-
dividuals at each facility was calculated, along with the 
proportion of participants by facility receiving each of 
the 52 components of care. The proportion of partici-
pants ever to receive each of the five PEPFAR C&S 
categories was compared between the six facilities. The 
proportion of participants receiving care from the facil-
ity and from elsewhere was also calculated by facility, 
and a series of stacked bar charts was produced show-
ing the mean number of care components received from 
each location by facility and time. Finally, mean and 
standard deviation of physical and mental health scores 
and total APCA African POS scores were calculated at 
baseline for each facility, and the extent of the differ-
ence was analysed using Kruskal Wallis tests.
Participant Characteristics and Health
28. Do men and women have the same physical and mental health?
29. Do older people have the same physical and mental health as younger 
people?
30. Does education or wealth make a difference to physical and mental 
health?
31. Do people whose HIV is more advanced have worse physical or mental 
health?
32. Do people receiving ART or TB treatment have different physical or 
mental health?
33. Do patients accompanied by a carer have different physical or mental 
health?
The association of baseline physical and mental 
health with demographic characteristics was analysed 
using appropriate statistical tests, with a significance 
level of 5% throughout. Mean health scores for men 
and women were compared using t-tests. The ordinal 
variables, education, and wealth quintile, were analysed 
using ANOVA, and the continuous variable age was 
analysed using linear regression. 
CD4 count at T1 was used to represent illness 
severity. CD4 count was converted into an ordinal 
variable with four categories which are most com-
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monly referred to for clinical decision-making (27) and 
epidemiological studies (28). The categories were (a) 
0–50: increased mortality risk (29); (b) 51–200: severe 
immunosuppression; (c) 201–350: immunosuppres-
sion; and (d) above 350. The association of health scores 
with CD4 category was analysed using ANOVA. In 
addition, linear regression was used to identify whether 
mental health was associated with CD4 count after 
controlling for physical health.
Mean physical and mental health, with standard er-
ror, was calculated for people who received antiretrovi-
ral therapy at T1 compared to those who did not. CD4 
counts for T1 (and the year preceding it) were also 
compared according to receipt of ART. The hypothesis 
was that in this observational, non-randomised study 
of an outpatient population, participants not receiving 
ART would be those in earlier stages of illness who had 
not yet been prescribed it. Accordingly, people receiv-
ing ART at T1 would have a lower CD4 count (which 
is one of the criteria for beginning ART), and lower 
physical and mental health due to their more advanced 
disease. These hypotheses were tested using t-tests with 
a 5% significance level. The same analysis was repeated 
for TB treatment.
It was hypothesised that participants with lower 
physical health would be more likely to be accompanied 
by a carer, but the same would not be true of mental 
health. To test this hypothesis, linear regression was 
used to separate the associations of carer presence with 
physical and mental summary scores at T0. 
4.1.3—Section B: Longitudinal Analysis
Longitudinal multilevel modelling is an approach 
which makes the most efficient use of data collected 
over time. Unlike most statistical tests, longitudinal 
modelling includes all timepoints at once, which both 
reduces the number of tests to be carried out (making 
false positive results less likely) and allows change to be 
modelled as a continuous effect. This means that rather 
than simply finding variables which are associated with 
any change in outcome, the magnitude of the change 
can also be considered. 
A common problem in longitudinal studies of 
health outcomes is that patients with the worst health 
are the most likely to be lost to follow-up, so that a 
comparison between the beginning and end of the 
study could find improved outcomes only because a 
proportion of those with poor health would not con-
tribute to the later timepoint. Longitudinal analysis 
does not have this bias because all participants can be 
included whether they complete the study or not. 
Additionally, longitudinal analysis can reveal pat-
terns over time which would not be identified using 
traditional methods such as t-tests. For example, in this 
population a cross-sectional study at any time would 
have found that people with greater relative wealth had 
higher health scores. Longitudinal analysis showed that 
although this was true, wealth was not associated with 
change in outcomes over time. Rich and poor gained 
equally from the care they received, and the difference 
in health scores was due to poorer participants arriving 
at the facility with a lower level of health, not to any 
disparity in care.
The technique adopted in this study was multilevel 
mixed-effects linear regression, selected because it al-
lowed data to be clustered at two levels, by individual 
and by facility. 
34. Were people with worse health at the beginning of the study more likely 
to drop out?
The question of whether people with lower health 
scores at the beginning of the study were more likely 
to be lost to follow-up was a very important one. Many 
longitudinal studies suffer from the bias caused by the 
most unwell individuals being most likely to leave the 
study. To determine whether this bias was present, 
t-tests were used to compare the mean physical and 
mental health scores of those who completed all four 
observations with those who missed at least one. Tradi-
tional analysis of longitudinal data involves comparing 
the earliest observation with the last, so any difference 
in the scores of completers versus non-completers 
would bias the findings.
In addition, the same tests were used to compare 
the mean scores of those who only completed a single 
observation with those who completed two or more. 
This was to test the suitability of multi-level modelling, 
which is explained below. Multi-level modelling uses 
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all data points except the first one, so anyone who only 
completed one observation would be excluded and it was 
necessary to test whether this would also cause a bias.
Changes in Health Over Time
34. On average, does participants’ health improve, stay the same or get 
worse during three months of care?
35. On average, do participants’ multidimensional problems improve, stay 
the same or get worse?
36. Do the people with the worst physical and mental health at the 
beginning of the study get better, stay the same or get worse?
37. Do all six facilities find their participants’ physical and mental health 
changes by the same amount?
Mean, standard deviation and 95% confidence intervals 
of physical and mental health at each timepoint were 
calculated and graphed. The change in mean health 
score from T0 to T3 was calculated, with its standard 
deviation, and checked for clinical significance. 
Comparing mental and physical health score change 
at different facilities was accomplished using graphs 
rather than statistical analysis, because graphs were suf-
ficient for the purpose and provided clarity on exactly 
how facilities varied. Change in outcomes over time 
was calculated separately for each participant at each 
timepoint. Mean change over time was reported as the 
mean of all individual score changes, rather than mean 
health score at one time point subtracted from mean 
health score at another. For example, mean change in 
mental health score from T0 to T2 was derived by find-
ing the change in health score for each person who had 
completed both T0 and T2, and then taking the average 
of these, rather than by subtracting mean mental health 
at T0 from mean mental health at T2. This method 
removes the risk of bias due to non-response. 
To test whether physical and mental health sum-
mary scores changed significantly over time throughout 
the course of the study, a multilevel modelling method 
was adopted (30). The methods are detailed in Ap-
pendix I. This analysis was repeated with the 20% of 
participants (n=128) who had the lowest physical health 
score at T0, and with the 20% who had the lowest men-
tal health score at T0, to determine whether the effect 
of improved outcomes over time extended to those in 
greatest need. For the APCA African POS, score dis-
tribution at each timepoint was tabulated for those who 
scored 0 (worst possible problem) on the items relating 
to pain and symptoms. This simple approach was ad-
opted because very few people scored 0 on these items 
and mean scores could have been biased by a single 
outlier. The items for pain and symptoms were selected 
because people with complex, intractable problems in 
advanced disease may not experience improvement 
although average scores for the population increase.
Changes in Health Over Time in Detail
38. Do men and women experience the same improvements in physical 
and mental health?
39. Does, age, education or wealth have any effect on whether a person’s 
physical and mental health improves?
40. Do people taking ART or having TB treatment experience the same 
improvement in physical and mental health as people who don’t?
41. Does being at a facility which offers certain kinds of care have an effect 
on whether physical and mental health improves?
Differences between Individuals
To identify whether demographic variables were associ-
ated with different changes in physical or mental health 
over time, the multi-level models developed earlier were 
now rerun with the addition of each demographic vari-
able (age, gender, education level and wealth quintile), 
one by one. The models were run exactly as before, 
except that each contained one demographic covariate. 
This process of univariate analysis was adopted because 
it is more careful and the methods were new, to remove 
the risk of finding unwarranted associations. Education 
level and wealth quintile were treated as continuous 
variables for this analysis, because each of them had 
enough categories of sufficient size to approximate to a 
continuous distribution. 
ART and TB treatment were considered particu-
larly important variables to model over time, for several 
reasons. Both of them must be maintained over time 
(for TB treatment, usually for six months; for ART, 
usually indefinitely), both of them are lifesaving treat-
ments which are associated with side effects, possible 
drug resistance, and the need for monitoring. Multi-
level models were developed to show the association 
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of physical and mental health with ART and with TB 
treatment over time. 
These covariates, unlike any others studied so far, 
varied over time. Time-invariant characteristics such as 
age and relative wealth were only measured once and 
remain constant for each individual. Care availability, 
discussed below, is constant by facility. By contrast, 
receipt of ART or TB treatment was elicited at ev-
ery timepoint and so each of the (maximum of three) 
observations an individual contributes to the model has 
its own value. 
It was necessary to include CD4 count at T1 in the 
model as well, because previous analysis had shown that 
CD4 count was lower in people receiving ART or TB 
treatment at T1, and it was possible that any effect on 
health scores could be confounded by lower CD4 count 
and its consequences. The intention had been to analyse 
CTX using the same techniques, but this was not car-
ried out because CTX provision reached almost 100%, 
meaning that those few individuals who for some 
reason did not receive it could have been different from 
the rest in ways which would bias the findings. 
Differences between Facilities
Examining the relationship between health outcomes 
and care received was complicated by the potential bias 
that those in the worst health would probably receive 
the most care, whereas a lack of care could mean either 
no need of it, or lack of appropriate provision. To avoid 
this problem, a variable representing available care 
needed to be developed, which might have a closer 
association with health outcomes than the level of care 
individually received. Availability of care was defined as 
the percentage of individuals at a facility who received 
care in a particular theme. Care themes were used rath-
er than individual components in order to reduce the 
number of variables needed in the model and ensure 
stability. For example, the variable “psychological care,” 
contains information on the percentage of people, per 
facility, who received at least one component of psycho-
logical care at T1, T2 or T3. T0 was excluded because 
the model analysed change from T0 onwards.
Each of the eight remaining care themes (coun-
selling/advice, nursing care, spiritual care, prevention, 
nutrition, social care, pain management and symptom 
management) were included one by one in a univariate 
multi-level model to identify which ones were as-
sociated with mental or physical health over time. As 
before, multilevel mixed-effects linear regression was 
used with repeated measures at the individual level and 
individuals clustered within facilities. The outcomes 
were mental health score and physical health score. 
Additional covariates included the baseline value of the 
other outcome variables (i.e., if mental health score was 
the outcome of the model, both T0 mental health score 
and T0 physical health score would be individual-level 
covariates) and any demographic covariates which had 
been identified as associated with the outcome. Both 
T0 outcome scores were included because a separate 
piece of analysis (Appendix I) showed that the two 
scores were closely associated and that in some cases an 
apparent association with mental health score was in 
fact entirely confounded by physical health score. 
All variables had fixed coefficients, with the excep-
tion of interview number which was allowed to vary at 
the individual level. All individual-level and facility-
level covariates which were associated with outcome at 
the 10% level in univariate analysis were taken forward 
into a multivariate model and eliminated in a downward 
stepwise procedure if the association was lost. It is usual 
to use 10% as the acceptance level with stepwise down-
ward regression to avoid dismissing variables too early. 
4.2—Qualitative Interviews
The interview transcripts were imported from Word 
into NVivo 7 for coding and analysis. Information on 
interviewees’ age, gender, household location, family 
size, profession (for staff ), relationship to patient (for 
carers) and whether they were receiving ART (for pa-
tients) was extracted into an Excel table, subsequently 
imported into NVivo. Identifying information such as 
names of individuals or care facilities was removed from 
transcripts. Thematic analysis of content was conducted 
concurrently on the patient, carer and staff interviews to 
enable multiple perspectives on each coded theme. 
42. How do facilities provide HIV care and what is the nature of the care 
they provide?
43. What is the experience of participants receiving care and their families?
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4.2.1—Development of Coding Frame
Two coding frames were developed and subsequently 
combined into a single version used for the remainder 
of the coding. One coding frame was developed in 
Kenya by the team of APCA researchers at KEHPCA 
who had conducted the interviews. The other coding 
frame was developed at KCL in London. The intention 
was to explore cross-cultural differences and similarities 
in coding. 
In both three-person teams, each researcher coded 
eight randomly selected interviews (three with a 
patient, three with a member of staff and two with a 
carer), creating hierarchical codes. The team members 
agreed on a coding frame by discussion, comparison 
and consensus. At a meeting in Kampala, Uganda, the 
two coding frames were compared and found to be 
similar in many respects. A unified coding frame was 
developed, combining the strengths of both country-
level frames. Each code was reviewed for internal con-
sistency and given an agreed definition to ensure it was 
applied using a standard meaning by each researcher. 
The Kenya researchers were trained in the use of NVivo 
7 and in application of the new coding frame, which 
was applied to the entire dataset.
Each of the APCA researchers coded three inter-
views which were checked for consistency at KCL. The 
APCA researchers then proceeded to code all remain-
ing interviews. 
4.3—Costing Study
44. What is the cost of supplying the HIV care received by study 
participants?
45. What are the main cost drivers of HIV care and support?
46. Are there economies of scale in HIV care and support delivery?
The costing study makes it possible to understand what 
factors influence costs per patient. For example the 
capital costs of rural facilities might be expected to be 
less than those in urban settings. Similarly if a facility 
tends to use relatively inexpensive providers it may be 
less expensive in providing the same service as a facility 
that has lots of trained physicians. Facilities that do 
not provide ART or do not provide testing may also 
have lower costs per patient. We might also expect to 
observe economies of scale with larger facilities (judged 
by numbers of patients) registering lower per patient 
costs than smaller ones.
Another possible use of costing data is to guide re-
source allocation. If two programmes have similar out-
comes but different costs it may be possible to reallo-
cate resources to the lower cost programme with no loss 
in health benefits or the less efficient programme might 
change the way it allocates resources so as to emulate 
the more efficient programme. This cost-effectiveness 
analysis, however, was not part of the present study.
Analysis was carried out using an Excel spread-
sheet. Most data were collected in local currency (Ke-
nyan shillings), and converted to US dollars at the cur-
rent exchange rates. Since only six facilities per country 
were included and these facilities were not meant to be 
statistically representative, all results are reported per 
facility without aggregation across the sample. The av-
erage costs per patient for one year of care and support 
were calculated using aggregated average costs per pa-
tient for each of the main components of care for a year. 
Scatter plots of per-staff member patient load against 
staff costs, and of per-patient costs against number of 
patients, were used to investigate economies of scale.
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5.1—Facility Characteristics
The facilities taking part in Phase 2 of this PHE also 
took part in Phase 1 (the facility survey). Phase 1 data 
collection took place between April and August 2007. 
Some of the key results from Phase 1 are presented 
here to provide context with respect to the nature and 
scope of HIV care and support provision at the Phase 2 
facilities. 
Of the six facilities taking part in Phase 2, all but 
one were government-run facilities (Table 1). Three 
facilities were secondary or tertiary hospitals, two were 
district hospitals, and one was a non-governmental 
health centre. The facilities had between 1126 and 5975 
HIV positive patients registered in 2008, of whom 
between 246 and 796 were newly registered in that 
time. Registered HIV patients were between 25.8% and 
48.2% male.
All facilities had full time doctors, although four 
facilities did not have any specialist spiritual staff and 
four did not have any specialist psychological staff. Five 
facilities had a small number of volunteer staff, and one 
facility employed 40 of their 99 staff members on a 
voluntary basis. All facilities provided between 50 and 
54 of the 69 components of care examined. Facilities 
157, 159, and 160 all provided at least one component 
of care under each domain of the PEPFAR care and 
support guidelines (clinical, psychological, spiritual, 
social and prevention). 
Table 2 shows facilities’ self-reports of the care 
components they provided, either directly or by re-
ferral. “Yes” has been abbreviated to “Y” to make the 
other responses stand out more clearly. Most symptom 
management care components were reported at all 
facilities, but social care and opioid drugs were often 
not reported.
Table 3 shows the number of staff of several key 
professions working at each facility as reported in Phase 
1. Fulltime, part-time and volunteer staff were reported 
separately. Facilities 156, 157 and 159 had large num-
bers of fulltime clinical staff, while only Facilities 155, 
158 and 160 employed community health workers. 
5.2—Participant and Interview Numbers
Of the 728 patients approached to participate at the 
six facilities, 696 gave consent and were recruited to 
the study (response rate=95.6%). Of the 696 partici-
pants recruited, 634 (91.1%) completed more than one 
interview and 592 (85.1%) completed all four. The most 
common reason given for leaving the study was leav-
ing the facility (attributed to 30 of the 104 participants 
who were lost to follow up). Figure 1 displays the loss 
to follow-up over time, after recoding of timepoints as 
described in the Methods section. The median (IQR) 
number of days between each subsequent interview 
was 28 (28–31). The responses by interview month and 
facility are shown in Table 4.
5
Table 1: Characteristics of Facilities
Facility Type Location No. Patients in 2007 No. New Patients in 2007
155 HIV clinic of public hospital Rural N/K 246
156 HIV clinic of public hospital Urban 3031 377
157 HIV clinic of public hospital Urban 4334 463
158 NGO Urban 1126 796
159 HIV clinic of public hospital Urban 4963 547
160 HIV health centre Rural 5975 422
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Table 2: Facility Self-Reported Care Provision from Phase 1 Survey
Type Component of Care Service Provided
Facility 155 156 157 158 159 160
General clinical 
 
 
 
 
 
Nursing care Y Y Y Y Y Y
ARVs Y Y Y Y Y Y
Weighing Y Y Y Y Y Y
Assess ARV treatment failure Y Y Y Y Y Y
Monitor ARV toxicity Y Y Y Y Y Y
Wound care Y Y Y Y referred Y
Physiotherapy Y Y Y No referred Y
Pain management
 
 
 
Assessment of pain Y Y Y Y Y No
Strong opioids No No No No No No
Weak opioids No No No Y No No
Non-opioids Y Y Y Y Y Y
Treatment for neuropathic pain Y Y Y Y Y Y
Symptoms
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Anxiety/depression treatment Y Y Y Y Y Y
Treatment for nausea/vomiting Y Y Y Y Y Y
Treatment for skin rash/itching Y Y Y Y Y Y
Treatment for diarrhoea Y Y Y Y Y Y
Treatment for constipation/laxatives No Y Y Y Y Y
Treatment for thrush Y Y Y Y Y Y
Treatment for oral candidiasis Y Y Y Y Y Y
Treatment for cryptococcus Y Y Y Y Y Y
Treatment for other fungal infections Y Y Y Y Y Y
Treatment for herpes Y Y Y Y Y Y
Treatment for malaria Y Y Y Y Y Y
TB detection Y Y Y Y Y Y
TB treatment Y Y Y Y Y Y
Therapeutic feeding for malnutrition Y Y Y Y Y referred
Treatment for other 
opportunistic infections
Y Y Y Y Y Y
Management of cancer referred Y referred Y Y Y
Psychological
 
 
 
 
 
 
Pre- and post-test counselling Y Y Y Y Y Y
Adherence counselling Y Y Y Y Y Y
Family planning counselling Y Y Y Y Y Y
Patient HIV support groups Y Y Y Y Y Y
Family care-givers support group No Y Y Y No No
Family counselling Y Y Y referred No Y
Psychiatric therapy referred Y Y No referred referred
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Table 2: Facility Self-Reported Care Provision from Phase 1 Survey
Type Component of Care Service Provided
Facility 155 156 157 158 159 160
Spiritual
 
 
Visit by faith leader No No No No Y No
Prayer with patients No Y Y No No Y
Contact with traditional healer No No No No No No
Social
 
 
 
 
 
 
 
 
Home help Y No No No No No
Transport to care centre Y No No Y Y Y
Employment training Y No No Y Y Y
Provide household items Y No No referred No No
Legal services No No Y No No referred
Memory book work No No No No No No
Family home help Y No No No No No
Loans/microfinance No No No No No Y
Infection control training Y Y Y Y Y Y
Prophylaxis/ 
preventive care
 
 
 
Support for family testing Y Y Y Y Y Y
Prevention with positives Y Y Y Y Y Y
Multivitamins Y Y Y Y Y Y
Nutritional advice Y Y Y Y Y Y
Access to safe drinking
 water at home
Y No Y Y Y No
CTX Y Y Y Y Y Y
Isoniazid No No No Y No Y
Condoms Y Y Y Y Y Y
ITNs No No No Y No No
Laboratory
 
 
Malaria film Y Y Y Y Y Y
AFB smear Y Y Y Y Y Y
CD4 count test Y Y Y Y Y referred
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Table 3: Staff Working at Each Facility (FT=full-time, PT=part-time, Vol=volunteer)
Facility 155 156 157 158 159 160
Staff Type FT PT Vol FT PT Vol FT PT Vol FT PT Vol FT PT Vol FT PT Vol
Doctor 2 0 1 51 0 0 20 0 0 2 2 0 16 0 0 1 0 0
Clinical officer 10 1 0 24 0 0 22 0 0 5 0 0 30 0 0 16 0 0
Nurse 48 0 0 294 0 0 216 0 0 25 0 0 124 0 0 26 0 0
Lab staff 5 0 0 15 0 0 19 0 0 5 0 2 5 0 0 4 0 0
CHW 4 2 2 0 0 0 0 0 0 10 0 30 0 0 0 0 30 0
Social worker 0 0 0 1 0 1 2 0 0 0 0 0 2 0 0 2 0 0
Spiritual leader 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0
Nutritionist 1 0 0 5 0 0 7 0 1 2 0 0 4 0 0 2 0 1
Counsellor 0 0 0 0 0 0 0 0 0 3 0 8 0 0 0 7 0 0
Physiotherapist 1 0 0 8 0 0 5 0 0 0 0 0 6 0 0 1 0 0
Table 4: Participant Numbers and Interview Details
Facility
Total
155 156 157 158 159 160
No. recruited, baseline (T0) 109 111 120 120 125 111 696
No. completing two timepoints 107 105 106 107 104 105 634
No. completing three timepoints 106 104 100 102 101 100 613
No. completing four timepoints 103 101 100 93 99 96 592
No. dropouts 6 10 20 27 26 15 104
Mean time between interviews (days) 28.6 28.2 30.2 32.6 31.4 30.5 30.2
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Figure 1: Flowchart of Study Participation
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Table 4 shows that the loss to follow-up was high-
est at facilities 158 and 159. These facilities also re-
cruited more participants than average. All facilities had 
a mean time between interviews that approximated one 
month (range 28.2–32.6 days).
5.3—Participant Characteristics
5.3.1—Demography
Participants were 31% male. Participants’ mean age 
was 34.6 years (sd 9 years, range: 18–69 years). Female 
participants were on average slightly but significantly 
younger than male participants, with a mean of 33.4 
years compared to 37.2 years (t=10.00, p<0.01). The age 
range of female participants was also younger (18–64 
years) than males (21–69 years). The age distribution of 
participants is shown in Figure 2.
Participants travelled for a median of 60 minutes 
(IQR 30–90 minutes, range from two minutes to 12 
hours) to attend the facility and had a median of three 
dependants (range=0–18). Women had on average 3.3 
dependants and men 4.6.
For the majority of the population, the highest 
education level attended was primary (53.6%, Table 5). 
Approximately a third of respondents lived in homes 
with walls made of thatch/mud and pole walls and 
another third with stone/burnt bricks walls. The major-
ity of participants’ houses had cement/concrete floors 
(55.8%), and corrugated roofs (82.3). The most com-
mon water source was pipe-borne outside the house 
(38.1%), and fuel source was firewood (48.9). Nearly 
half (47.4%) of participants lived in a house with a 
private latrine.
5.3.2—HIV Diagnosis and Reason for Attending 
the Clinic
At the first interview, participants gave their reason for 
coming to the facility that day (Table 6). Participants 
who reported the date of their HIV positive diagnosis 
within the 14 days prior to beginning the study were 
coded as coming because of a new HIV test result. This 
was done because some facilities recorded these people 
as referred from VCT.
The reason most commonly given by participants 
for attending the clinic was because they had recently 
Figure 2: Age of Participants
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Table 5: Population Demographic Characteristics
Population Characteristic N (Total=696) % Population Characteristic N (Total=696) %
Highest Level of Schooling Attended Wall Material
None 21 3.0 Thatch/mud and poles 234 33.6
Began Primary 373 53.6 Mud/unburnt bricks 39 5.6
Began secondary 249 35.8 Metal sheet/cement block 179 25.7
Diploma + 52 7.5 Stone/wood/burnt bricks 244 35.1
Floor Material Roof Material
Earth 291 41.8 Natural 78 11.2
Cement/concrete 388 55.8 Corrugated iron 572 82.3
Other finished 17 2.4 Finished 45 6.5
Source of Drinking Water Fuel Source
Pipe-borne inside/bottle 79 11.4 Electricity/gas 34 4.9
Pipe-borne outside 265 38.1 Paraffin/coal 122 17.5
Other, safe 138 19.8 Charcoal 200 28.7
Other, unsafe 214 30.8 Firewood/straw/grass 340 48.9
Personal Property Type of Toilet
Car 82 11.8 Private flush 74 10.6
Bicycle 25 39.5 Private latrine 330 47.4
Fridge 84 12.1 Public/shared/outside 292 42.0
T.V. 317 45.6
Mobile Phone 522 75.0
Radio 609 87.5
Table 6: Reasons for Attending Facility at Recruitment to 
Study
Participant-Reported Reason N (%)
HIV diagnosis within past two weeks 267 38.4
HIV diagnosis more than two weeks ago 61 8.8
Referred 34 4.9
Obtain medication or lab test result 172 24.7
New illness 148 21.3
Other 14 2.0
been diagnosed as HIV positive (38.4%, Table 6). At 
the time of recruitment to the study the median time 
since having been diagnosed as HIV positive for a par-
ticipant was 36 days, and participants most commonly 
had been registered at the health facility involved in the 
study for about a week.
5.3.3—Relative Wealth
The information presented above on home construc-
tion, fuel, water and sanitation use, ownership of goods 
and education was used in a principal components 
analysis to generate a factor which was then split into 
equal wealth quintiles. Table 7 presents the percentage 
of participants reporting assets by quintile. Details of 
how each component loaded onto the factor are pre-
sented in Appendix I.
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Table 7: Percent of Participants in Each Quintile Reporting 
the Assets Surveyed (1=poorest, 5=richest)
Asset
Wealth Quintile
1 2 3 4 5
Floor Material
Earth 100 84.6 22 1.5 0
Cement 0 15.4 75.2 95.6 93.5
Finished 0 0 2.8 2.9 6.5
Wall Materials 
Thatch/mud and poles 91.6 51.5 14.9 7.3 1.4
Bricks—mud or unburnt 6.3 7.4 6.4 5.8 2.2
Metal sheet/cement block 0.7 8.1 33.3 36.5 50.4
Stone/wood/burnt bricks 1.4 33.1 45.4 50.4 46.0
Roof Material
Natural 50.7 0.7 2.1 1.5 0
Corrugated iron 49.3 98.5 97.2 97.8 69.8
Finished 0 0.7 0.7 0.7 30.2
Type of Toilet
Public/shared/outside 51.4 37.5 34 55.5 30.9
Latrine 48.6 62.5 65.3 40.9 20.1
Private flush 0 0 0.7 3.7 48.9
Source of Drinking Water
Bottle/piped inside 0 0.7 4.3 6.6 45.3
Piped outside 2.8 30.9 35.5 72.3 50.4
Other, safe 27.5 27.2 29.1 11.7 3.6
Other, unsafe 69.7 41.2 31.2 9.5 0.7
Source of Cooking Fuel
Electricity/gas 0 0 0.7 2.2 21.6
Paraffin/coal 0 5.2 7.8 30.7 44.6
Charcoal 2.1 22.1 37.6 53.3 29.5
Firewood/straw/grass 97.9 72.8 53.9 13.9 4.3
Personal Property
Car 0.7 6.6 9.9 10.2 31.7
Bicycle 39.4 44.9 37.6 35 40.3
Refrigerator 0 1.5 4.3 8 46.8
Television 2.8 22.1 48.2 63.5 92.1
Mobile phone 47.2 71.3 78 83.2 96.4
Radio 85.2 85.3 87.9 85.4 93.5
5.3.4—Illness Severity
ECOG (physical function): The ECOG (Eastern Co-
operative Oncology Group) is a measure of physical 
function, from fully active at 0 to dead at 5. In this 
study, the relevant range was from 0 to 4 (completely 
disabled, cannot carry on any self care). Participant 
physical function was high at all timepoints. The per-
cent of participants rated with an ECOG of 0, i.e., fully 
active, increased slightly from 69.3% at T0 to 81.2% at 
T3 (Figure 3).
WHO staging: There was great variation in the 
availability of a participant’s WHO HIV status by facil-
ity. Nearly all participants at two facilities had a WHO 
stage recorded, whereas over half of participants at 
another three facilities did not have a WHO status re-
corded. Such variation in the availability of the measure 
made it unsuitable for inclusion in further analysis. The 
existing data (Table 8) show that WHO levels 2 and 3 
were the most common.
CD4 counts: Table 9 shows that 90% of participants 
had a CD4 count recorded in the thirteen months 
before T1. Twenty-four participants who had a count at 
T3 did not have a count at T1. Recorded CD4 counts 
ranged widely, from 0 to over 1100. The distributions of 
CD4 counts at T1 and T3 for participants completing 
T3 are shown in Figure 4. When examining change in 
counts over time there was found to be a mean increase 
in CD4 count of 45.1 (standard error of the mean 
10.7) for participants who had counts at T1 and T3. 
Figure 3: Health worker-rated participant ECOG values
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Table 8: Participant WHO Stage by Facility
Facility
Stage 1 Stage 2 Stage 3 Stage 4 Unknown/Missing
N % N % N % N % N %
155 9 8.4 34 31.8 44 41.1 20 18.7 0 0.0
156 15 14.3 52 49.5 17 15.3 0 0.0 21 20.0
157 6 5.7 10 9.4 17 16.0 0 0.0 73 68.9
158 12 11.4 6 5.7 8 7.6 0 0.0 81 75.7
159 19 18.3 14 13.5 15 14.4 1 1.0 55 52.9
160 29 27.6 27 25.7 40 38.1 7 6.7 2 1.9
Total 90 13.0 143 20.7 141 20.4 28 4.1 290 41.9
Table 9: CD4 Count Statistics
Group N % Median Mean SD 95% CI
All CD4 T1 counts 628 90.2 276 322.3 244.4 303.2–341.5
All CD4 T3 counts 250 35.9 312 346.0 205.8 320.4–371.7
CD4 T1 for those with two counts 226 32.5 269 304.1 222.1 319.6–373.4
CD4 T3 for those with two counts 226 32.5 312 346.5 205.4 320.4–371.7
Figure 5: Change in CD4 Count from T1 to T3 for Those  
Completing T3
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Figure 4: CD4 Counts at T1 and T3 of Participants Completing T3
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As shown by the median and mean, and illustrated in 
Figure 5, the distribution was approximately parametric 
with a tail to the left. Paired t-test analysis showed the 
mean count at T3 to be statistically significantly higher 
than the mean count at T1 for those participants (t= 
-4.2, p<0.001).
As only 35% of participants had CD4 counts at 
both T1 and T3 and 90% of participants had a count 
at T1, for subsequent analysis the T1 CD4 counts only 
were used as an indicator of illness severity. T1 counts 
were grouped according to clinical definitions (28) into 
<50, 51–200, 201–350 and >350. The distributions of 
T1 CD4 counts in these groups are shown in Table 
10. The table shows that in the year before T1 about 
a quarter of participants had CD4 counts of between 
51–200 and 210–350. In the same time period fewer 
than 10% of participants had CD4 counts below 50, 
and 37.1% of participants had CD4 counts of over 350.
Validation of CD4 counts: A lowered CD4 count is 
associated with disease progression and poorer physi-
cal function. The T1 CD4 counts were compared by 
ECOG score to establish whether this expected asso-
ciation was confirmed in the study sample, and validate 
the use of CD4 in later analysis. As shown in Table 
11, there was a clear trend with higher ECOG being 
associated with lower CD4 count, but the confidence 
intervals overlapped for most ranges. A t-test was used 
to compare the distributions for those scoring 0 and 
1 on the ECOG scale, and found a highly significant 
association between ECOG and CD4 count(t=3.96, 
p<0.001). Other ECOG values were not used in a test 
due to low numbers.
5.4—Care Participants Received
5.4.1—All Care Components
Out of the 52 care components examined, a mean of 
11.9 components of care (sd=6.5) was received by a 
participant in the month preceding each data collection 
time point, and a mean of 9.6 (sd=6.1) of those were 
received at the facility the participant was attending. 
There was little variation in the number of care compo-
nents received per month (lowest was T0 (mean 11.7, 
sd 7.1), highest T3 (mean 12.2, sd 5.7). The highest 
number of items received in a month preceding any 
Table 10: Participant CD4 Counts at T1, Grouped 
CD4 Count 
Group
Description of CD4 Group
Participants  
Completing T1
N %
<50 High risk of mortality 57 9.0
51–200 Severe immunosuppression 151 26.3
201–350 Immunosuppression 155 24.4
>350 – 212 37.1
Total – 573 100.0
Table 11: T1 CD4 Count Statistics by ECOG Score
ECOG Score N Median Mean 95% CI
0—fully active 439 308 353.4 329.3–377.5
1—restricted 153 208 262.6 230.8–294.4
2—ambulatory 33 152 199.2 146.3–252.0
3—limited self care 2 141 141.0 101.7–180.3
4—completely disabled 0 – –
time point was 40. The maximum number of care com-
ponents received by a single individual in the course of 
the study was 44 and the minimum was zero, with a 
mean of 20.1 and median of 20 (Figure 7). 
Ten components of care (adherence counselling, 
prevention with positives, CTX, assessment of ART 
treatment, multivitamins, pre and post test counselling, 
nutritional advice, non-opioids, ART/ARV and as-
sessment of pain) were received at least one time point 
during the study by over 75% of participants (Table 12). 
The components of care most commonly received in the 
month before T0, before recruitment to the study (i.e., 
the month before testing positive or developing a new 
problem), were pre and post test counselling, adherence 
counselling and prevention with positives. 
The most common opportunistic infection treat-
ment received was for malaria (received by 50% of the 
study population on at least one time point). Non-
opioids were the most commonly received analgesic, 
received by over 75% of participants on at least one 
time point. Eighteen components of care were received 
by less than 10% of the study population at every time 
point.
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Table 12: Percent of Participants Receiving Each Component of Care During the Study (in Descending Order of Most Commonly 
Ever Received)
Component of Care
T0
(n=696)
T1
(n=634)
T2
(n=613)
T3
(n=592)
Ever
(n=696)
Adherence counselling 63.7 79.7 74.0 71.5 90.8
Prevention with positives 65.1 72.2 67.7 71.0 90.2
CTX to take every day 60.1 84.9 84.5 85.1 89.1
Assess ART treatment 45.8 66.7 67.4 67.6 84.2
Multivitamins 51.1 77.4 77.1 76.9 83.5
Pre- and post-test counselling 70.5 57.1 44.1 40.5 82.5
Nutritional advice 42.9 64.5 59.7 56.8 80.5
Non-opioid analgesics 46.9 43.6 41.4 41.3 78.3
ART/ARV 44.7 58.5 63.4 67.4 76.1
Assessment of pain 42.4 46.9 43.4 43.2 75.9
Visit by religious leader 43.2 40.4 40.5 43.9 67.7
Condoms 34.3 42.3 43.3 42.9 64.5
Access to safe drinking water at home 37.3 44.5 40.5 47.8 63.9
Other nursing care 32.6 38.6 42.8 42.1 63.4
Family planning counselling 30.7 38.6 36.8 36.5 61.8
Patient HIV support groups 31.3 39.0 34.7 43.6 60.2
Wound care 27.4 33.3 37.3 41.2 58.8
Family counselling 28.3 29.0 29.4 31.9 54.6
Treatment for other opportunistic infections 28.9 25.4 21.2 23.7 53.9
Treatment for malaria 33.3 15.9 12.6 16.2 50.0
Prayer with staff 19.7 26.7 22.6 22.1 46.8
ITNs 21.3 22.4 25.3 24.7 46.1
Infection control training 29.0 25.9 21.4 16.1 45.8
TB testing 27.3 21.0 14.2 12.0 40.5
Food 15.4 21.0 17.0 14.4 35.1
Treatment for skin rash/itching 18.0 14.0 11.1 10.8 31.9
Treatment for other fungal infections 14.7 14.0 8.3 5.9 26.1
Memory book work 6.2 13.3 8.5 7.3 23.4
Treatment for nausea/vomiting 11.4 9.5 6.9 5.2 23.0
Treatment for diarrhoea, including ORS 12.7 8.0 7.0 5.2 22.4
Employment training/IGA 10.4 8.0 8.0 6.8 20.7
Home help 11.7 6.6 5.1 5.7 20.0
TB treatment 12.4 12.9 13.7 12.8 19.5
Treatment for genital thrush 8.2 8.5 5.9 5.4 18.1
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Table 12: Percent of Participants Receiving Each Component of Care During the Study (in Descending Order of Most Commonly 
Ever Received)
Component of Care
T0
(n=696)
T1
(n=634)
T2
(n=613)
T3
(n=592)
Ever
(n=696)
Treatment for oral thrush/candidiasis 7.8 10.3 5.1 4.2 16.8
Physiotherapy 6.3 6.3 5.4 5.6 15.1
Treatment for neuropathic pain 6.2 5.7 4.1 4.4 14.2
Loans/microfinance 8.2 5.1 3.1 4.4 14.2
Legal services 4.6 3.5 3.1 3.0 11.8
Treatment for constipation/laxatives 5.5 3.9 2.0 2.7 10.9
Contact with traditional healer or herbalist 7.9 2.8 2.0 0.8 10.8
Treatment for herpes (e.g. acyclovir) 7.2 4.1 1.6 2.0 10.2
Therapeutic feeding for severe malnutrition 5.5 3.6 1.3 1.2 9.5
Anxiety/depression treatment 4.5 3.6 1.5 1.5 8.9
Provide household items 4.3 1.6 2.0 1.7 7.8
Psychiatric therapy 5.1 3.0 1.5 0.2 7.5
Weak opioids 3.2 1.6 1.5 0.0 5.3
Isoniazid (INH) to prevent TB 2.3 1.9 1.8 1.2 5.0
Strong opioids 2.5 1.7 0.8 0.0 4.5
Treatment for cryptococcal meningitis 1.3 1.4 0.3 0.2 2.4
Management of cancer 0.9 0.8 0.7 0.7 2.4
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Figure 6: Number of care components Ever Received by an 
Individual During the Study
5.4.2—Care Received from a Different Facility
Table 13 shows the proportion of patients who re-
ceived each component of care at the facility where 
data collection was carried out, and the proportion who 
received each component from another source, reported 
at each timepoint. The majority of care items were more 
commonly received at the facility than elsewhere. The 
exceptions were a visit from a religious leader, ITN, 
home help, loans and microfinance, IGA programmes, 
household items, and contact with traditional healer. 
Apart from ITNs, these are components of social and 
spiritual care. Frequency of receipt of care components 
from other sources generally declined over time.
5.4.3—PEPFAR Care and Support Categories
The CSRI components were grouped according to the 
PEPFAR categories of clinical, spiritual, social, psy-
chological, and prevention (of new HIV infections) 
as listed in Appendix J. This grouping was carried out 
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 Table 13: Percentage of People Receiving Care at the Facility and Elsewhere
Component of Care
T0
n=696
T1
n=634
T2
n=613
T3
n=592
Fac Else Fac Else Fac Else Fac Else
CTX 53.3 6.6 83.3 1.6 83.4 1.0 84.0 1.2
Adherence counselling 55.6 7.9 76.7 3.0 72.6 1.3 69.3 2.2
Multivitamins 45.0 5.9 75.6 1.9 74.9 2.1 74.3 2.5
Prevention with positives 52.3 12.5 67.7 4.6 64.6 2.9 66.6 4.4
Assess ART treatment 42.2 2.3 65.6 0.9 66.2 1.0 66.4 1.2
ART/ARV 40.5 4.0 57.3 1.3 62.2 1.1 65.9 1.5
Nutritional advice 36.2 6.6 61.5 3.0 57.9 1.6 53.5 3.2
Pre and post test counselling 53.9 16.4 50.3 6.8 41.6 2.4 38.0 2.5
Assessment of pain 31.2 11.1 42.7 4.1 40.5 2.8 40.0 3.2
Non-opioids 24.9 21.6 31.9 11.5 29.7 11.6 28.9 12.3
access to drinking water 24.9 12.4 34.1 10.4 35.2 5.2 37.3 10.5
Visit by faith leader 1.7 41.4 1.1 39.3 2.0 38.5 1.9 42.1
Condoms 26.4 7.6 37.9 4.4 38.0 5.2 39.2 3.7
Other nursing care 24.1 8.3 35.5 3.2 40.5 2.3 39.5 2.5
Patient HIV support groups 23.0 8.2 32.8 6.2 30.0 4.6 35.8 7.8
Family planning counselling 21.7 8.9 32.2 6.5 32.6 4.1 32.4 4.1
Wound care 20.0 7.3 29.8 3.5 35.4 1.8 38.9 2.4
Family counselling 18.8 9.3 20.3 8.7 20.2 9.1 21.5 10.5
Treatment for other OIs 21.3 7.3 22.6 2.8 18.8 2.3 21.3 2.4
ITNs 9.3 11.9 10.9 11.5 13.7 11.6 12.5 12.2
Infection control training 22.1 6.8 22.2 3.6 19.1 2.3 14.5 1.5
Prayer with staff 4.9 14.7 14.8 11.8 15.0 7.5 15.5 6.6
Treatment for malaria 15.8 17.4 10.7 5.2 8.3 4.2 9.8 6.4
TB testing 20.7 6.5 18.8 2.2 13.4 0.8 11.1 0.8
Food 9.2 6.2 18.1 2.8 15.5 1.5 12.0 2.4
Treatment for skin rash/itching 12.1 5.9 12.8 1.3 10.4 0.7 10.1 0.7
TB treatment 8.2 4.2 10.3 2.7 11.7 2.0 10.5 2.4
Treatment for fungal infections 7.5 7.2 11.8 2.2 7.0 1.3 5.4 0.5
Memory book 1.6 4.6 11.0 2.2 7.2 1.3 6.1 1.2
Treatment for diarrhoea 7.0 5.6 6.6 1.4 5.9 1.1 4.1 1.2
Treatment for nausea/vomiting 6.5 4.9 8.4 1.1 5.7 1.1 4.7 0.5
IGA 1.9 8.3 2.7 5.4 2.6 3.9 1.7 5.1
Home help 0.6 11.1 0.8 5.8 0.8 4.2 0.3 5.4
Treatment for genital thrush 5.3 2.9 7.7 0.8 5.5 0.3 5.2 0.2
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 Table 13: Percentage of People Receiving Care at the Facility and Elsewhere
Component of Care
T0
n=696
T1
n=634
T2
n=613
T3
n=592
Fac Else Fac Else Fac Else Fac Else
Treatment for oral thrush 5.5 2.3 9.9 0.3 4.2 0.8 3.9 0.3
Physiotherapy 4.2 2.2 5.4 0.9 5.1 0.3 4.7 0.8
Loans/microfinance 0.3 7.9 1.1 3.9 0.7 2.4 0.3 4.1
Treatment for neuropathic pain 3.9 2.3 4.7 0.9 3.8 0.3 3.5 0.8
Treatment for herpes 3.3 4.0 3.5 0.6 1.5 0.2 2.0 0.0
Legal services 0.7 3.9 1.4 2.1 2.4 0.7 2.0 1.0
Treatment for constipation/laxatives 2.9 2.6 3.3 0.6 1.8 0.2 2.5 0.2
Contact with traditional healer 0.3 7.6 0.2 2.7 0.2 1.8 0.0 0.8
Therapeutic feeding for malnutrition 3.9 1.6 3.3 0.3 1.3 0.0 1.2 0.0
Treatment for anxiety and depression 2.6 1.9 3.2 0.5 1.3 0.2 1.2 0.5
Psychiatric therapy 4.0 1.0 2.4 0.6 1.0 0.5 0.2 0.0
Household items 1.0 3.3 0.3 1.3 0.8 1.1 0.0 1.7
Isoniazid 1.9 0.4 1.7 0.2 1.6 0.2 1.2 0.0
Weak opioids 1.6 1.6 1.1 0.5 1.1 0.3 0.0 0.0
Strong opioids 1.4 1.0 1.1 0.6 0.7 0.2 0.0 0.0
Treatment for cryptococcal meningitis 0.6 0.7 1.3 0.2 0.3 0.0 0.2 0.0
Cancer management 0.6 0.3 0.6 0.2 0.5 0.2 0.5 0.2
during Phase 1 analysis and circulated to country teams 
and other stakeholders for review. ART, with assess-
ment of ART treatment, was kept as a separate care 
component. The three CSRI items not included in 
Phase 1 were grouped under the PEPFAR categories as 
(a) food=social; (b) provision of household items=social; 
and (c) infection control training=clinical.
Table 14 shows that there was little variation in the 
proportion of participants receiving care over time in 
the areas of clinical, psychological and spiritual care. The 
percent of participants receiving any element of social 
care decreased from 34.1% at T0 to 26.9% at T2. The 
percent of participants receiving any component of pre-
ventive care increased from 75.6% at T0 to 81.9% at T3. 
Nearly all participants received some element of 
clinical care during the course of the study. The area 
of care least received by participants was psychologi-
cal care; 57.6% of participants received an element of 
psychological care during the course of the study.
Table 14: Percent of Participants Receiving Care within  
PEPFAR Care and Treatment Categories, by Timepoint
Area of Care T0 T1 T2 T3 Ever
n 696 634 613 592
Clinical 96.8 99.8 99.2 99.5 98.9
Psychological 30.9 32.5 31.0 32.6 57.6
Spiritual 56.5 59.0 56.0 57.4 82.6
Social 34.1 33.9 26.9 28.0 60.1
Prevention 75.6 80.9 80.3 81.9 93.7
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Table 15: Percent Newly Diagnosed Participants Receiving Each Component of Care During the Study (in Descending Order of 
Most Commonly Ever Received)
Component of Care
T0
n=267
T1
n=233
T2
n=219
T3
n=208
Ever
n=267
Pre and post test counselling 86.9 68.7 49.5 41.8 93.6
Adherence counselling 58.8 82.8 79.4 70.2 89.9
Prevention with positives 62.9 81.1 76.1 74.5 88.4
CTX 41.6 83.3 88.5 84.6 85.0
Multivitamins 32.6 79.8 79.8 76.9 80.1
Nutritional advice 33.3 67.8 61.9 56.7 77.5
Assessment of pain 39.3 47.2 45.9 42.3 76.8
Assess ART treatment 23.2 59.2 62.4 60.1 75.7
Non-opioid analgesics 46.1 39.9 38.1 38.0 74.9
ART/ARVs 25.8 41.6 52.8 59.1 65.9
Condoms 27.3 45.9 45.9 44.7 62.9
Access to safe water supply 33.0 46.4 45.4 46.6 59.2
Visit by faith leader 36.3 36.5 34.9 38.9 58.4
Patient HIV support groups 23.2 36.5 38.1 43.8 57.7
Family planning counselling 24.3 38.2 36.7 34.1 56.2
Treatment for malaria 39.0 15.9 16.1 14.9 55.4
Wound care 25.8 36.9 40.8 41.8 55.1
Other  nursing care 28.5 38.2 47.2 41.3 54.3
Family counselling 24.3 29.2 31.2 27.9 53.2
Treatment for other OIs 25.5 27.9 19.7 20.7 50.2
ITNs 19.1 22.7 28.0 24.5 45.3
Infection control training 30.3 24.9 23.9 14.4 43.8
TB testing 30.0 25.8 16.1 12.0 43.4
Prayer with staff 15.0 25.3 26.1 25.0 40.8
Food 10.5 21.0 16.5 11.5 32.6
Treatment for skin rash/itching 16.1 10.3 12.4 10.6 30.3
Treatment for fungal infections 14.6 16.3 5.5 6.7 26.2
Memory book work 3.4 11.6 8.3 10.6 22.8
Treatment for diarrhoea 12.0 6.9 7.3 4.8 22.5
Treatment for genital thrush 8.6 9.4 7.3 6.3 20.2
TB treatment 10.9 14.6 16.1 13.9 18.4
Treatment for nausea/vomiting 7.1 7.7 5.5 4.3 18.0
Treatment for oral thrush 5.2 13.3 6.4 3.8 17.6
Contact with traditional healer 11.6 4.7 3.2 1.4 16.5
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Table 15: Percent Newly Diagnosed Participants Receiving Each Component of Care During the Study (in Descending Order of 
Most Commonly Ever Received)
Component of Care
T0
n=267
T1
n=233
T2
n=219
T3
n=208
Ever
n=267
Home help 9.0 5.2 3.7 2.9 14.6
Physiotherapy 3.7 6.9 6.4 3.8 13.5
IGA 7.5 6.0 6.9 2.9 13.1
Loans 9.0 3.9 3.7 2.9 13.1
Legal services 3.7 3.4 4.1 4.3 12.4
Treatment for neuropathic pain 4.9 2.1 2.3 5.8 10.9
Treatment for constipation/laxatives 3.4 3.4 1.8 1.4 9.0
Treatment for herpes 6.4 3.0 0.5 2.4 8.6
Therapeutic feeding 5.2 4.3 0.5 0.5 8.6
Treatment for anxiety and depression 3.0 3.0 0.5 0.5 6.4
Psychiatric therapy 4.1 1.7 0.5 0.0 5.6
Weak opioids 2.6 1.7 0.9 0.0 4.5
Household items 2.6 0.4 1.4 1.0 4.5
Strong opioids 0.7 1.7 0.5 0.0 2.6
Isoniazid for TB prophylaxis 0.4 0.9 0.9 1.0 1.9
Treatment for cryptococcal meningitis 0.4 0.9 0.0 0.0 1.1
Cancer management 0.4 0.9 0.5 0.0 1.1
5.4.4—Care for People Newly Diagnosed with 
HIV
Participants whose positive HIV test was dated less 
than two weeks before beginning the study were desig-
nated “newly diagnosed.” The most commonly received 
components of care for people newly diagnosed as HIV 
positive were pre and post-test counselling, adherence 
counselling, prevention with positives, CTX, multivita-
mins, nutritional advice, pain assessment, assessment of 
ART treatment and non-opioid analgesics, which were 
received by over 70% of newly diagnosed participants at 
some point during the study (Table 15).
The receipt of a number of care components 
changed dramatically after T0. The proportion of 
patients receiving pre- and post-test counselling was 
highest at T0 (86.9%), which decreased to 41.8% of 
patients by T3. Receipt of other components showed 
increases after T0. The proportion of patients receiving 
adherence counselling, CTX, multivitamins, assessment 
of ART treatment and nutritional advice each increased 
by 25 percentage points or greater between T0 and T1. 
There was a similar decrease in the proportion of newly 
diagnosed patients receiving malaria treatment as there 
was for the whole study population, from 39.0% at T0 
to 15.9% at T1, remaining at this level for the rest of the 
study. Other components of care that showed notable 
decreases were infection control training (30.3% at T0 to 
14.4% at T3), contact with a traditional healer (11.6% at 
T0 to 1.4% at T3) and loans (9.0% at T0 to 2.9% at T3).
5.4.5—Preventive Care Package
PEPFAR developed the concept of the Preventive Care 
Package (PCP), a number of specified care components 
which should be considered essential to prevent op-
portunistic infections, delay disease progression and 
prevent HIV transmission (31). A defined PCP was 
not developed for Kenya but in Uganda this concept 
was refined into the Basic Care Package (BCP), which 
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consists of CTX prophylaxis, an ITN, water disinfec-
tion, family VCT information and condoms (32, 33). 
In Table 16, the five elements of the BCP are presented 
by location of care delivery and time since diagnosis. 
Table 16 shows that there was little difference in the 
probability of receiving elements of the BCP for newly 
diagnosed and previously diagnosed participants. Less 
than a quarter of participants in either group received 
all five elements during the study, but each component 
apart from an ITN was received by more than half. 
5.5—Care Themes 
The components of care were grouped into eight 
themes as described in the Methods section.
5.5.1—Spiritual Care
Receiving a visit from a religious leader was the most 
common component of spiritual care that patients 
reported receiving (Table 17). The proportion of par-
ticipants praying with staff increased from 19.7% at T0 
to 26.7% at T1, after which the proportion remained at 
just over a fifth. Contact with a traditional healer was 
reported by 7.9% of participants in the month before 
T0, and this decreased to 2.8% by T1 and 0.8% by T3. 
5.5.2—Counselling and Advice
Except for psychiatric therapy, all types of counsel-
ling were received by the majority of participants, with 
adherence counselling the most commonly received 
(Table 18).
Table 16: Components of the PCP Ever Received by New and Existing Patients, at the Facility or From Anywhere
Component of Care
Newly Diagnosed, n=267 Diagnosed Previously, n=429
facility anywhere facility anywhere
Family VCT information 39.3 53.2 43.4 55.5
Access to safe water supply 50.2 59.2 50.1 66.9
ITN 30.7 45.3 29.1 46.6
Condoms 58.8 62.9 57.8 65.3
CTX 82.0 85.0 90.7 91.6
Two components 10.9 13.1 20.8 16.6
Three components 14.6 14.6 20.1 16.8
Four components 24.0 24.0 22.8 31.5
Five components 15.4 24.7 11.4 21.0
Table 17: Percent of Participants Receiving Spiritual Care 
Theme Components Over Time
Component of Care T0 T1 T2 T3 Ever
n 696 634 613 592 696
Visit by religious leader 43.2 40.4 40.5 43.9 67.7
Prayer with staff 19.7 26.7 22.6 22.1 46.8
Contact with traditional healer 7.9 2.8 2.0 0.8 10.8
Table 18: Percent of Patients Receiving Counselling and 
Advice Care Theme Components Over Time
Component of Care T0 T1 T2 T3 Ever
n 696 634 613 592 696
Adherence counselling 63.7 79.7 74.0 71.5 90.8
Patient HIV support groups 31.3 39.0 34.7 43.6 60.2
Family planning counselling 30.7 38.6 36.8 36.5 61.8
Family counselling 28.3 29.0 29.4 31.9 54.6
Pre and post test counselling 70.5 57.1 44.1 40.5 82.5
Psychiatric therapy 5.1 3.0 1.5 0.2 7.5
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Table 19: Percent of Participants Receiving Nursing Care 
Theme Components Over Time
Component of care T0 T1 T2 T3 Ever
n 696 634 613 592 696
Other nursing care 32.6 38.6 42.8 42.1 63.4
Wound care 27.4 33.3 37.3 41.2 58.8
5.5.3—Nursing
Nursing and wound care were each received by around 
a third of participants at any time point, and around 
two-thirds of participants received these two care items 
in the course of the study (Table 19).
5.5.4—Pain Management
Non-opioid analgesics were received by over three-
quarters of participants during the study and a similar 
proportion had their pain assessed (Table 20). Receipt 
of other pain medication was rare. The overall trend in 
receipt of analgesics was decreasing over the course of 
the study.
5.5.5—Symptom Management
The single symptom for which participants most com-
monly received treatment was malaria (50.0% of all 
participants) and, as noted previously, malaria treat-
ment was most commonly received in the month before 
recruitment to the study (Table 21). Treatment for skin 
rash or itching was received by about a third of partici-
pants. Although treatments for the other single symp-
toms examined were not commonly received, over half 
of participants reported receiving treatment for other 
unspecified opportunistic infections.
5.5.6—Nutrition
Care relating to nutrition was commonly received by 
participants in the study (Table 22). The majority of 
participants received nutritional advice (80.5%), multi-
vitamins (83.5%) and help with access to drinking water 
(63.9%) at some point during the study. Furthermore a 
third of participants received food during this time.
Table 20: Percent of Participants Receiving Pain  
Management Care Theme Components Over Time
Component of Care T0 T1 T2 T3 Ever
n 696 634 613 592 696
Non-opioid analgesics 46.9 43.6 41.4 41.3 78.3
Assessment of pain 42.4 46.9 43.4 43.2 75.9
Treatment for neuropathic pain 6.2 5.7 4.1 4.4 14.2
Weak opioids 3.2 1.6 1.5 0.0 5.3
Strong opioids 2.5 1.7 0.8 0.0 4.5
Table 21: Percent of Participants Receiving Symptom  
Management Care Theme Components Over Time
Component of Care T0 T1 T2 T3 Ever
n 696 634 613 592 696
Treatment for other OIs 28.9 25.4 21.2 23.7 53.9
Treatment for malaria 33.3 15.9 12.6 16.2 50.0
Treatment for skin rash/itching 18.0 14.0 11.1 10.8 31.9
Treatment for genital thrush 8.2 8.5 5.9 5.4 18.1
Treatment for fungal infections 14.7 14.0 8.3 5.9 26.1
Treatment for nausea/vomiting 11.4 9.5 6.9 5.2 23.0
Treatment for diarrhoea 12.7 8.0 7.0 5.2 22.4
Treatment for anxiety/depression 4.5 3.6 1.5 1.5 8.9
Treatment for oral thrush/candidiasis 7.8 10.3 5.1 4.2 16.8
Treatment for herpes 7.2 4.1 1.6 2.0 10.2
Treatment for constipation/laxatives 5.5 3.9 2.0 2.7 10.9
Treatment for cryptococcal meningitis 1.3 1.4 0.3 0.2 2.4
Table 22: Percent of Participants Receiving Nutrition Care 
Theme Components Over Time
Component of Care T0 T1 T2 T3 Ever
n 696 634 613 592 696
Nutritional advice 42.9 64.5 59.7 56.8 80.5
Multivitamins 51.1 77.4 77.1 76.9 83.5
Access to drinking water 37.3 44.5 40.5 47.8 63.9
Food 15.4 21.0 17.0 14.4 35.1
Therapeutic feeding for malnutrition 5.5 3.6 1.3 1.2 9.5
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5.5.7—Social Care
The most common form of social care received by par-
ticipants was memory book work (23.4% ever received) 
and the least common was household items (7.8% ever 
received, Table 23). With the exception of memory 
book work, all social care items were most commonly 
received in the month before T0.
5.5.8—Prevention
Components of care aimed at preventing infections 
relating to HIV were commonly received (Table 24). 
Nearly all (90.2%) participants received prevention with 
positives counselling at some point during the study. 
Nearly 65% of participants received condoms. Over 
45% of participants received ITNs and the same pro-
portion reported receiving infection control training.
5.5.9—ART
The proportion of participants receiving ART increased 
after each study interview from 44.7% at T0 to 67.4% 
at T3 (Table 25). Over three-quarters of participants 
received ART at some point during the study. A similar 
proportion of patients received assessment of their 
ART treatment as received ART itself, although overall 
the former was received by more participants during 
the course of the study.
Table 26 shows that the proportion of participants 
receiving ART who also received support and moni-
toring was highest at T2. At Facilities 155 and 159, 
the probability of receiving support and monitoring 
increased over time, but at Facility 156 it decreased and 
Facility 157 peaked at T2. In general, at all time points 
the proportion of ART patients to receive support and 
monitoring was between 83% and 91%; high, but not 
universal.
Table 23: Percent of Participants Receiving Social Care 
Theme Components Over Time
Component of Care T0 T1 T2 T3 Ever
n 696 634 613 592 696
Employment training/IGA 10.4 8.0 8.0 6.8 20.7
Loans/microfinance 8.2 5.1 3.1 4.4 14.2
Legal services 4.6 3.5 3.1 3.0 11.8
Memory book work 6.2 13.3 8.5 7.3 23.4
Home help 11.7 6.6 5.1 5.7 20.0
Household items 4.3 1.6 2.0 1.7 7.8
Table 24: Percent of Participants Receiving Prevention Care 
Theme Components Over Time
Component of Care T0 T1 T2 T3 Ever
n 696 634 613 592 696
Prevention with positives 65.1 72.2 67.7 71.0 90.2
Condoms 34.3 42.3 43.3 42.9 64.5
ITNs 21.3 22.4 25.3 24.7 46.1
Infection control training 29.0 25.9 21.4 16.1 45.8
Isoniazid for TB prevention 2.3 1.9 1.8 1.2 5.0
Table 25: Percent of Participants Receiving ART Care Theme 
Components Over Time
Component of Care T0 T1 T2 T3 Ever
n 696 634 613 592 696
ARVs 44.7 58.5 63.4 67.4 76.1
Assess ART treatment 45.8 66.7 67.4 67.6 84.2
Table 26: Number and Percent of People Who Received ARVs to Also Receive ART Support and Monitoring, by Facility and Timepoint
155 156 157 158 159 160 Total
N % N % N % N % N % N % N %
T0 48 67 63 84 9 90 41 85 67 96 29 83 257 83
T1 59 79 62 79 39 98 67 97 64 86 35 97 326 88
T2 61 82 60 78 50 100 68 100 65 96 48 94 352 91
T3 61 84 62 79 53 93 66 100 66 90 44 81 352 88
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5.5.10—CTX
About three fifths of participants received CTX in the 
month before T0 (Table 27) but this proportion rapidly 
increased between T0 and T1, and then remained 
stable. CTX was one of the most widely received com-
ponents of care during the study. 
Table 28 shows the number of participants who 
reported receiving daily prophylactic CTX compared 
to the number who reported taking it on the previous 
day. Numbers rather than percentages are reported, 
because both the proportion of CTX recipients to take 
the medication and the proportion of CTX takers to be 
prescribed it as a prophylactic are of interest. Bearing in 
mind that the number of active participants decreased 
over time, the proportion of participants to be pre-
scribed CTX increased over time, as did the number of 
people to have taken it on the day before the interview. 
5.5.11—TB Treatment
TB testing was dropped from analysis on the grounds 
that it was not a component of care in itself. It had 
been thought all participants would receive TB screen-
ing. This does happen, but it emerged that screening 
consists of checking for signs of TB (persistent cough, 
night sweats and weight loss), and asking about these 
symptoms was not recorded as a TB test. Only people 
showing symptoms were sent for a sputum test (a “TB 
test”). The proportion of participants to receive TB 
treatment varied very little over time from entry to 
the study (Table 29), although the proportion to ever 
receive it was slightly higher, showing that many recipi-
ents, but not all, were treated at each time point.
5.5.12—All Care Themes
The proportion of participants receiving any component 
of spiritual care, counselling/advice, prevention care or 
TB treatment varied by less than five percentage points 
over the course of the study (Table 30 and Figure 7). 
The proportion of participants receiving nursing care, 
nutrition, ART or CTX to take every day increased for 
each subsequent month of the study. Conversely the 
proportion of participants receiving pain management, 
symptom management or social care decreased over 
the course of the study (the latter two groups showing 
slight increases in T3 compared to T2).
Table 27: Percent of Participants Receiving CTX Over Time
T0
n=696
T1
n=634
T2
n=613
T3
n=592
Ever
n=696
60.1 84.9 84.5 85.1 89.1
Table 28: Adherence to CTX
T0 T1 T2 T3
Took CTX Yesterday yes no yes no yes no Yes no
Has daily CTX 321 96 507 31 496 21 484 20
Does not have daily CTX 32 245 28 68 26 69 13 75
Table 29: Percent of Participants Receiving TB Treatment 
Over Time
T0
n=696
T1
n=634
T2
n=613
T3
n=592
Ever
n=696
12.4 12.9 13.7 12.8 19.5
Table 30: Percent of Participants Receiving Care Within 
Selected Themes, by Timepoint
Care Theme T0 T1 T2 T3 Ever
n 696 634 613 592 696
Spiritual 51.7 52.1 52.0 55.1 78.2
Counselling/advice 86.1 87.1 82.7 82.4 96.6
Nursing 38.1 43.5 45.7 47.3 67.5
Pain management 59.2 59.5 55.3 54.2 87.2
Symptom management 58.5 52.7 43.6 44.9 82.8
Nutrition 67.0 87.2 86.1 86.8 93.5
Social 17.5 13.1 10.3 11.3 20.7
Prevention 75.9 80.6 77.0 80.4 93.8
ART 44.7 58.5 63.4 67.4 84.2
CTX to take every day 60.1 84.9 84.5 85.1 89.1
TB treatment 12.4 12.9 13.7 12.8 19.5
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5.6—Health at the Beginning of the Study
5.6.1—Physical and Mental Health Scores
The raw responses to the MOS-HIV at baseline are 
displayed in Appendix L. These were converted into the 
two outcome variables, physical health score and mental 
health score, each with possible values from 0=worst 
possible health to 100=best possible health. The physi-
cal health score of the study population at baseline 
ranged from 10.7 to 65.4, with a mean of 46.1 (sd 11.3, 
Figure 6). The mental health score of the study popula-
tion at baseline ranged from 14.2 to 66.8, with a mean 
of 48.1 (sd 9.5, Figure 9). 
5.6.2—Multidimensional Care Scores
Each outcome in the APCA African POS is scored 
from 0 to 5. The scores were reversed for some items, 
such that in all cases 0 represented the worst situa-
tion and 5 the best. This direction was used because it 
corresponds to the MOS-HIV, where a higher score 
corresponds to a better quality of life.
At baseline the items on which participants report-
ed most problems in relation to their HIV diagnosis 
were being unable to share how they felt with others 
(median=1) and feeling that they and their family were 
not getting enough help to plan for the future (me-
dian=1) (Table 31). Participants had low levels of worry, 
were not feeling greatly affected by their symptoms, 
felt life was worthwhile and felt at peace (median=4 for 
all). The distributions of APCA African POS items in 
the study population at baseline are shown in Figures 
Figure 7: Proportion Receiving Each Care Theme Over Time
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Figure 9: Mental Health Score at Baseline
Table 31: APCA African POS Item Distributions, at Baseline 
(T0) (N=696)
Item Median IQR
Pain 3 3–5
Symptoms 4 3–5
Worry 4 3–5
Share 1 0–3
Worthwhile 4 3–5
Peace 4 2–5
Help 1 (0–3
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Figure 10: APCA African POS at T0: Please Rate Your Pain  
During the Last Three Days
Figure 11: APCA African POS at T0: Have Any Other Symptoms 
Been Affecting How You Feel? 
Figure 12: APCA African POS at T0: Have You Been Feeling  
Worried About Your Illness?
Figure 13: APCA African POS at T0: Over the Past Three Days 
Have You Been Able to Share How You Feel?
Figure 14: APCA African POS at T0: Over the Past Three Days 
Have You Felt that Life Was Worthwhile?
Figure 15: APCA African POS at T0: Over the Past Three Days 
Have You Felt at Peace?
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Figure 16: APCA African POS at T0: In the Past Three Days Have 
You Had Enough Help and Advice for Your Family to Plan for 
the Future?
Figure 17: APCA African POS Total Score at T0
12–15. The sum of the responses to the seven POS 
items was calculated to create an APCA African POS 
score with a possible range of 0–35. At baseline partici-
pants APCA African POS summary score ranged from 
4 to 35, with a mean of 21.7 (sd= 5.3) (Figure 17). 
5.6.3—Problems Facing Family Caregivers
The APCA African POS contains three items for 
informal carers accompanying the participant to answer 
(Appendix B). APCA African POS domains for carers 
were frequently not completed as carers were often not 
present at the participant’s clinical appointment. Of 
the number of participants completing each timepoint, 
83 (11.9%) carers completed all three APCA African 
POS carer questions at baseline, 43 (6.8%) at T1, 23 
(3.8%) at T2 and 20 (3.4%) at T3. Owing to the small 
proportion of completed carer questions, responses to 
these items are described here but were not included in 
further analyses.
Table 32 shows that the amount of information 
received by the carer was the area with the lowest 
score (median at baseline=3, quite a lot of information 
received, increased to a median of 4, a great deal of 
information received, at all subsequent timepoints), but 
they were not worried about the participant (median=5, 
not at all worried, at all time points).
5.7—How Participants Siffer by Facility
5.7.1—Participant Characteristics at Different 
Facilities
The facilities included in the study are from different 
parts of the country. The characteristics of the facilities 
themselves have been studied in detail in Phase 1 and 
summarised in section E1. In addition, the variety of 
locations of the facilities is likely to mean the character-
istics of the participants attending vary also. 
The variations in participants’ key demographic 
characteristics by facility are shown in Table 33. At all 
facilities the majority of participants were female. The 
facility with the greatest proportion of male partici-
pants was 160 (42.3%) and the lowest was 156 (25.2%). 
The facility with the youngest participants was 155 
(mean age 33.0 years) and the oldest was 156 (mean 
age 38.6 years). There was little variation in the median 
Table 32: APCA African POS Carer Item Responses
Carer Item
T0 T1 T2 T3
M
ed
ian
IQ
R
M
ed
ian
IQ
R
M
ed
ian
IQ
R
M
ed
ian
IQ
R
Information 3 1–5 4 2–5 4 3–5 4 2–5
Confidence 4 2–5 4 3–5 5 4–5 4 3–5
Worry 5 3–5 5 3–5 5 4–5 5 3–5
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Table 33: Demographic Characteristics of Participants, by Facility
Facility Males Age Dependants Minutes to Facility Attended Secondary School
N % Mean SD Median IQR Median IQR N %
155 34 31.2 33 10.8 4 2–6 60 37.5–120 24 22.2
156 28 25.2 38.6 8.9 3 2–4 60 30–90 43 38.7
157 41 34.2 33.9 8.5 3 1–4 60 30–82.5 37 30.8
158 33 27.5 33.5 8.4 3 1–4 30 20–60 45 37.5
159 37 29.6 34.8 8.1 4 2–6 60 30–120 58 46.4
160 47 42.3 33.7 8.4 4 2–6 60 30–90 42 37.8
Table 35: Reasons for Attending Facility at Recruitment to Study
155 156 157 158 159 160
n % n % n % n % n % n %
New HIV test result 43 39.5 4 3.6 77 64.2 66 55 38 30.4 39 35.1
HIV test result >14 days ago 10 9.2 10 9 0 0 3 92.5 12 9.6 26 23.4
Referred 5 4.6 2 1.8 12 10 2 1.7 8 6.4 5 4.5
Medication or lab test 4 3.7 69 62.2 24 20 39 32.5 8 6.4 28 25.2
New illness or problem 46 42.2 26 23.4 5 4.2 3 2.5 56 44.8 12 10.8
Other 1 0.9 0 0 2 1.7 7 5.8 3 2.4 1 0.9
Table 34: Percentage of Participants Coded to Each Quintile, 
by Facility
Facility
Wealth quintile (1=poorest; 5=richest)
1 2 3 4 5
155 (n=109) 51.38 22.94 20.18 4.59 0.92
156 (n=111) 3.6 31.53 28.83 18.92 17.12
157 (n=120) 8.33 24.17 13.33 24.17 30
158 (n=120) 1.67 4.17 11.67 34.17 48.33
159 (n=125) 19.2 12 31.2 23.2 14.4
160 (n=110)* 41.82 24.55 16.36 10.91 6.36
Total (n=695) 20.43 19.57 20.29 19.71 20
*Demographic information missing for one participant
number of dependents or time to reach the facility by 
facility. Nearly half of participants attending facility 159 
had attended secondary school, compared to 22.2% of 
participants at facility 155.
The wealth quintiles indicate that participants 
attending facility 155 were the poorest relative to the 
rest of the study population, and participants attending 
facility 158 were the richest (Table 34).
The highest proportion of newly diagnosed partici-
pants recruited was at facility 157 (64.2%), and the low-
est at facility 156 (3.6%) (Table 35). Over 40% of partic-
ipants from facility 155 and 159 reported a new illness 
at the time of recruitment. Facility 156 was the only one 
at which the majority of participants (62.2%) attended 
to receive medication or the results of a lab test.
5.7.2—Illness Severity at Different Facilities
The proportion of participants who had a CD4 count 
recorded from a year before T0 up to T1 was very high 
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for all facilities (from 87.5 to 100% of participants, 
Table 37). Over a third (37.8%) of participants who 
completed T3 had a CD4 count at both T1 and T3, 
although there was a wide variation in proportions by 
facility. The facility with the largest proportion of par-
ticipants having CD4 counts at both time periods was 
156 (74.2%), and the lowest was 155 (15.5%). 
At T1 participants at facility 156 had the highest 
mean CD4 count (358.9) and those at facility 158 the 
lowest (210.6). At each facility the mean CD4 count 
increased over the study period and the overall increase 
was significant. Participants at facility 160 showed the 
greatest increase in CD4 count between the 2 time-
points (a mean increase of 124.5 counts), and facility 
159 the lowest (mean increase of 2.4 counts).
5.7.3—Care Received at Different Facilities
Table 37 shows that the mean number of care com-
ponents received per month ranged from 8.4 at facil-
ity 157 to 15.8 at facility 156, out of the 52 surveyed. 
Participants attending facility 157 received the lowest 
number of components of care, both on site (7.1) and 
when including care received from elsewhere (8.4).
Table 38 shows there was great variety in the 
proportion of participants receiving many components 
of care over the course of the study. Variations in the re-
ceipt of the some of the key components are described 
here. Nearly all participants in the study at facility 155 
took ART at some point during the study (95.4%) 
compared to just over half of participants at facility 157 
(52.5%). CTX and multivitamins were received at least 
once during the study by the vast majority of partici-
pants at all facilities, except for facility 160 (53.2% and 
33.3% respectively). 
By facility there was great variety in the propor-
tion of participants ever receiving an ITN (from 31.7 
at facility 157 to 82.5% at facility 158) or safe water 
treatment (from 35.0 at facility 157 to 98.2% at facil-
ity 155). Almost no participants received strong opi-
oids, except at facility 159 where 21.6% of participants 
received them at some point during the study. A similar 
pattern of receipt was seen for weak opioids, with many 
more participants attending facility 159 reporting 
receipt of this medication than at the other facilities. 
Nearly a quarter of participants attending facility 155 
Table 36: CD4 Count by Facility
Facility
Those Completing 
T1 with CD4 Count 
at T1
CD4 Count at T1
Those Completing 
T3 with CD4 Count 
at T3
CD4 Count at T3
Those Completing 
T3 with CD4 Count 
at T3 and T1
Change in CD4 
Count
N % Mean sem N % Mean sem N % Mean sem
155 95 88.8 349.4 29.9 16 15.5 475.9 70.4 12 11.7 25.6 112.3
156 95 90.5 353.5 19 74 73.3 403.5 23.3 72 71.3 43.4 12.2
157 92 86.8 304.3 28.3 34 34 292.6 37.2 28 28 37.8 40
158 104 97.2 266.1 21.1 44 47.3 290.2 29.3 42 45.2 66 20.6
159 95 91.3 354.4 24.6 40 40.4 319.4 26.1 38 38.4 25.9 17.8
160 95 90.5 343.4 27.3 23 24 345.5 38.7 19 19.8 140.5 35.5
Total 576 90.9 327.9 10.3 231 39 350.3 13.7 207 35 51.7 11
Table 37: Mean Number of Components of Care Received by 
Participants at Each Facility During the Study
Facility
Any Location On Site
mean sd mean sd
155 15.5 6.0 13.5 5.7
156 11.5 6.2 8.3 5.7
157 8.4 4.9 7.1 5.0
158 15.8 6.7 13.3 6.4
159 10.1 5.8 7.4 5.0
160 9.9 5.1 8.0 4.7
Phase 2 Kenya 43
results of longitudinal Quantitative study section a 43
Table 38: Percent of Participants Ever Receiving Components of Care by Facility
Care Component 155 156 157 158 159 160
Visit by religious leader 78.9 76.6 45.8 51.7 67.2 89.2
Prayer with staff 62.4 33.3 65.8 10.8 50.4 59.5
Contact with traditional healer 18.3 5.4 3.3 9.2 16.8 11.7
Pre- and post-test counselling 87.2 63.1 90 99.2 56.8 100
Adherence counselling 98.2 90.1 75 99.2 84 100
Family planning counselling 92.7 68.5 37.5 76.7 44 55
Patient HIV support groups 93.6 53.2 32.5 91.7 28.8 65.8
Family counselling 84.4 56.8 20 64.2 60 44.1
Psychiatric therapy 24.8 9 0 6.7 2.4 3.6
Prevention with positives 99.1 85.6 85 95 80.8 97.3
Wound care 90.8 45 12.5 90.8 40 77.5
Other nursing care 99.1 46.8 7.5 89.2 60.8 80.2
ART/ARV 95.4 88.3 52.5 71.7 87.2 63.1
Assessment of ART treatment 94.5 85.6 70.8 68.3 90.4 97.3
Assessment of pain 94.5 46.8 70 84.2 68.8 91.9
Strong opioids 0 0.9 0 2.5 21.6 0
Weak opioids 3.7 3.6 1.7 4.2 17.6 0
Non-opioids 82.6 65.8 65.8 86.7 80.8 88.3
Treatment for neuropathic pain 14.7 4.5 8.3 11.7 23.2 22.5
Anxiety and depression 13.8 11.7 5.8 10 8.0 4.5
Nausea/vomiting 25.7 19.8 16.7 30.8 26.4 18
Treatment for skin rash/itching 34.9 22.5 31.7 46.7 35.2 18.9
Treatment for diarrhoea 27.5 19.8 17.5 22.5 20 27.9
Treatment for constipation/laxatives 9.2 10.8 4.2 18.3 12 10.8
Treatment for genital thrush 15.6 3.6 25 30.8 16.8 15.3
Treatment for oral thrush 14.7 9.9 23.3 25 17.6 9
Treatment for cryptococcal meningitis 3.7 5.4 1.7 2.5 1.6 0
Treatment for fungal infections 18.3 21.6 25.8 50 30.4 8.1
Treatment for herpes 6.4 6.3 10.8 17.5 14.4 4.5
Treatment for malaria 69.7 18.9 37.5 59.2 55.2 59.5
TB testing 42.2 31.5 31.7 68.3 24.8 45
TB treatment 22.9 19.8 19.2 25.8 13.6 16.2
Therapeutic feeding 11.9 10.8 3.3 21.7 4 5.4
Treatment for other OIs 54.1 45 28.3 76.7 64 54.1
Cancer management 2.8 6.3 0 4.2 0.8 0.9
Physiotherapy 50.5 16.2 0.8 16.7 3.2 6.3
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Table 38: Percent of Participants Ever Receiving Components of Care by Facility
Care Component 155 156 157 158 159 160
Food 56.9 42.3 25 46.7 19.2 22.5
Multivitamins 99.1 97.3 90 97.5 82.4 33.3
Nutritional advice 99.1 89.2 87.5 92.5 41.6 76.6
Access to drinking water 98.2 74.8 35 95 41.6 42.3
CTX 99.1 98.2 90.8 98.3 93.6 53.2
Isoniazid 7.3 6.3 0 3.3 12 0.9
Condoms 90.8 67.6 56.7 82.5 51.2 39.6
ITNs 46.8 44.1 31.7 82.5 35.2 36
Household items 14.7 16.2 1.7 8.3 3.2 3.6
Home help 33.9 32.4 5 22.5 16 11.7
IGA 44 32.4 2.5 10 20.8 17.1
Transport to care centre 17.4 8.1 20 11.7 6.4 7.2
Legal services 18.3 13.5 38.3 13.3 50.4 2.7
Memory book work 14.7 17.1 4.2 22.5 22.4 3.6
Loans 85.3 46.8 17.5 78.3 32 17.1
Infection control training 78.9 76.6 45.8 51.7 67.2 89.2
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Table 39: Percentage of People Ever Receiving Care at the Facility and Elsewhere, by Facility
Component of Care
155 156 157 158 159 160
fac else fac else fac else fac else fac else fac else
Visit by religious leader 6.4 78.9 14.4 73 5 41.7 3.3 50.8 0.8 67.2 4.5 88.3
Prayer with staff 37.6 40.4 17.1 17.1 61.7 17.5 1.7 10 16 38.4 28.8 42.3
Contact with traditional healer 0.9 17.4 0.9 4.5 0 3.3 0 9.2 0 16.8 1.8 10.8
Pre and post test counselling 81.7 15.6 50.5 17.1 73.3 29.2 96.7 30.8 44 16 100 10.8
Adherence counselling 98.2 14.7 89.2 19.8 74.2 8.3 97.5 7.5 84 8.8 100 9
Family planning counselling 91.7 9.2 62.2 23.4 33.3 11.7 65.8 30.8 44 12.8 48.6 13.5
Patient HIV support groups 90.8 18.3 30.6 31.5 30 7.5 90.8 7.5 17.6 16 59.5 13.5
Family counselling 80.7 20.2 42.3 27 15 8.3 58.3 15.8 26.4 52 31.5 20.7
Psychiatric therapy 22.9 1.8 4.5 4.5 0 0 4.2 2.5 1.6 0.8 2.7 0.9
Prevention with positives 99.1 13.8 76.6 21.6 85 11.7 95 26.7 73.6 24 93.7 18
Wound care 90.8 9.2 33.3 18 7.5 7.5 90 20.8 35.2 8 73 7.2
Other nursing care 99.1 7.3 33.3 18.9 4.2 3.3 87.5 17.5 55.2 15.2 74.8 13.5
ART/ARV 95.4 4.6 86.5 10.8 52.5 7.5 70.8 2.5 85.6 7.2 63.1 4.5
Assessment of ART treatment 94.5 5.5 81.1 9.9 70.8 5.8 68.3 1.7 90.4 6.4 97.3 0.9
Assessment of pain 91.7 8.3 38.7 11.7 63.3 19.2 83.3 8.3 61.6 24 86.5 28.8
Strong opioids 0 0 0.9 0 0 0 1.7 0.8 13.6 8 0 0
Weak opioids 1.8 1.8 2.7 0.9 0.8 0.8 4.2 0 9.6 8.8 0 0
Non-opioid analgesics 65.1 44 32.4 42.3 44.2 35 75 35.8 68 39.2 78.4 39.6
Treatment for neuropathic pain 11.9 2.8 4.5 0 5 3.3 6.7 5 17.6 6.4 21.6 4.5
Treatment for anxiety and depression 11.9 1.8 8.1 3.6 3.3 2.5 7.5 2.5 4.8 3.2 2.7 1.8
Treatment for nausea/vomiting 20.2 8.3 12.6 9 10.8 5.8 26.7 6.7 20.8 6.4 12.6 6.3
Treatment for skin rash/itching 29.4 9.2 19.8 2.7 25 10 41.7 8.3 28 12 15.3 4.5
Treatment for diarrhoea 20.2 8.3 17.1 3.6 10.8 8.3 15 10.8 12.8 8.8 18 9.9
Treatment for constipation/laxatives 6.4 3.7 9 2.7 2.5 1.7 13.3 5.8 9.6 3.2 9 3.6
Treatment for genital thrush 13.8 2.8 2.7 1.8 23.3 3.3 28.3 3.3 14.4 4.8 10.8 5.4
Treatment for oral thrush 13.8 2.8 8.1 2.7 22.5 2.5 20. 5.8 16.8 3.2 8.1 0.9
Treatment for cryptococcal meningitis 1.8 2.8 4.5 0.9 1.7 0 1.7 0.8 0.8 0.8 0 0
Treatment for fungal infections 17.4 3.7 14.4 8.1 15.8 14.2 43.3 14.2 25.6 11.2 6.3 3.6
Treatment for herpes 4.6 3.7 6.3 0.9 6.7 5 10 8.3 9.6 5.6 1.8 2.7
Treatment for malaria 51.4 29.4 12.6 8.1 13.3 27.5 27.5 40.8 40 24.8 39.6 28.8
TB testing 38.5 5.5 29.7 3.6 21.7 15 60.8 17.5 23.2 4 40.5 5.4
TB treatment 20.2 3.7 18.9 3.6 15 8.3 16.7 18.3 13.6 0 15.3 3.6
Therapeutic feeding 7.3 4.6 9.9 0.9 2.5 0.8 19.2 3.3 3.2 0.8 4.5 0.9
Treatment for other OIs 49.5 6.4 36.0 9.9 19.2 10.8 71.7 15.8 58.4 15.2 46.8 14.4
Cancer management 0.9 1.8 4.5 1.8 0 0 3.3 0.8 0.8 0 0.9 0
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Table 39: Percentage of People Ever Receiving Care at the Facility and Elsewhere, by Facility
Component of Care
155 156 157 158 159 160
fac else fac else fac else fac else fac else fac else
Physiotherapy 47.7 3.7 13.5 3.6 0.8 0 10 7.5 1.6 1.6 3.6 3.6
Food 56 2.8 23.4 24.3 23.3 4.2 44.2 5.8 5.6 15.2 16.2 6.3
Multivitamins 99.1 7.3 97.3 11.7 90 10.8 97.5 5.8 79.2 15.2 27.9 5.4
Nutritional advice 99.1 5.5 82.9 33.3 85.8 7.5 92.5 5 38.4 7.2 75.7 5.4
Access to drinking water 98.2 10.1 36.9 60.4 31.7 5.8 92.5 19.2 12.8 32.8 32.4 17.1
CTX 99.1 2.8 97.3 13.5 90 11.7 97.5 4.2 89.6 13.6 49.5 7.2
Isoniazid 7.3 0 4.5 2.7 0 0 2.5 0.8 12 0 0.9 0
Condoms 89.9 9.2 55 24.3 54.2 9.2 79.2 18.3 40 22.4 32.4 10.8
ITN 37.6 22 22.5 29.7 28.3 8.3 45 67.5 24.8 17.6 19.8 20.7
Household items 4.6 11 0.9 15.3 0 1.7 5 3.3 0.8 2.4 0.9 2.7
Home help 4.6 32.1 0.9 31.5 1.7 3.3 4.2 20.8 0 16 0.9 11.7
IGA 17.4 33.9 7.2 28.8 0.8 1.7 1.7 8.3 4.8 16 11.7 6.3
Legal services 0.9 16.5 2.7 5.4 17.5 2.5 8.3 3.3 0 6.4 1.8 5.4
Memory book work 9.2 12.8 3.6 10.8 36.7 2.5 5.8 7.5 46.4 8.8 1.8 0.9
Loans 1.8 12.8 0.9 16.2 0 4.2 6.7 20 1.6 20.8 0.9 2.7
Infection control training 80.7 11 39.6 13.5 17.5 2.5 74.2 15 21.6 17.6 10.8 6.3
had received psychiatric therapy, compared to less then 
10% of participants at each of the other facilities. 
Participants at facility 160 reported the lowest level 
of receipt of several key care components, such as CTX, 
multivitamins and weak opioids, many of these levels 
being much lower than all the other facilities.
5.7.4—Care Themes
Receipt of care for the themes to be used in later 
analysis also varied by facility, but as Table 40 shows, 
there were no trends in which facilities had the high-
est or lowest proportion of participants receiving care. 
For example, some component of spiritual care was 
received by 47.7% of participants at facility 158 and 
92.4% of participants at facility 160. Receipt of support 
and counselling care was received by all participants at 
facilities 155, 158, and 160, and over 90% at the other 
three facilities. The widest variation in receipt of care by 
facility was for nursing care, which ranged from 9.4% 
of participants ever receiving some form of nursing 
Table 40: Percent of Participants at T1 to Receive Care Theme 
in T1–T3, by Facility
Care Theme
Facility
155 156 157 158 159 160
Spiritual 83.2 74.3 79.2 47.7 69.2 92.4
Support/Counselling 100 94.3 93.4 100 93.3 100
Preventive 100 97.1 92.5 100 84.6 93.3
Nursing 98.1 50.5 9.4 98.1 66.3 77.1
Pain 93.5 70.5 74.5 93.5 81.7 89.5
Symptoms 76.6 56.2 72.6 88.8 84.6 75.2
Nutrition 100 100 99.1 100 97.1 72.4
Social 41.1 46.7 3.8 19.6 28.8 13.3
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care at facility 157 to 98.1% at facilities 155 and 158. 
The care themes included care reported at T1, T2 or T3 
only, because they were used to predict change in health 
scores from T0. The denominator was the number of 
participants to complete T1.
5.7.5—PEPFAR Care and Support Categories
Looking at the proportion of participants ever receiving 
a component of care from each of the PEPFAR care 
and support categories of care by facility (Table 41), it 
can be seen that nearly all participants at every facility 
received some form of clinical care during the course of 
the study, and over 85% of participants at all facilities 
received some component of preventive care. The other 
areas of care showed more variation. The proportion of 
participants receiving some component of psychologi-
cal care ranged from 24.2% at facility 157 to 89.0% at 
facility 155. Social care receipt ranged from 24.3% of 
participants at facility 160 to 62.4% at facility 155. It 
is important to note that Table 40 refers to only three 
timepoints, and Table 41 to all four. 
5.7.6—Health at Baseline at Different Facilities
At baseline there was greater variation in physi-
cal health score than mental health score by facility, 
although the variation was statistically significant for 
both (p<0.001 and p=0.018 respectively using Kruskal 
Wallis tests). The highest and lowest means for the two 
scores were reported by the same facilities (Table 42). 
Mean scores ranged from 42.6 (sd 11.2) for physical 
health score and 46.4 (sd 8.6) for mental health score 
at facility 160 to 49.5 (sd 9.2) for physical health score 
and 49.7 (sd 8.2) for mental health score at facil-
ity 156. Although there was little variation in APCA 
African POS total scores at baseline by facility, with 
scores ranging from 20.6 (sd 5.2) at facility 159 to 22.6 
(sd 5.5) at facility 155, this variation was statistically 
significant (p=0.012).
5.8—Participant Characteristics and Health
5.8.1—Gender
Mean physical health score was 45.5 in males and 46.4 
in females. Mean mental health score was 48.5 in males 
Table 41: Percent of Participants Ever to Receive PEPFAR Care 
Categories, by Facility
Care category
Facility
155 156 157 158 159 160 Total
N 109 111 120 120 125 111 696
Clinical 99.1 99.1 97.5 100 96.8 100 98.7
Psychological 89 59.5 24.2 68.3 61.6 45 57.6
Spiritual 88.1 79.3 77.5 56.7 79.2 90.1 78.2
Social 62.4 60.4 29.2 46.7 49.6 24.3 45.3
Prevention 99.1 97.3 86.7 95.8 87.2 97.3 93.7
Table 42: Mean Physical and Mental Health Score at Baseline 
(T0), by Facility
Facility
Physical Health 
Score
Mental Health 
Score
APCA African POS 
Total
mean sd mean sd mean sd
155 43.1 12.8 47 10.1 22.6 5.5
156 49.5 9.2 49.7 8.2 22.1 4.9
157 47.4 11.6 47.5 10.2 20.9 5.5
158 46.7 11.8 48.4 9.5 22.4 4.9
159 47.1 9.6 49.5 9.7 20.6 5.2
160 42.6 11.2 46.4 8.6 22 5.8
and 47.9 in females. The difference between males and 
females was not significant for either score (p=0.348 
and p=0.414 respectively).
5.8.2—Age
The association of age with the MOS summary scores 
was tested using linear regression. Treating age as a 
continuous variable, outcomes at the intercept (where 
age=0) were 48.4 for physical health score and 45.7 for 
mental health score. Physical health score declined by 
1.4 per increasing year of age, but this was not signifi-
cant (p=0.162). Mental health score increased by 1.73 
with each increasing year of age, but this also was not 
significant (p=0.084). 
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Table 43: Mean Health Scores at Baseline for Different Levels of Education
Education Level
Physical Health Score Mental Health Score APCA African POS Total Score
Mean sd Mean sd Mean sd
None 40.5 12.3 46.5 9.2 21.4 5.2
Begun primary 45.8 11.2 47.8 9.6 21.4 5.2
Begun secondary 46.8 10.7 48.3 9.4 21.9 5.5
Diploma or higher 47.7 13.5 50 8.8 23.8 4.8
F 2.49 1.04 3.50
p 0.060 0.375 0.015
Table 44: Mean Health Scores at Baseline for Different Level of Wealth (1=poorest, 5=wealthiest)
Wealth Quintile Mean Physical Health Score Mean Mental Health Score Mean APCA African POS Total Score
Mean sd mean sd mean sd
1 44.1 11.3 46.7 9.7 21.8 5.3
2 45.1 11.8 47.4 10 21.1 5.2
3 45.7 11.4 48.3 9 21.6 5.8
4 48 9.8 48.8 8.9 21.3 5
5 47.9 11.7 49.5 9.5 22.9 5.2
F 3.25 1.91 2.55
p 0.012 0.108 0.038
5.8.3—Education
Mean physical health score and mental health score 
scores increased for each increasing level of education 
completed by the participants (Table 43). This variation 
in scores according to education level was not signifi-
cant for either score (one way ANOVA p=0.060 and 
0.375 respectively). Mean APCA African POS total 
score increased with education and the variation was 
significant at the 5% level (p=0.015).
5.8.4—Relative Wealth
Participants who reported greater relative wealth also 
reported better physical and mental health at baseline 
(Table 44). This variation in outcomes by wealth quin-
tile was significant for physical health score (p=0.012) 
but not mental health score (p=0.108) using one way 
ANOVA. Mean physical health score was associated 
with wealth quintile, with participants in the wealthier 
quintiles having a higher mean physical health score 
(p=0.012). 
The same effect was not observed for mental health 
score. The ANOVA test showed an association between 
APCA African POS total score and wealth quintile 
(p=0.038) but without a clear directional trend.
5.8.5—Illness Severity
The association between outcomes and illness sever-
ity were explored using the first CD4 counts collected, 
which relate to T1 and up to 12 months prior and the 
participant outcomes at T1. From Table 45 it can be 
seen that participants with higher CD4 counts tended 
to report higher physical and mental health scores, 
and there were significant differences in both scores 
between the four groups (p<0.001 and p=0.059 re-
spectively). There was little variation in APCA African 
POS total score between participants who had differ-
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Table 45: Physical Health Score, Mental Health Score and Total APCA African POS Total Score at T1 by CD4 Groupings
CD4 group <50 51–200 201–350 >350 One way ANOVA
N at T1 57 151 155 213 p
Mean (sd) physical health score at T1 45.5 (12.3) 48.1 (11.3) 52.4 (9.0) 52.2 (8.8) <0.001
Mean (sd) mental health score at T1 49.9 (9.1) 51.7 (8.3) 52.9 (8.9) 53.0 (7.9) 0.059
Mean (sd) POS total score at T1 24.4 (4.8) 24.6 (5.0) 25.0 (4.8) 24.7 (4.6) 0.851
Table 46: A Comparison of Outcomes Between Participants Receiving and Those Not Receiving Specific Care Components at T1
Received
Physical health Mental heath CD4 count
n mean se n mean se n mean se
TB treatment
Yes 82 46.04 1.46 82 51.45 0.99 77 217 21
No 552 50.91 0.42 552 52.36 0.36 499 344 11
ART
Yes 371 50.54 0.63 371 52.22 0.45 339 285 13
No 263 50.10 0.55 263 52.28 0.51 237 388 17
ent CD4 counts, and this variation was not statistically 
significant.
Linear regression was used, with CD4 count as a 
continuous variable, to explore the effect of CD4 on 
mental health score adjusting for physical health score, 
and vice versa. The results (in Appendix I) showed that 
after adjusting for physical health there was no associa-
tion between mental health and CD4 count. The same 
did not apply when physical health was adjusted for 
mental health, proving that the result was not simply 
due to close correlation between the two health scores.
Very few participants were accompanied by a care-
giver. To explore whether outcomes predicted having 
a caregiver, linear regression was used to model each 
health score associated with carer presence, and with 
carer presence plus the other health score (Appendix 
I). The results showed that having a carer was associ-
ated with lower physical health, but after adjusting 
for physical health there was no association between 
mental health and presence of a caregiver. 
5.8.6—Individual Care Components
Owing to their importance in HIV care, the receipt of 
certain individual care components was examined for 
their association with outcomes at baseline. The mean 
and standard error of physical health, mental health and 
CD4 count are presented in Table 46. Participants who 
had received TB treatment in the month before base-
line had lower physical and mental health scores and a 
lower CD4 count than those who had not. 
The differences in mean physical score (t= -4.00, 
p<0.001) and CD4 count (t= -4.25, p<0.001) were both 
statistically significant but the difference in mental 
health score was not (t= -0.90, p=0.366). Participants 
who received ART in the month before baseline had 
almost identical scores for physical and mental health, 
and a lower CD4 count, compared to those who had 
not. CD4 count showed a significant difference (t=4.99, 
p<0.001), but physical health and mental health 
were not associated with receipt of ART (t=0.53 and 
p=0.597 for physical, t=0.084 and p=0.933 for mental). 
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6.1—Association of Outcomes with Loss to  
Follow-Up
To determine whether missing data were missing at 
random with relation to the outcomes, or whether the 
outcomes were associated with the probability of loss 
to follow-up, mean physical and mental health scores at 
T0 for completers and non-completers were compared 
using t-tests.
Table 47 shows that the 60 participants who only 
completed the first observation had a mean score two 
points lower than the mean for the remaining partici-
pants, and the difference was not statistically significant 
(t=1.30, p=0.194). However, the 104 who left the study 
before completion had a significantly lower mean phys-
ical health score at the 5% level than those 588 who 
completed all four observations (t= –2.15, p=0.032). 
In Table 48, the participants who only completed 
one observation did not have significantly lower scores 
than those who completed more than one (t=0.28, 
p=0.78). The 104 participants who dropped out at some 
point during the study had lower mean mental health 
scores than the 588 who completed all observations but 
this difference was also not statistically significant (t= 
–1.49, p=0.14). 
The implication of these results is that any analysis 
which only included people who had completed all four 
observations would be biased towards a higher level 
of physical health than was visible in the whole study 
population. On the other hand, analysis which included 
all participants except the 60 who only completed an 
interview at T0 would not bias the result. Therefore, 
multilevel modelling, which operates using all observa-
tions except the first, is a more appropriate way of ex-
ploring change over time in this study than traditional 
techniques which often exclude non-completers. 
6.2—Changes in Hhealth Over Time
6.2.1—Physical and Mental Health Scores
Table 49 shows both mean health summary scores at 
6
Table 47: Mean Physical Health Scores at T0 by Number of 
Observations Completed
Observations 
completed
N Mean sd 95% CI
One 60 44.32 11.53 41.33–47.29
More than one 632 46.30 11.28 45.42–47.18
Less than four 104 43.93 11.71 41.65–46.21
Four 588 46.51 11.20 45.61–47.42
Table 48: Mean Mental Health Scores at T0 by Number of  
Observations Completed
Observations 
Completed
N Mean sd 95% CI
One 60 47.77 10.85 44.97–48.81
More than one 632 48.13 9.32 47.40–48.86
Less than four 104 46.83 10.63 44.77–48.90
Four 588 48.33 9.23 47.58–49.07
Table 49: Mean MOS Summary Score Changes Over Time
T0 T1 T2 T3
Mental health summary score 48.10 52.24 54.22 54.98
Physical health summary score 46.13 50.28 51.96 53.35
each timepoint. From observation, mean scores in-
creased over time for both physical and mental health. 
Mental and physical health score values at T3 were 
significantly higher than at T0 (both p<0.001) as il-
lustrated in Figures 18 and 19. The mean increase from 
baseline to T3 was 6.6 (sd 9.9) for mental health score 
and 6.8 (sd 11.9) for physical health score, which are 
both clinically significant (11). The greatest increase 
for both physical and mental health occurred between 
T0 and T1. Mixed methods analysis accounting for 
repeated measures on individuals and the clustering of 
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individuals at facilities also showed that the increase 
in the mental and physical health summary score were 
significant (p<0.001, Tables 50 and 51).
6.2.2—Multidimensional Care Scores
According to the domains measured in the APCA 
African POS, at all time points participants rated their 
symptoms, worry and feeling that life was worthwhile 
to be relatively lesser problems, but obtaining help for 
their family and sharing their problems were the areas 
with the lowest score (Table 52). Participants’ reported 
ability to share feelings with others showed no change 
over the course of the study, even though the median 
score was low at baseline (2 [IQR 0–4]). Participants’ 
reported rating of feeling that had received enough 
help and advice was the lowest scoring APCA African 
POS item at baseline (median 1 [IQR 0–3]), and also 
showed the greatest increase by T3 (median 3 [IQR 
1–4]). The remaining items showed modest increases 
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Figure 18: Change in Average Physical Health Score Over Time
Figure 19: Change in Average Mental Health Score Over Time
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Table 50: Mixed-Effects Model of Physical Health Score  
Adjusting for Physical Health at T0 and Time
Coefficient
Standard 
Error
p 95% CI
Baseline physical 
health score
0.4 0.0 <0.001 0.4–0.5
Interview 
number
1.4 0.2 <0.001 1.0–1.8
constant 28.8 1.3 <0.001 26.3–31.4
Table 51: Mixed-Effects Model of Mental Health Score  
Adjusting for Mental Health at T0 and Time
Coefficient
Standard 
Error
p 95% CI
Baseline mental 
health score
0.4 0.0 <0.001 0.3–0.4
Interview 
number
1.3 0.2 <0.001 1.0–1.6
constant 33.7 1.3 <0.001 31.2–36.3
Table 52: Median APCA African POS Scores for Items (All 0–5)
APCA African 
POS Item
Median (IQR)
Baseline T1 T2 T3
Pain 3 (2–4) 4 (3–5) 4 (3–5) 4 (3–5)
Symptoms 4 (3–5) 4 (3–5) 4 (3–5) 5 (4–5)
Worry 4 (3–5) 4 (3–5) 5 (3–5) 5 (3–5)
Sharing 2 (0–4) 2 (0–4) 2 (1–4) 2 (0–4)
Life worthwhile 4 (3–5) 4 (3–5) 5 (4–5) 5 (3–5)
Peace 3 (2–4) 4 (3–5) 4 (3–5) 4 (3–5)
Help and advice 1 (0–3) 2 (1–3) 2 (1–4) 3 (1–4)
Phase 2 Kenya 52
results of longitudinal study section B 52
18
19
20
21
22
23
24
25
26
27
28
T0 T1 T2 T3
95% CI mean
over the course of the study.
Table 53 presents a different summary of the same 
information. The proportion reporting “severe” (the 
worst two scores) and “moderate” (the middle two 
scores) problems on each item are reported by time. 
The results show that the reduction in median scores 
shown in Table 52 had clinical meaning. In most cases 
the proportion experiencing either severe or moderate 
problems decreased, particularly between T0 and T1 
when the largest reduction in severe problem scores oc-
curred. The exception to this rule was in the two items 
causing most need at baseline; not being able to share 
feelings and not having enough help and advice for the 
family to cope. In these areas, severe problems were ap-
parently reduced only to the status of moderate prob-
lems, causing an increase in the proportion to report 
moderate problems.
Figure 20 and Table 54 show the change in APCA 
African POS total score over time. APCA African 
POS total score increased, reflecting a reduction in 
multidimensional problems. The multilevel model in 
Table 54 shows that the average increase between time 
points was 0.68 and the improvement over time was 
statistically significant (p<0.001).
6.3—Participants with the Most Need at Baseline
It is of particular concern that individuals with the 
most severe problems relating to their HIV status 
should receive appropriate care. It is possible that the 
most intractable problems are not dealt with sufficient-
ly, and that an average improvement in scores hides 
this. For this reason the participants with the worst 
outcomes at baseline were examined to see how their 
outcomes changed over time.
Table 53: Proportion Reporting Severe and Moderate  
Problems by Multidimensional Item Over Time
T0
n=696
T1
n=634
T2
n=613
T3
n=592
Pain severe 8.1 2.5 2.6 2.0
moderate 43.3 27.1 22.0 22.8
Symptoms severe 2.7 1.1 0.7 0.8
moderate 32.2 16.4 18.3 15.0
Worry severe 11.2 3.3 2.1 3.2
moderate 27.7 19.1 16.2 15.2
Share feelings severe 54.5 49.7 42.4 40.9
moderate 24.0 28.1 37.7 34.8
Life worthwhile severe 13.4 8.4 5.6 4.2
moderate 15.5 10.3 8.5 10.1
Peace severe 15.8 8.5 7.3 6.3
moderate 27.0 19.9 17.0 17.1
Help and advice severe 51.3 39.0 29.9 30.2
moderate 25.1 35.2 33.6 32.8
Table 54: Mixed-Effects Model of APCA African POS Total Score Adjusting for Baseline APCA African POS Total Score and Time
Coefficient Standard Error Z P 95% CI
Baseline total POS score 0.239 0.025 9.39 <0.001 0.189–0.288
Interview number 0.684 0.111 6.14 <0.001 0.466–0.902
Constant 18.883 0.847 22.30 <0.001 17.223–30.543
Figure 20: Change in APCA African POS Total Score Over Time
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Table 55: Mixed-Effects Model of Physical Health Score  
Adjusting for Baseline Physical Health Score and Time for 
the 20% with the Lowest Physical Health Score at Baseline
Coefficient
Standard 
Error
p 95% CI
Baseline physical 
health score
0.6 0.2 <0.001 0.3–0.9
Interview 
number
3.6 0.6 <0.001 2.5–4.7
Constant 21.3 4.7 <0.001 12.0–30.6
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Figure 21: Mean Physical Health Score Over Time for the 20% 
with the Lowest Physical Health at T0
Table 56: Mixed-Effects Model of Mental Health Score 
Adjusting for Baseline Mental Health Score and Time for the 
20% with the Lowest Mental Health Score at Baseline
Coefficient
Standard 
Error
p 95% CI
Baseline mental 
health score
0.3 0.1 0.022 0.04–0.5
Interview 
number
2.5 0.4 <0.001 1.7–3.4
constant 34.6 4.1 <0.001 26.6–42.6
Figure 22: Mean Mental Health Score Over Time for the 20% 
with the Lowest Mental Health Score at T0
6.3.1—Physical and Mental Health Scores
Participants who scored in the lowest 20% of the men-
tal health score and the physical health score at baseline 
(T0) were examined separately to see how their out-
comes changed during the time of the study.
The mean physical health score of participants in 
the lowest 20% physical health score of the popula-
tion (n=138) was 28.2 (sd 5.9) at baseline (T0), and a 
mean of 48.1 (sd 11.7) at T3. This was a mean increase 
of 19.8 (sd 12.6), which was clinically and statistically 
(p<0.001) significant and shows that participants with 
poorest physical health at baseline also improved during 
time under care (Figure 21 and Table 55). 
The mean mental health score of participants in 
the lowest 20% of the population (n=552) was 34.0 
(sd 6.1), and a mean of 51.4 (sd 8.1) at T3. This was a 
mean increase of 17.3 (sd 9.5). The increase over time 
was statistically significant (Table 56 and Figure 22), 
although the baseline value of mental health score was 
less predictive of change than was the case for physical 
health score, shown by the wide 95% confidence limits 
and higher (but still significant) p-value.
6.3.2—Multidimensional Care Scores
Severe pain and symptoms are sometimes complex and 
intractable. The scores over time for those who reported 
either overwhelming or very severe pain and symptoms 
at T0 were analysed to determine whether these prob-
lems were resolved. 
Table 57 shows that, for both pain and symp-
toms, most participants with the worst problems at T0 
showed improvement. 
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Table 57: Pain and Symptom APCA African POS Item Scores 
Over Time for Those Who Experienced the Worst Two Scores 
at T0
Pain Symptoms
T0 T1 T2 T3 T0 T1 T2 T3
Overwhelming (0) 9 0 1 0 3 0 0 0
Very severe (1) 48 2 2 3 16 0 0 0
Severe (2) – 6 2 3 – 3 0 1
Moderate (3) – 17 13 14 – 4 3 4
Slight (4) – 16 9 12 – 8 4 4
None (5) – 11 23 16 – 3 9 7
Total 56 52 50 48 19 18 16 16
Table 58: Mean Physical Health Score by Timepoint and Facility
Facility
T0 T1 T2 T3
mean sd mean sd mean sd mean sd
155 43.1 12.8 49.0 11.7 51.3 11.7 52.9 10.0
156 49.5 9.2 51.8 9.3 51.5 9.6 51.9 9.8
157 47.4 11.6 52.8 9.4 54.2 8.6 56.6 7.4
158 46.7 11.8 50.3 10.3 52.3 8.9 54.6 6.9
159 47.1 9.6 51.3 9.1 53.2 7.8 53.4 7.7
160 42.6 11.2 46.5 11.3 49.2 11.5 50.8 11.5
Figure 23: Change in Mean Physical Health Score Over Time for 
Each Facility
6.4—Variation by Facility
Multilevel models of the health outcomes over time 
without covariates showed that the great majority of 
variance was between individuals rather than between 
facilities (results in Appendix I). For physical health, 
the variance was 52.1 (se 4.0) between individuals and 
2.9 (se 2.3) between facilities. Nonetheless there was 
a measurable difference between facilities, which is 
explored in the following section.
Table 58 and Figure 23 show that the mean physi-
cal health score increased at all facilities over the course 
of the study. Facility 156 had the highest mean physi-
cal health score at baseline (49.5), and Facility 160 the 
lowest (42.6). Participants at Facility 155 showed the 
largest increase in physical health score (an increase of 
9.8 by T3). Participants at facility 156 had the smallest 
increase in physical health score (2.4 by T3) and also 
showed little increase in mental health score after T1. 
Mean physical health score for all facilities except 156 
and 159 showed steady increases with each subsequent 
month.
Table 59 and Figure 24 show that the mean mental 
health score increased at all facilities over the course 
of the study. Facility 156 had the highest mean mental 
health score at baseline (49.7), and Facility 160 the 
lowest (46.4). Participants at Facilities 157 showed the 
largest increase in mental health score (9.9 by T3) and 
participants at facility 156 the lowest (4.7 by T3). The 
trajectory of change in mental health score varied by 
facility. Participant mean mental health score at facili-
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Table 60: Association of Physical Health Score with  
Demographic Variables (One at a Time), Using Fixed Effects
Variable Coefficient
Standard 
Error
z p 95% CI
Gender 0.829 0.599 1.38 0.166 -0.345 to 2.003
Age -0.065 0.031 -2.10 0.036 -0.125 to -0.004
Education -0.166 0.390 -0.43 0.670 -0.931 to 0.599
Wealth 0.562 0.219 2.56 0.010 0.132 to 0.992
CD4 count 0.003 0.001 2.11 0.035 0.000 to 0.005
Table 61: Association of Mental Health Score with  
Demographic Variables (One at a Time), Using Fixed Effects
Variable Coefficient
Standard 
Error
z p 95% CI
Gender 0.030 0.489 0.06 0.951 -0.928 to 0.987
Age -0.041 0.025 -1.63 0.103 -0.090 to 0.008
Education 0.418 0.317 1.32 0.188 -2.036 to 1.040
Wealth 0.589 0.185 3.19 0.001 0.227 to 0.951
CD4 count 0.001 0.001 0.63 0.530 -0.001 to 0.003
ties 155 and 160 showed rapid increases between T0 
and T1, which subsequently levelled off. Participant 
mean mental health score at facilities 156, 157 and 
158 showed steady increases from month to month. At 
Facility 159 mean mental health score increased from 
T0 to T2, but then decreased at T3. 
6.5—Participant Characteristics
The two outcomes, physical and mental health score, 
were modelled with each of the five demographic 
covariates gender, age, education, wealth quintile and 
CD4 count, one by one. The relationships between each 
outcome and each covariate and presented in Tables 60 
and 61. Table 60 shows that age, poverty quintile and 
CD4 count were individually associated with change in 
physical health score over time at the 5% level. Table 61 
shows that poverty was associated with change in men-
tal health score over time. These variables were carried 
forward into the multivariate analysis.
Table 59: Mean Mental Health Score by Timepoint and Facility
Facility
T0 T1 T2 T3
mean sd mean sd mean sd mean sd
155 47.0 10.1 53.6 8.4 55.1 6.8 55.7 6.2
156 49.7 8.2 51.8 9.1 53.3 9.0 54.4 7.9
157 47.5 10.2 53.1 9.0 55.0 7.8 57.4 7.0
158 48.4 9.5 51.5 8.5 53.3 8.0 55.2 7.9
159 49.5 9.7 52.2 8.2 56.0 6.6 54.7 7.4
160 46.4 8.6 51.2 7.8 52.6 8.9 52.5 8.9
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Figure 24: Change in Mean Mental Health Over Time for Each 
Facility
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baseline mental health score were associated with the 
outcome; on average, mental health improved, and ini-
tial score was a good predictor of improvement. Neither 
TB treatment nor ART was associated with change in 
mental health score over time (TB treatment coefficient 
= -0.55, p=0.383, ART coefficient=0.014, p=0.974). 
6.7—Care Availability
Each of the eight care themes was included in a multi-
level model to identify which ones were associated 
with mental or physical health over time. In the tables 
below, each row refers to a different model including the 
named coefficient. These models also included T0 physi-
cal health score, T0 mental health score and time, and 
the demographic variables which were associated with 
the outcome (age, poverty quintile and CD4 count for 
physical health score, poverty for mental health score).
Table 64 shows that mental health score was not 
significantly associated with any care variables when 
they were modelled individually with wealth quintile 
and baseline outcome values. 
Physical health score was not associated with 
any care theme variables at the 10% level when each 
care theme was modelled separately (Table 65). Only 
baseline CD4 count, baseline physical health score, and 
mental health score were associated with the outcome. 
6.6—Antiretroviral Therapy and TB Treatment
Having established that receipt of TB treatment at 
baseline was associated with lower physical health, 
while receipt of ART was not associated with either 
outcome, longitudinal analysis was used to investigate 
the association of care with outcomes over time. 
Table 62 shows the results of three models of 
physical health over time, all of them including CD4 
count and physical health score at the beginning of the 
study. In addition, one model includes the receipt of TB 
treatment and the other includes ART. The table shows 
that TB treatment was weakly associated with physi-
cal health score over time (coefficient= -1.35, p=0.075). 
There is some evidence that people receiving TB treat-
ment had lower physical health score and experienced 
less improvement in physical health score over three 
months, although it does not meet the previously estab-
lished criteria for significance. By contrast, there was no 
association between receipt of ART and physical health 
score, either at baseline or over time (coefficient=0.26, 
p=0.590). CD4 count was positively associated with 
physical health over time. Table 62 also reveals that the 
majority of unexplained variance was between individu-
als rather than between facilities. 
Table 63 shows the results of the same analysis us-
ing mental health score as the outcome. Only time and 
Table 62: Multi-level Mixed-Effects Models of Physical Health Over Time Adjusting for Individual Care Received
No Treatment TB Treatment ART
coeff se p coeff se p coeff se p
Intercept 28.500 1.378 <0.001 29.232 1.433 <0.001 28.285 1.437 <0.001
Time-invariant Physical health score at T0 0.431 0.027 <0.001 0.420 0.028 <0.001 0.431 0.027 <0.001
CD4 at T1 0.003 0.001 0.035 0.002 0.001 0.053 0.003 0.001 0.030
Time-varying ART – – – – – – 0.257 0.477 0.590
TB treatment – – – -1.349 0.758 0.075 – – –
Time 1.245 0.206 <0.001 1.246 0.206 <0.001 1.234 0.207 <0.001
var se var se var se
Random Between facilities 1.014 0.968 1.140 1.046 1.024 0.975
Between individuals 22.741 3.371 22.156 3.350 22.778 3.374
Time slope 3.069 0.719 3.028 0.714 3.063 0.719
Residual 40.273 1.912 40.506 1.925 40.292 1.912
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Table 64: Mixed-Effects Models of Mental Health Score Over Time with Individual Care Themes
Covariate Coefficient Standard Error Z P 95% CI
Pain  
management
2.637 7.234 0.36 0.715 -11.541 to 16.815
Spiritual care 4.856 4.210 1.15 0.249 -3.396 to 13.108
Counselling/advice 0.776 20.764 0.04 0.970 -39.922 to 41.473
Nursing care -0.325 2.153 -0.15 0.880 -4.546 to 3.896
Symptom  
management
1.066 6.368 0.17 0.867 -11.414 to 13.546
Nutrition 2.164 6.489 0.33 0.739 -10.555 to 14.883
Social care -0.054 4.399 -0.01 0.990 -8.675 to 8.567
Prevention care -0.911 12.379 -0.07 0.941 -25.173 to 23.351
6.8—Multivariate Modelling
The only covariates to be associated with change in 
health outcomes were demographic variables which did 
not change over time. For mental health, only wealth 
was associated with outcome. Three demographic 
variables (age, CD4 count at baseline, and relative 
wealth) were associated with change in physical health. 
These are modelled below in Table 66. In Model A, the 
association of change in physical health with the CD4 
count was just under significance (p=0.051) so Model B 
was developed without including CD4 count. 
Table 66 shows that all covariates in Model B 
showed significant association with the outcome, but 
Model A had less unexplained variance and missed 
significance on one covariate by only 0.1%. In both 
models, higher baseline health scores, greater relative 
wealth and younger age were associated with better 
physical health and greater improvement in physical 
health score over time. The great majority of variance 
was between individuals rather than between facilities.
Table 63: Multi-level Mixed-Effects Models of Mental Health Over Time Adjusting for Individual Care Received
No treatment TB treatment ART
coeff se p coeff se p coeff se p
Intercept 34.205 1.387 <0.001 34.391 1.403 <0.001 34.194 1.432 <0.001
Time-invariant Mental health score at T0 0.350 0.026 <0.001 0.348 0.026 <0.001 0.350 0.026 <0.001
CD4 at T1 0.001 0.001 0.530 0.001 0.001 0.619 0.001 0.001 0.535
Time-varying ART – – – – – – 0.014 0.416 0.974
TB treatment – – – -0.553 0.633 0.383 – – –
Time 1.289 0.177 <0.001 1.288 0.177 <0.001 1.288 0.178 <0.001
var se var se var se
Random Between facilities 0.980 0.835 0.996 0.845 0.983 0.837
Between individuals 19.393 2.576 19.399 2.572 19.406 2.578
Time slope 0.185 0.478 0.172 0.477 0.186 0.478
Residual 34.270 1.549 34.307 1.551 34.290 1.550
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Table 66: Multi-level Mixed-Effects Models for Physical Health Over Time
Model A Model B
Fixed Effects coeff se p coeff Se p
Time 1.240 0.206 <0.001 1.371 0.196 <0.001
Physical health at T0 0.373 0.034 <0.001 0.370 0.031 <0.001
Mental health at T0 0.094 0.039 0.017 0.113 0.037 0.002
Relative wealth 0.643 0.228 0.005 0.532 0.217 0.014
Age -0.075 0.032 0.020 -0.072 0.031 0.019
CD4 count at T1 0.002 0.001 0.051 - - -
Random Effects variance se variance se
Facility 0.743 0.787 0.875 0.840
Individual—time slope 3.044 0.716 2.392 0.669
Individual 21.366 3.318 23.658 3.201
Residual 40.435 1.922 41.241 1.870
Table 65: Mixed-Effects Model of Physical Health Score Over Time with Individual Care Themes
Covariate Coefficient Standard Error z p 95% CI
Pain  
management
-2.574 5.528 -0.47 0.642 -13.408 to 8.261
Spiritual care 0.650 3.759 0.17 0.863 -6.717 to 8.017
Counselling/advice -14.625 14.281 -1.02 0.306 -42.614 to 13.365
Nursing care -1.580 1.470 -1.07 0.282 -4.461 to 1.301
Symptom management 0.721 4.992 0.15 0.884 -8.926 to 10.368
Nutrition 5.985 4.168 1.44 0.151 -2.184 to 14.154
Social care -1.071 3.368 -0.32 0.751 -7.673 to 5.531
Prevention care -3.683 9.317 -0.40 0.693 21.944 to 14.577
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The coding frame is presented below. Italicised phrases 
are examples and explanations of the codes. This frame 
was derived from two independently developed frames, 
one in Kenya and one in the UK, which are presented 
in Appendix K. Patient, carer and staff interviews were 
all coded using the same frame. 
7.1—Agreed Coding Frame
 » Unmet needs—not what is provided, but what is self-
identified as needed
•	 staff
•	 carer
•	 patient
 - social/financial
* food
 - clinical (e.g., CD4, pain, skin rash, diarrhoea)
 - emotional/psychological (e.g., stigma, worry, 
bereavement, anxiety, desire for child)
 - preventive (e.g., ITNs, safe water, condoms)
 » Components of care provided—what facilities say 
they actually do and what patients say they got
•	 bereavement/care of dying
•	 carers
•	 spiritual
•	 socio-economic
•	 psychological and emotional (e.g., information 
and advice)
•	 clinical (e.g., VCT, RCT,ART, curative, lab 
services)
 - adherence counselling
•	 preventive (e.g., ITNs, CTX, condoms, water)
 » Experiences of delivering and receiving care—staff, 
patient, and carer views
•	 experiences of receiving care—patient and carer 
only
 - positive
 - negative
•	 facility strengths and challenges
 - strengths
* best practice and lessons learned
 - challenges
•	 suggestions for improvement
 » Multiple identities: patient, staff and carer roles—
description of how patients perform multiple patient, 
staff and carer roles
 » Access to care—factors associated with starting care 
and choice of facility
•	 health seeking behaviour—reason for initiating 
care
•	 process of choosing facility—including being 
given referral letter
•	 eligibility criteria
•	 retention/shopping around
•	 costs to patient
 » Clinical standards—care processes and protocols
•	 process of enrollment
•	 frequency of contact
•	 monitoring and documentation
•	 referral mechanisms and reasons
•	 education and training of staff
•	 supervision of staff
The data are presented by each coding frame cat-
egory in turn, and then the broad themes are reviewed 
and integrated. Each data theme is illustrated using 
a direct quote from the transcripts and the anony-
mous identification for each respondent is given. The 
inclusion of identification numbers demonstrates the 
selection of data from across the sample. The number 
represents the facility ID, and P=patient interview, 
S=Staff interview and C=family carer interview. 
7.2—Description of Sample
At each facility, seven patient interviews and five staff 
interviews were conducted. Four of the facilities hosted 
7
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five carer interviews each, and there were three at facili-
ties 156 and 159. Patients were 67% (n=28) female, 
aged from 20 to 56 with a median of 34. The majority 
(n=23) lived in rural areas, the mean household size 
was 4.7 and 71% (n=29) were receiving ART. Just over 
half of carers (n=14) were female, aged from 20 to 72 
with a median of 37, living in households of a mean 
5.6 people. By self-described relationship to the patient 
they consisted of four mothers, one father, one sister, 
one brother, two daughters, two sons, two wives, six 
husbands, three aunts, one friend and one cousin. 
These terms may be more expressive of social than 
blood relationship; one carer introduced himself as a 
patient’s father but later explained he was her uncle. 
The staff interviewed had worked at the facility for a 
median of two years, ranging from two months to 26 
years. They were six clinical officers, four nurses, four 
nutritionists, two nurse counsellors, two doctors, two 
community nurses and ten staff of other grades.
7.3—Unmet Needs 
The data category of unmet needs demonstrate that 
patients and families reported having multidimensional 
needs across domains. Further, the clinical staff identi-
fied their own professional needs to enhance care. 
7.3.1—Staff Needs
A wide range of professional needs to be able to 
perform their roles were described. Firstly, they had 
a number of training and education needs that were 
broadly non-clinical and managerial by nature, encom-
passing administration, management and IT: 
“we handle a lot of logistics, I would wish to do logistic management… 
I use computer also in dispensing, so programming sometimes become a 
problem; you log a patient and it is just bringing its own things, it is not 
bringing you what you want. That requires more knowledge of computer.” 
—S001 155
Second, the clinical management of paediatric HIV 
and patients was identified as a staff need: 
“I would like to learn more on dosage and care for children who are HIV 
positive and also on the issue of disclosure to children about their status.” 
—S001 156
Third, general clinical updates were identified, 
including ART, palliative care, nutrition, and PMTCT 
to keep clinical skills up to date: 
“You know in training you are supposed to be updated so these should be 
continuous. It’s a long time since I attended a training to update me on 
HIV/AIDS treatment and management. It’s good to attend such training 
so that you can update yourself because may be there are new drugs or 
therapy in the market and there is need for one to be updated on this.” 
—S005 156
“I think ART is a new area and I think there is always a lot to learn. I have 
always wished to go and do an in depth course.” —S001 159
“Training on dealing with co morbidity because sometimes we have 
patients who present with hypertension, diabetes, are HIV positive and are 
taking a myriad of drugs.” —S002 156
“…the palliative care. Sometimes we have the very sick ones with the 
pains, Kaposi’s and all that. So I would want. I have something small but I 
feel I need to know more of how to assist them with these pains.” —S003 
157
Fourth, training needs were described in general 
psychosocial care, including death and dying: 
“I would like to be trained in psychosocial issues and also on how to help 
HIV/AIDS patients die a peaceful death i.e., so that one does not die cursing 
their next of kin or partner.” —S003 156
“I want to be trained in psychology. I am dealing in paediatric, the 
adolescent age is a very difficult age; they want to become sexually active 
and they realise they are HIV positive and disclosure is a challenge to me 
because when the child reaches the age of 10–12 years, some children 
even refuse to take the medicine; in fact I wanted to be trained on paediat-
rics and psychology on how to go about it.” —S004 158
Fifth, staff were keen to be able to engage mean-
ingfully in research within their facility, to be able to 
collaborate with overseas research partners and to lead 
research locally: 
“I think I can do some research work better that is what I feel and think 
especially related to HIV. I have been in the field for the last 4 years and I 
think I can do research better.” —S004 158
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“The way we are here at [name], we can be able to do our own research 
other than having outsiders like from New York coming to tell us to do 
certain things. We can sit as ourselves here at [name] and decide because 
whatever the New York people are trying to collect, these are the things 
that we are doing here. When they come they just write the information 
that we have. We are lacking the methodologies.” —S002 158
7.3.2—Family/Carer Needs
Family/carer needs focused on the socioeconomic 
problems of feeding and caring for the patient, enabling 
them to attend clinical care, and on the psychological 
challenges of being a carer:
“We have had money related problems; we have to look for money to en-
able us attend her clinical appointments… I would say is that my biggest 
problem is how to get money to bring her to the clinic.” —C001 156
“But they could be assisted through issuing of loans. This could really 
improve their lives.” —C001 158
“That is the burden which I have because I have to work hard, I am forced 
to borrow or take a loan so as to provide food for him. The other issue is 
transport… What I would like to say is that I have clients who are sick, 
this patient being one of them, although he stays separately. I have other 
whom I stay with. How can the government assist me so that I am encour-
aged as I take care of these clients since I was not blessed with children but 
He gave me a helping heart to help those in need?” —C001 160
“Again, she has school-going children and school fees then also becomes a 
problem. So that is where the problem is.” —C002 159 
Family poverty is compounded by caring for their 
HIV positive family member: 
“You see when I am offering assistance to [name], it is not easy but I have 
to try real hard and I don’t come from a very good background… For 
instance my parents died when I was very young so I am also have been 
struggling in life. So when I am looking for my own support I have to look 
into her needs as well.” —C003 156
“We can work hard to get our daily needs like food but we may only be 
getting one type of food. If we could get things like fruits, it would be 
very good. Sometimes I can get an orange but when I cut it into pieces for 
everyone including my children, I may feel like I am giving the patient a 
small piece. This is because the patient cannot eat alone while the child is 
just watching.” —C004 158
However, the psychological needs of family carers 
were also described: 
“I don’t think there is any other thing I can say. Otherwise I don’t want to 
look that I am sick and I don’t want my wife to be stressed. What we need 
is the home based care people to come and see us; you know when you 
come and talk to us, we feel that we are with you, but when we are alone 
we feel lonely” —C003 155
“I have had emotional problems; sometimes one gets disturbing thoughts 
and you find that her illness also affects me because I have to keep think-
ing about her constantly.” —C003 156
7.3.3—Patient Needs
The multidimensional needs of patients spanned the 
social/financial (especially food), the clinical/medical, 
the emotional/psychological and preventive care needs: 
“The biggest problem is food because sometimes we are on drugs and 
we need to get the diet as claimed, because you know sometimes we are 
sick and we are not on payroll. This forces us to look for what we can eat” 
—C003 155
Respondent: “As a parent, I have financial problems because the kids are 
not going to school.”
Interviewer: “Are there some children who have dropped out of school?”
Respondent: “Some have dropped out and some are not in school, in fact 
most of them are not in school.” —C003 155
“I am a sister to her mother and my husband died and I am unable to 
provide; so if they could assist us in whichever way, because she needs to 
eat well. At times you may get something to eat and other times you may 
not get something to eat. But we know that God is there.” —C004 157 
The ability to attend and benefit from a clinic is 
challenged by poverty even if the patient is able to pay 
for transport to attend:
“When we come here, we should at least be given something to drink. 
Because at times you can be waiting to be attended to until 1pm and may 
be you don’t even have some money to buy a cup of tea.” —P001 157
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“I am unemployed. When I am asked to buy some medicines, I don’t have 
the money. There was a time when I was prescribed for some eye drops 
that were about five hundred and something shillings and I was unable to 
buy it. When I came back to the clinic for my next appointment, I told them 
that I had not purchased the medicine.” —P001 157 
“Yes, even last week I was told by someone who was in the pharmacy 
that, ‘we don’t have these drugs for the stomach; Go and buy these drugs.’ 
” —P004 159
Patients’ clinical and medical needs focused mainly 
around the ability to obtain prescribed medications. 
Stock-outs in pharmacies necessitate patients going 
elsewhere to purchase medicines to relieve problems:
Interviewer: “Are there times you have had to buy?”
Respondent: “Yes, several times. They seem to miss Dapsone so much but 
foliate and multi vitamin they do have.”
Interviewer: “So Dapsone, many times you have to go and buy. 
Respondent: “Yes, I have to go and buy and sometimes also foliate I used to 
buy.” —P002 156 
This was verified by staff interview data:
 
“Also as much as we have drugs, they are not enough for patients. Oc-
casionally we run out of drugs especially the Opportunistic Infection drugs.” 
—S003 155 
“The two or I would say three key drugs which we usually buy but they are 
never enough for our patients are Pyridoxine, amitriptyline or other tricyclic 
antidepressants which most of the time is not well supplied. We also need 
acyclovir because we discovered that it is a very expensive drug and we use 
it frequently; so most of the time even if we prescribe it, the patients are 
not able to buy.” —S003 155
The most commonly reported patient physical 
problem was pain:
Respondent: “And my chest is painful and uncomfortable; I am coughing 
and producing very black/dark saliva and thus I am wondering why… I 
have painful joints and especially when I am sleeping.
Interviewer: “So you have painful joints?”
Respondent: “Yes, whenever I lie down, it becomes difficult to rise up.” 
—P003 159
“My whole body hurts and I spend a lot of time in bed; I have no energy 
and I am not able to get out of bed.” —P006 159 
Emotional and psychological care needs were un-
derlined by the experience of living with the diagnosis, 
made more difficult by the stigma, which may originate 
within the family:
“I used to live with my sister and I don’t get along with her. When she 
heard that I have the HIV virus, she chased me away. I now live with other 
ladies and I don’t work.” [Starts to cry] —P002 158
“It’s that if your family does not accept you, you have to suffer; but if your 
family realise that you are a part of them, they will help you.” —P002 156 
The discrimination was also reported as originating 
from within the wider community:
“Also the society; the society does not accept someone who is HIV positive; 
they still fear; they still talk about you and many patients are affected by 
the stigma.” —P002 156
“I can stay without telling anybody about it; also I do not disclose to people 
that I have the HIV virus because I fear if I disclose to anyone, they will look 
at me differently and then start discriminating me in front of other people, 
so I just say I will die with it in my heart.” —P002 159 
Emotional problems were multifaceted- both as 
a result of living with the knowledge of diagnosis and 
related to the financial problems experienced as a result 
of the diagnosis:
“At times when I start having a lot of thoughts my head throbs.” —P002 
159
“The other problem is, you come to town; you try to find a job; you don’t 
get; you go home; you are so troubled; my heart sometimes go down; 
psychologically, I am so much affected.” —P002 156
Patients and families had a number of preventive 
care needs, and these were broadly representative of the 
preventive care package (prevention of transmission, 
nutrition, ITNs) plus the recurring issue of food and 
finance.
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“Buying for her fruits is also a challenge since people do not grow fruits 
in my village and thus one has to go looking for them with lack of money 
also being a challenge and it was during the dry season.” —C003 156 
“The assistance that we would like to get is provision of bed nets especially 
to those of us who cannot afford because there are a lot of mosquitoes at 
our place.” —P005 158
Patients described a wide range of discussions that 
centred on infection and transmission control, however 
a small number had not received this:
Interviewer: “You know this disease is not only transmitted through 
sexual intercourse; you can also infect other people through other ways; 
so whenever you come here, do they ever tell you how you can prevent 
infecting others?”
Respondent: “I have never gotten someone to ask me what you are asking 
me now.” —P005 156
7.4—Components of Care Provided
When staff, patients and families were asked about 
the care they have specifically delivered and received, 
prompts were given for the multidimensional possible 
areas of care. 
7.4.1—Bereavement Care and Care of the Dying
The provision of bereavement care appeared rare in this 
sample, most likely due to research interviews taking 
place in the outpatient setting: 
Interviewer: “What happens to dying patients?”
Respondent: “Dying patients; well…we have not received such most of 
them are in the ward. Most people who walk up to here are able… It 
could be their relatives who come and pick the drugs for them, but we 
don’t quite encounter them” —S001 155 
“Who are referred on to wards, although some work is done to prepare for 
death after we have seen the patient for sometime, and we realise that this 
patient is definitely not coming up, we do counsel them. When the patient 
is at a very advanced stage of HIV and they open up, that’s the time we 
counsel the family members and tell them to be prepared. Again, because 
it’s a chronic disease and our patients are generally out patients, we don’t 
take the really sick patients in our clinic. The only people we counsel are 
their family members.” —S001 158
“We have not had any arrangement of that kind in the [name] program, 
but normally when we get cases that are reported in the clinic that has 
passed away, there is little we can do because we don’t have any funds for 
that. The only thing we can do is just to close the file and say ‘we are sorry’. 
If willingly you as a person you have something that you can give them, 
you can either chip in or give as an individual. But for the [name] they have 
not put in any program of that kind.” —S002 160 
There was recognition that acceptance of death 
should be advanced:
“Like they need to know that; yes we are giving them hope or I as a coun-
selor/ nutritionist am giving them hope but they also need to know that 
they will be dead sometimes. But actually, so as to say, there is no formula 
for death; whether one has HIV or no HIV, there is death. And so, I would 
really like to go ahead and encourage them and actually make them know 
that death will come and it is good if they also had it in their minds. And if 
they know this, then they should also prepare for it and if possible if they 
are brave enough, they will discuss with the family members.” —S002 159 
When it was delivered, end of life care could have 
appeared rudimentary:
Interviewer: “What about bereavement? That is things to do with death 
and dying.”
Respondent: “Rarely… I tell them that it’s God’s wish and am sorry about 
it.” —S001 156 
When terminal and bereavement care was provid-
ed, it appeared to be about preparation for death rather 
than palliation:
“We haven’t talked much about it although we tell them to take photos 
for their young ones. But we tell them it’s not like they are going to die, 
because even us we take photos. We tell them it’s so that their children can 
have a look at the photos and see how their mum looked like. We also talk 
about legal things like how they can write a will so that their property is 
not taken by other people.” —S001 157
The (erroneous) perceived cost of palliative drugs 
was offered as a reason for lack of provision:
Interviewer: “What happens with the dying patients?”
Respondent: “They need more palliative drugs. The cost is very expensive.” 
—S001 157
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There is a reluctance to talk about, and to hear, the 
topic of end of life apart from those with advanced 
disease and HIV-related cancers:
Interviewer: “OK. Do you talk about bereavement?”
Respondent: “Not that much. It’s a painful subject that people sometimes 
are afraid to discuss not unless you have talked with a patient may be three 
or four times and you have developed some rapport. Otherwise it would be 
rather negative the first time you see a patient and you are talking about 
death and bereavement. It’s like you are not giving them any hope whereas 
in this clinic we are trying to say there is hope because we offer ARVs. 
So unless you have been with a patient for long, this is only when then 
you can sit down and say “you know this can actually happen [meaning 
death]. May be there are two or three patients who have come our way 
who are HIV positive and have got cancers and these are the ones we have 
tried to prepare and tell them “yes, I think we can do something about the 
HIV but for this cancer, I think we are stuck and this is may be what is going 
to happen”. I have had an opportunity to prepare one or two patients like 
these.” —S001 159
Those clinicians able to broach the topic of death 
and dying were seen as “brave”:
“I was saying, in this set up since its just like a normal ward set up, we 
have not put any extra effort as in we just want to give life support. If you 
find that there is a brave clinician in the ward, then he/she can be able to 
prepare the relatives and tell them ‘this person I do not think we will be 
able to save them and we are just waiting for time. Have you done one, 
two things, three and four?’ But then there aren’t very many health care 
workers who are able to do this.” —S001 159
Some appropriate clinical intervention and concepts 
of palliation were well described, and the lack of inpa-
tient space seen as limiting end of life care potential:
“we admit the patients because they might need oxygen or something 
which they can’t get at home. At the same time the general condition 
might be poor so the patient can’t even take oral medicine so they are 
given food using IG tubes or IV infusion. They are given analgesics. We try 
to make their last days not as painful or as stressful as it would have been. 
Sorry to say that… but in the wards there is a problem. The space limits 
our efforts.” S002 157
7.4.2—Family Carers
The focus on carers within clinical time was described 
to be as a means to ask questions about the patient 
rather than carer wellbeing:
Interviewer: “And do the HCWs ever ask you whether you have any prob-
lems as you provide care to [name]?”
Respondent: “Yes, they usually ask me because I am the one who brings 
her here most of the times.”
Interviewer: “What questions do they usually ask you?”
Respondent: “They usually ask me how she is doing and I tell them.” —
C002 159
“The advice that I am mostly given is on how to live with and take care of 
my patient.” —C003 159 
Interviewer: “When you come here and meet with the HCWs (health care 
workers), what are some of the things that you discuss with them? What 
do they tell you?”
Respondent: “Nothing.”
Interviewer: “They don’t ask you questions?”
Respondent: “No.” —P005 157 
This lack of focus on family carers was confirmed 
by staff:
Interviewer: “Do you ever see their families, the families of these patients?”
Respondent: “Ahhh… Not really unless the patient is incapacitated or the 
patient is unable or is not adhering well to the drugs.” —S001 155
Interviewer: “Do you offer any support to these families?”
Respondent: “None at all.” —S001 156 
There were, however, some examples of good prac-
tice in care for family carers:
“Support in terms of our advice, counselling, that’s the support we give 
the family members. We have a comprehensive family program where 
we send letters of invitation to the family members through the patient 
himself. We invite the family members to come to the clinic. They are seen 
by the counsellors. He talks to them about the kind of care expected by the 
positive member of the family and the kind of support they should give 
him in terms of nutrition general support about positive living and we also 
encourage them to test themselves in order for them to know their status. 
If they are willing to test, they test and if they are positive, they are free 
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to enroll in the program. If they are negative, then they are counselled on 
how to continue living as HIV negative people and about prevention of HIV 
from the positive ones.” —S001 158 
7.4.3—Spiritual Care
Facility staff often encouraged patients and families to 
keep hope through spiritual belief:
“They tell us to lay our hopes in God.” —C002 159 
“The HCW will also counsel from a biblical point of view and tell us that 
these problems are common and that one must persevere.” —P003 159 
“Sometimes when we are sitting at the waiting bay, someone may come 
and start preaching to us and eventually we pray together.” —P001 156 
“Since February, we started singing at the waiting area. We then pray and 
if you have a question, you can ask before you are treated and you are 
answered.” —P002 157 
However, it was slightly more common that 
patients/families were never spoken to about spiritual 
wellbeing by their clinical team:
“We only talk about clinical matters. I haven’t heard anything to do with 
spirituality.” —P001 158 
As well as providing support and meeting patients 
needs for spiritual wellbeing, religious observance is 
also instructed as part of clinical advice:
“They tell me, and especially the matron who has just left, “that we must 
trust God; this a problem in this world and there is nothing we can do; but 
just continue taking your medicine. So go to church, pray all the time; pray 
in the evening before you sleep; pray before you eat.” —P004 159 
“They tell us that we have to pray to God.” —P004 158 
This element of religious instruction as part of 
clinical guidance was confirmed by staff:
“Not so often but apart from talking about their disease of course one 
must always acknowledge that we as human beings can only do a certain 
amount and that there is somebody else who can definitely do much 
more-God.” —S001 159 
7.4.4—Socio-economic Care 
Interestingly, social support seems to be gained from 
fellow patients:
Interviewer: “Do you discuss social issues with the health care worker?”
Respondent: “No but a lot of these things we discuss amongst ourselves 
when we meet at the clinic.” —P001 156
It was not common for facility staff to ask about 
socioeconomic problems, and patients were sustaining 
themselves:
Interviewer: “What about financial issues?”
Respondent: the health workers?
Interviewer: “Yes.”
Respondent: “No they don’t. When you have been treated, you just go and 
pick your medicines and go home. That’s it.” —P001 157 
Interviewer: “What about social and financial issues, do you talk about 
them?”
Respondent: “We have not talked about it yet neither have talked it with 
us.” —P001 160
Patients and families had rarely discussed their so-
cioeconomic problems with facility staff or been asked 
about them. Several did mention having discussed and 
found support through their community, micro finance 
from a bank project, and their Church. The most com-
mon intervention appeared to be advice and encourage-
ment to be self sufficient:
“Yes, they advice to work for myself and not to always think that I am sick 
and that I cannot be able to work. They advice me to go out and look for 
work to do; say in a week I should try and work for two days.” —P006 156
Some patients did report being able to ask for 
transport cost reimbursement occasionally and to waive 
drug fees, and this was confirmed by staff who de-
scribed their attempts to meet the needs of those with 
fewest resources:
“Our health facility normally deals with very poor people. I am not saying 
that we don’t deal with people who can afford; but in most cases our cli-
ents who come to this facility are very poor they can’t afford; some cannot 
even afford a meal per day. Like now most of them are being cared for by 
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their grandmothers, especially the paediatrics, and others are retrenched 
and they can’t go to work because they are sick. So we give priority to 
those who cannot take care of themselves.” —S004 158
“The transport reimbursement. At the pharmacy if there are drugs that 
they need to buy, they can be waived.” —S001 157
Example of an employment opportunity and in-
come generation skills training were also given:
“We have a small farm where people who are strong can actually be 
employed on casual basis” —S001 159 
“Our patients also have support groups and within the support groups we 
assist them on knowledge on how to conduct income generating activi-
ties.” —S003 155 
“For those who think that they cannot do anything, I encourage them to 
look for something small. A business; something that can keep them going 
instead of just sitting down and waiting for handouts. For those who say 
that they don’t know how to start, I have some connections with some 
people who teach people about business and what have you. I tell them 
“go and see this person, this person will help you, you will understand how 
to start a business and how to help yourself.” —S003 158 
Referral on to appropriate agencies was also  
reported:
“They know that I deal with welfare issues and when patients are referred 
to me, I offer the necessary assistance. For instance in the case of orphaned 
and Vulnerable Children (OVC), I refer the very needy cases to children’s 
homes or advice them accordingly. Point number two, if a patient has no 
finances; they are referred to me and I am able to organize for a waiver 
system with the finance department.” —S003 156 
7.4.5—Psychological and Emotional Care
Provision of psychological care is both integrated and 
offered as a stand-alone intervention:
Respondent: “Yes, and I kept wondering, ‘now whom shall I talk to?’ But 
everytime I felt weighed down by stress, I just used to come to the [facility] 
and they were always welcoming.”
Interviewer: “So you sometimes you just come for counselling?”
Respondent: “Yes, for only.” —P003 156
Although the psychological problems associated 
with an HIV diagnosis was a common problem, and it 
was often described as a component received and highly 
valued, it was not routinely provided to patients and 
families:
Interviewer: “Do you ever discuss issues around stress with the HCWs?”
Respondent: “No, we do not discuss such things.” —C001 156
Interviewer: “And what about you personally; were you given some 
encouraging words?”
Respondent: “No.” —C002 156
A common coping strategy cited by patients as be-
ing the psychological care advice received was to avoid 
“thinking”, which could be seen as a cheap and effective 
intervention or as lacking a true component of psycho-
logical care:
Interviewer: “What about psychological care?”
Respondent: “No they don’t. The only time that we discussed with them 
is during that time when I was diagnosed with the virus. They told me to 
avoid having very many thoughts.” —P003 158
The provision of information was highly valued by 
family carers in being to cope psychologically:
“I can say the service here is good because it as helped me with a lot of 
information which has reduced the mental anguish that I had been having 
for a long time.” —C002 156 
Patients were encouraged to improve their psycho-
logical wellbeing through engaged in activities of daily 
living and social engagement:
“You should join a support group; they really insist that one should join a 
support group. If there is a wedding somewhere, you try to get involved; if 
there are some celebrations around, get involved. That is, you should try to 
be in the company of other people; you should not stay alone. That is the 
first thing that they tell you when you come here. It is something that you 
should discipline yourself. They tell us to not ever think like other people 
are isolating us. This is the first thing that they tell us.” —P003 158“
The concept of “counselling” in HIV care in 
Africa is worthy of exploration to understand what is 
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sought and delivered in this area of care. Interestingly, 
it appears to have a broader content than in Western 
cultures, and includes medical advice:
Interviewer: “And during these sessions; what do the HCWs tell you/do 
they give you any counselling?”
Respondent: “Yes they counsel me. In the first place I ask them questions 
such as; whether my weight is okay; whether my CD4 count is okay; and 
then I tell them how I am getting on with the medicine—if it has given 
me any side effects or its okay with me.” —P001 159 
Interviewer: “What are you told during counselling?”
Respondent: “We are told about the proper time to take your medicines, 
the kind of food that you should eat; a balanced diet. Things like that.” —
P001 157 
The support groups facilitated by clinics were 
highly valued:
Interviewer: “And what do you do during your support group meetings?”
Respondent: “During our meetings together with our HCWs, every person 
speaks out about their problems. There are times they visit us and we 
also tell them our problems. And there are times that even us, those who 
are HIV positive visit each other say, once per week we visit each other; 
educate each other; share experiences; talk to each other; encourage each 
other; and if we see one of us is down emotionally we try to uplift them.” 
—P001 159 
Psychological wellbeing is enhanced through reli-
gious support even when stigma has arguably reduced 
perceived community support:
“Even now that my neighbours do not come to visit me, I just feel 
contented because I am born again (saved); my children are born again 
too and they also come to console me. My husband is also born again and 
men from the church also come to visit him and we share the word of God 
together; so I feel contented even when neighbours shun me. And in any 
case, most of these people from the community will only visit with bad 
intentions of going to spread bad messages about a sick person.” —P005 
156 
7.4.6—Clinical and Medical Care
Attendance for routine phlebotomy and to collect anti-
retrovirals was the core clinical and medical activity:
“There is nothing else apart from being prescribed for medicine; dispensing 
to us medicine after which we just go home.” —C002 159 
This was enhanced by very frequent description of 
advice on adherence:
“They try to tell us about taking the medications and problems which may 
occur due to non adherence or not taking medicine.” —C001 160 
“We have been told that if she adheres to her medication and follows the 
doctor’s instructions, she will be okey with these. And that, things can only 
be bad if she fails to follow the doctor’s instructions.” C003 156 
“They tell us to use our medicine correctly and consistently; because if we 
stop, it can have effects on our bodies/health.” —P001 159
Being able to express problems is an essential 
component of HIV care, and patients also valued this 
opportunity and the feeling of being able to express 
their problems:
“They greet us; welcome us and they tell us to be comfortable; and to relax 
when we go to see the doctors and to explain whatever we are suffering 
from… to pour out just what we are suffering from.” —P001 156
“You know there are doctors that when you go to see them you get scared 
of telling them your problem, but these ones I can tell them everything 
that I want. I am free and I can say anything in case I don’t like something 
or I feel that what was done is not professional.” —P002 158 
7.4.7—Preventive Care
Core preventive activities were reported such as provi-
sion of condoms:
“As we have decided, I with my two wives have decided that we don’t 
want any more child, If I am out of my stock of the condoms, they give me 
all those.” —P001 155 
Provision of prophylactic antibiotics:
“The first day I came, the fact that I had already been confirmed that I was 
positive, I explained to them and that is why they first gave me septrin to 
see how it was going with my body. When I came back for the second time 
they found that I was improving, so they’ve continued giving me septrin up 
to date.” —P001 155 
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Nutritional advice:
“Most of the time we talk about feeding habits, how to live positively and 
the importance of disclosure to ones family. Usually the health worker 
gives me good advice and am able to relate well with my family and they 
take me just the way I am. They also tell me that if I get sick, I should 
just go back to them because they are in a position to understand my 
problems.” P001 156 
“We talk about nutrition, the food that I am supposed to eat, fruits, any 
problems that I could be experiencing as a result of taking the medicines, 
any side effects, and things like those… they tell you about a balanced 
diet, about vitamins, carbohydrates, proteins, things like those… carbohy-
drates like rice, ugali (meal made from maize flour); proteins like fish; fruits 
like paw paws, passion fruits and bananas.” —P003 157 
Prevention of transmission:
“When you finish using the condom, wrap it with tissue paper and dispose 
it off in a pit latrine so that your partner cannot get infected with the virus. 
If you have a wound somewhere and your partner doesn’t have, if you 
want to help, put on gloves and help in washing the wound. When you are 
assisting someone to give birth, for someone like me who has the virus, 
I must put on gloves. I cannot help the lady who s giving birth without 
wearing gloves. They teach us all that.” —P005 158 
7.5—Experience of Delivering and Receiving Care
7.5.1—Patient and Carer Experiences of 
Receiving Care
Positive experiences: The vast majority of respondents 
reported positive experiences of being under care. The 
three factors that appeared to constitute a positive expe-
rience were good staff attitude, availability of drugs, and 
short waiting times. A good staff attitude was associ-
ated with being welcoming, and an ability to effectively 
communicate needs and experiences to clinicians:
Respondent: “They talk to us very nicely. And you know nurses talk very 
rudely.”
Interviewer: “Talking very nicely is like telling you what?”
Respondent: [laughs] “You know you can ask a nurse something and she 
doesn’t respond. But these ones listen to you and give you a response.” 
—P001 157
“According to me, I find the facility okay… Because people are treated 
well.” —P003 159 
“OK, when we get in here, let me say nowadays we really thank God 
because the CCC staff supports us even in the way they approach us; they 
welcome us well; they say hallo and then ask you, ‘yes, my friend, how are 
you?’ and this helps to build the relationship further. So, this helps us to 
open up with anything that we may want to tell the HCW because it makes 
us fell like we have been to this person for long.” —P003 156 
“There is no pushing while getting the drugs, the nurses don’t insult us. 
Here they have very good intentions of helping us. Even if you are so help-
less, they assist you.” —P004 158 
Several patients made comments that the staff at-
titude could sometimes vary:
“What delights me is the fact that, for instance those people whom we 
find at the reception, apart from the one who was rude to me who I also 
did not feel so bad about because probably she also had other issues both-
ering her; I do not see anything about this place. Even at the pharmacy, the 
first time I went to get my ARVs I was treated well.” —P003 160 
“The other good thing about this place is that usually they receive us very 
well and show us love.” —P006 156 
“There are some who talk to us badly and some talk to us nicely.” — P007 
155
The second factor associated with a positive experi-
ence was the availability of medicines:
“I tried in Nairobi, but the kind of services I get from those people is differ-
ent from the kind of services I get here. On the other side they just provide 
you with medication without checking on your health. Yes, To me their 
service is perfect. That is why I would come out of my way to spend trans-
port to come here every two months. What I would say why I love this area 
[district] is that when I was getting treatment at Nairobi, I would be sent to 
almost every clinic around the city , going round the city from this hospital 
to another hospital, they don’t have this type of medicine. They would tell 
me to come tomorrow. That is why I missed taking some medicines for one 
day. You would not get all you wanted from one facility. I would be sent to 
some other facilities like [name] from [name] to [name], from [name] to 
[name], from [name] to [name]. One day I roamed in the city for almost a 
whole day without getting ARVs.” —P004 156 
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“No I don’t have any problem. When I want any medicine, I get it.” —P003 
158 
“Let me say that at the moment, we have not gotten any problem in rela-
tion to getting medicine but before, one would come here and get some 
medicines and miss others; but for now, all medicines are available here 
and again service is offered fast.” —P003 156 
Not spending too long waiting for clinical investiga-
tions and appointments was also praised:
Interviewer: “What else is good about the services?”
Respondent: “We don’t overstay at the laboratory.” —P005 158 
“I love it because they attend to me quickly and when one comes in the 
morning, they are able to go back home early and continue with their 
work.” —P007 159
Negative experiences: The most common problem 
was waiting times for appointments and dispensing, 
although with the high numbers of patients and the 
reported staff pressures this is unsurprising and may be 
expected:
“Yes, we were very many; so I spent the whole day here from 7:30 a.m. to 
4:00 p.m. You see now, and it was not that I was number 50. We were so 
many and there were only two doctors [most patients will talk of doctor 
when referring to any HCWS—they do not differentiate the different 
cadres of HCWs]. We were in this room and the other one; you see now; 
patients were very many; more than the doctors.” —P002 156 
“It was easy because then there were few patients, but now there are 
many patients; you can even come in the morning and leave at four in the 
evening and reach the house at seven in the evening.” —P005 155
“The service delivery here is slow. Patients are spending a lot of time on 
the queue. Like now we have been here since 9 a.m. and we haven’t been 
attended to yet. She is being attended to now.” (It was around 11 a.m. at 
this time.) —C005 158 
“Express services, please. Not spending the whole day here. We have got 
so many commitments outside. When you come and spend an eternity 
here, and in any case, a hospital is not a place you are supposed to spend 
a whole day [laughs]. This is because when you are here, you find other 
people who are in a really bad state; so the sooner you are out of the facil-
ity, the better.” —C003 157
An implication of these perceived delays was pa-
tients leaving without the appropriate treatment:
“It takes a long time such that some people leave without their medicines.” 
—P003 157 
As reported above, staff attitude commonly shaped 
patient experiences:
“There are others who are cruel and others who are fine. Not everyone is 
the same.” —P002 160
Although social problems have been earlier de-
scribed as central needs to patients and families, they 
were sometimes ignored or clearly described as off-
limits in the clinical setting:
Interviewer: “When you meet with the HCW (health care worker), what do 
you discuss with them?”
Respondent: “To tell you the truth, we don’t discuss anything.” —P003 158
“They tell us that they can’t discuss with us social issues, and that their 
work is to give us medicines. They ask us whether we want to get well or 
to talk about social problems… there are some who talk to us badly and 
some talk to us nicely.” —P007 155
A facility not having resources to dispense for an 
eligible patient was also a problem :
“Another thing is that sometimes you may come to the facility and upon 
weighing they find out that you have dropped in weight, and hence qualify 
for the supplemental flour, but you do not get the flour.” —P005 155 
7.5.2—Facility Strengths and Challenges
Facility strengths: When asked about the particu-
lar strengths of a facility, these mirrored the positive 
experiences of care, particularly staff attitudes towards 
patients:
“Because when I used to go to the out patient department [i.e., the 
non-HIV general medical departments], and it’s not that there the nurses 
were harsh it’s just that here they have that personal touch. Here there are 
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people who know me; you can see that everybody is smiling. Sometimes 
the support overwhelms me. That is what I mean by going an extra mile.” 
—P002 158 
Related to staff attitude, facility (and staff ) re-
sponsiveness to need was also highlighted as a facility 
strength:
“The services are of very high quality which I don’t think can be found in 
other clinics… for one, if you are too weak and you cannot be able to fend 
for yourself, one is normally given some food supplements every month; 
if your weight is too low, you are given flour to make porridge and if you 
come from far and you don’t have bus fare, you are reimbursed.” —C003 
158 
“At that time she was unable to use the stairs and when we arrived at the 
clinic, one health care worker would come with a wheelchair quickly to 
help her come upstairs to the CCC (comprehensive care clinic). I was really 
overjoyed by the care that we received. I would cry tears of joy. The doctor 
that we found would ask us questions that would encourage us.” —C004 
158 
Rapid access to services and the availability of 
medicines were often cited again as strengths:
“Again, here we receive fast service and medicines are available.” —C003 
159 
Facility challenges: Again, the issue of patient load 
and waiting times was identified, and was related spe-
cifically to the problems of attending work:
“On my part, I have not experienced anything bad about it but what I 
would say is that; sometimes patients are too many and I was wonder-
ing whether they could increase the number of staff to reduce the time 
patients have to wait for service. This is because you find that sometimes 
there are people who come here for services but they would like to be 
attended to quickly so that they can go back to their jobs.” —C003 159 
Both confidentiality difficulties and waiting times 
were linked to basic infrastructure of space and human 
resources:
“There are no enough rooms. We would like to have enough rooms so that 
each clinician has a room to him/herself when seeing patients as opposed 
to two clinicians seeing two different patients in the same room… We 
need to have enough workers… The clinicians especially need another 
clinician and the data clerk is also one.” —S001 156 
“I know that because of lack of space, we haven’t had enough time to 
socially interact with the patients and even to do as much counselling as is 
required. So I think that is a component that is missing. We also have not 
been able to offer any spiritual care and not that there is lack of personnel 
and willingness, but it’s simply because there is lack of space. Then I think 
the other facility we have not been able to offer is adequate support care 
groups. These do not exist may be because we have lacked the space; so 
you don’t even have a room where you can meet with a support group to 
encourage others.” —S001 159 
“Let me come straight to the CCC—we need space. Like we have only 
two clinical rooms yet every month we are getting an average of 100 new 
patients which translates to about 1,200 new patients every year. We have 
three clinicians and at any given time, two of them have to share one con-
sultation room and this deprives the patient of privacy and confidentiality. 
Our waiting bay is becoming smaller because of the increased number of 
patients and sometimes some have to wait for their turn outside. If it rains, 
I don’t know what we would do.” —S002 156 
While patients have highlighted the issue of staff 
attitudes, staff themselves noted that they were some-
times faced with communication challenges:
“You can have a health care worker who is not from that community, and 
this patient does not understand Kiswahili or English. Therefore you as a 
health worker you cannot communicate to this patient; that communica-
tion barrier. There is a patient who is blind and you don’t know the Braille 
method so you don’t know how to communicate with them. There are 
also patients who are deaf and you don’t know how to communicate with 
them. What do you call it?” —S001 157 
Accessing medicines was also raised again, and as 
with not being able to attend work because of clinic 
queues, lack of medicines within a facility can also 
worsen poverty:
“There are problems because at times you may be sick and you need 
medication but the medicines are not available and what you can only get 
is septrin. You have to buy the ARVs from elsewhere. The problem now is 
that you may not have money and therefore you can’t buy the ARVs hence 
you are not assisted in any way.” —P007 157 
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“There are times you are given one medicine or two types and the other 
you are told there isn’t; so you go to the chemist.” —P002 156 
Staff underlined the problems of drug availability 
and that patients cannot afford to buy privately:
“Quite reliable in supplying ARVs. The problem comes in on OIs; these 
opportunistic infection drugs, that is where there is a big problem because 
the patients we have are many, and what we have is little. We hence have 
an inadequacy of OI drugs. Sometimes we don’t give them; sometimes we 
can even go for three months, two months without even having amoxil 
(for example) to give to patients. Patients keep on coming because they 
can’t buy; the truth is this patient cannot buy. If you give him a paper to go 
and buy, please be sure they will come back with that paper saying ‘Has 
that drug come? I have not bought the drug.’ ” —S001 155 
“But we have problem in supplying some drugs especially the antibiotics. 
You find that the only drugs that are available are amoxil and septrin. You 
might feel the need to put someone on a stronger drug which may mean 
going to buy. Other drugs that are donated have a short expiry date so 
within two weeks they are over. So you go back to amoxil, septrin. It’s the 
availability of the drugs. We do not have a stable supply.” —S002 157 
Respondent: “I would like to have nimesulides, ibuprofen, stronger analge-
sics and… good antibiotics.”
Interviewer: “Strong analgesics like which ones?
Respondent: Ibuprofen, diclofenac, nimesulides.” —S002 157 
Staff also recognised that an inability to appropri-
ately dispense led to a greater pressure on service due to 
patients returning with unresolved medical problems:
“Especially the antibiotics. Specifically for the treatment of common 
infections; what is for our clients. We have the antimalaria but sometimes 
you have a patient, who has a very bad infection; an ear infection, a 
throat infection, and they need a very strong antibiotic like augmentin, 
enthromycin, but they have to go and buy because we don’t have. You find 
that a patient is coming with the same problem like three times. When you 
ask, ‘you were here with the same problem’ and they say yes but I couldn’t 
afford. So they will keep coming again because of the same infections.” 
—S003 157
As patients respond to therapy and live longer, 
clinics will increasingly be faced with the challenge of 
delivering second and third line therapies:
“The main issue has been the second line drugs (ARVs) which are not read-
ily available and currently a number of our patients on these is increasing; 
such that I may book a patient for these for one month but the pharmacy 
just has enough for two weeks. The patients then have to come back for 
a refill. But for first line drugs, the hospital always has enough stock.” —
S002 156 
This supply problem also extends to lab agents and 
investigations:
“When it comes to the lab investigations, we have on and off supplies of 
reagents that we use. Sometimes we run out of them and have to stay 
without doing some investigations.” —S001 156 
“Another weakness would be the investigations we are not able to offer 
readily to patients. We sometimes have to refer patients to other labora-
tories outside the hospital for certain tests and these ones are expensive 
because they are private institutions.” —S002 157
It was felt that a fully comprehensive service avail-
able on site would be most desirable:
“We require so many things in the lab. Like doing early infant diagnosis 
for the children, viral loads, but you see most of our facilities in Kenya as 
a whole, are unable to. So you rely on other facilities like KEMRI [Kenya 
Medical Research Institute] where you take several weeks or months before 
you get the results. But if every facility in Kenya was to have comprehen-
sive care, the facility should have almost everything. Being able to do 
CD4, blood count, the liver, the viral load, the PCR, so that the patient gets 
everything that needs to be done.” —S002 158 
“Like at the pharmacy they have to send their clients all the way here coz 
of our weighing scale. If they could have one, we would reduce our queues. 
The lab, like now we don’t have the reagent for CD4 counts so we have to 
send them somewhere else and remember they don’t have transport. So 
for all those issues, we try where we can.” —S003 157 
The more comprehensive range of needs of patients 
and their families was recognised, and the limitations of 
facilities to meet these was also stated:
“They come with those very high hopes, because may be now this one she 
has a family and she is not employed. We explain to them the much that 
we are able to offer in terms of management, treatment, sometimes if very 
desperate, we send the social worker to assess. Sometimes the old grand-
Phase 2 Kenya 72
results of Qualitative interviews 72
mothers bringing in their orphans and all that. If they are very desperate, 
she links them up to the social service, even get some link to some schools 
for support. So, where we can, we do. But we are limited.” —S003 157 
Social workers were regarded as a very important 
resouce, but there were not enough of them:
“The social worker is all alone; one dealing with a hundred plus everyday. 
Like now we have a mother who has been visited by the social worker. She 
is one and now she is in the field for adoption and court cases; so at least 
there is somebody listening to them.” —S003 157
A further challenge was maintaining effective in-
formation and communication between facilities when 
patients have been referred outward for inpatient care:
“Because we don’t have patient in care, and the fact that we have to refer 
a patient, we refer the patient ourselves. We may at some point lose touch 
with that patient if he comes back to us especially if we don’t know the 
facility where that patient has gone to for inpatient care. We really are out 
of touch. And even though our tracers try to follow up on such patients, 
sometimes they get overwhelmed with work and it’s difficult for them 
to keep track of each and every patient who has been in admission and 
especially those patients who middle of the night and he would go to 
[name] or any other hospital such are the patients we would never know 
what is happening to them until they come back and tell us retrospectively 
that this is what happened to us. I see that there is a deficiency in that end. 
We tend to lose that little time of our care to the patients.” —S001 158 
The pressure on staff was understood to relate 
directly to the quality of care that could be offered, both 
in terms of time available to appropriately assess and 
provide care and the impact of staff burnout:
“The numbers are increasing and for us to continue giving the patients 
quality care, we need quality time. I don’t see the need to rush through so 
that I can finish with you. At the end of the day, 50% of the patients that 
I have seen, I haven’t given them quality… We are four of us, so it is a 
thousand patients per person. A thousand patients per person per month. 
So it becomes quite hectic. We don’t want to finish our work early or to 
be seen that we are seeing very many patients. Quality is the main thing.” 
—S002 157 
“Weaknesses are there; like the burn outs, some times you are alone at the 
adherence counselling and the clients are as many as you are seeing here. 
Sometimes you don’t get to sit and talk to clients, you shorten your discus-
sion period instead of taking for half an hour, you discuss important issues 
because of the workload and there are many who are coming and they 
want your services. You can’t stay for half an hour like it’s supposed to be. 
Those are some of the challenges and weaknesses, that is, the workload.” 
—S004 158 
The need to recruit multiprofessional staff to meet 
patient need appropriately was also noted:
“First of all I would start by adding nutritionists because actually the job I 
am doing, I sometimes go home feeling that I did not do enough. Some-
times you see a client is down but you are seeing all the files you have to 
tend to. I think maybe the personnel first.” —S001 160 
“And currently, we do not have a nutritionist at the CCC.” —S002 156 
For patients with complications or disease advance-
ment that requires an admission, limited inpatient re-
sources hamper potential for an appropriate admission:
“Patients, who present during the late stages of HIV, are patients who need 
attention to treat the opportunistic infections. If there is need to admit then 
you admit. Right now at [facility], admission is a problem because we have 
very many patients and with a very low bed capacity therefore patients are 
forced to sleep two in one bed. This is what discourages us from admitting 
patients because if we admit they may not be cared for as much as we 
would want to.” —S002 157 
Conversely, if a patient is cared for at home, there 
are also limited resources to provide appropriate care:
“The challenge is in taking care of the patients at home, not medically. 
Taking care of them like bathing them, cooking for them, giving them 
basic needs; those are the main problems that we encounter because the 
hospital doesn’t provide us with the things that we need. Like detergents; 
so I have to cough everything from my pocket.” —S003 158
A final challenge described was the extremely com-
plex goal of reducing stigma:
“I think we haven’t managed to reduce stigma.” —S001 157 
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7.5.3—Suggestions for Improvement 
Family carers suggested that they would like to be seen 
as service recipients and receive support:
“As I carer, I would like the HIV care facility to at least know how I am living 
with the patient; that is, they should of course be visiting me at home and 
having discussions with me the way you have had discussions with me 
and then we can see what is happening. I need an open discussion with 
the health care workers and in that case I will be able to give them my 
open mind.” —C003 155
As reflected throughout the data, the need for 
food and transport support was identified as a need for 
improvement:
“A would also like him to get food so that the wife can cook for him to 
improve his health. That is what I can say are my needs.” —C001 160
“The issue of money for transport, flour for making porridge and fruits are 
big concerns to most people coming here because you will hear them talk 
about them while we are sitting at the waiting bay.” —P004 156
“When I was told that I have HIV, I was advised to be eating foods like 
spinach, oranges; but for people like us who are jua kali (informal artisans), 
whatever I get to eat is what I eat. This is what is disturbing me; nothing 
else. I have a bodaboda (I operate a bicycle taxi). If I get kshs 200, that is 
what I use to buy flour for my children and some spinach. There is nothing 
else.” —P004 157
This view was supported by staff:
“Nutritional supplements and providing food because some of our patients 
come and say they actually don’t have food to eat at home and yet they 
have to take their drugs. Sometimes I also wish we could also be able to 
supplement transport for some patients because sometimes some of them 
come late for clinics because they had no money and they had to look for 
it.” —S002 156
Further support for basic care provision was also 
recommended:
“The assistance that we would like to get is provision of bed nets especially 
to those of us who cannot afford because there are a lot of mosquitoes at 
our place.” —P005 158
“Medicines like dettol and gloves are expensive. A pair of gloves is kshs 
30 [$0.41]. At times she may vomit or start diarrhoeaing at night or get a 
flu and when she goes for a long call, at times she may not get to where 
toilet is and soils herself; and may be the gloves I had I already used them 
and here is a situation that has just come and I don’t have an extra pair 
of gloves. But there was a time when we had a discussion that if you had 
used some gloves and then you wash them in anticipation of using them 
again, you will not be protecting yourself in any way. If only they could 
help us with such things.” —C004 158
Again, basic drug supply was recommended, fo-
cused on antibiotics and analgesia:
“Some antibiotics like Augumetine which is hardly found here and it’s 
very costly and patients have to buy. At least if this would be found here it 
would be a bit better.” —S001 156
“In addition to what we have, It would be good to at times have analgesics; 
Strong analgesics for patients with chronic pain. We do have painkillers, I 
didn’t mention pain killers, general basic analgesics is what we stock, but, 
at times its good to stock one strong analgesic not for all the patients but 
for those who do require… Oral analgesics are what we are talking about; 
Morphine or drugs in that category.” —S001 158
“We would really like to have Dapsone [which is a substitute for septrin] 
as this would be good for patients who are allergic to septrin since it’s 
sulphur-based. Currently these patients have to buy it from town. Then 
we would also like to have drugs for common opportunistic infections 
[e.g., Herpes Zoster; i.e., acyclovir]. We would also like to have a myriad of 
antibiotics because patients come with infections here and there. Then also 
cytotoxics for patients with Kaposi Sarcoma since we get a number who 
cannot afford to buy them. So such drugs would be of great help if they 
were readily available.” —S002 156
“We don’t have Morphine but I don’t know whether it is possible to have it. 
I think it would be important to have it because of some patients.” —S003 
159
7.6—Multiple Identities
In this qualitative component of the study, we aimed to 
collect information from patients, staff, and families to 
triangulate data and integrate the datasets on experi-
ences and views on care and support. The data demon-
strated an interrelatedness between these roles, reflect-
ing the fact that staff and carers may also be patients.
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“The services are really good because I am also a client here; I am HIV posi-
tive. The services are of very high quality which I don’t think can be found 
in other clinics.” —C003 158 
The presence of openly HIV positive staff/carers is 
seen to facilitate supportive counselling:
“You also find that when you are positive, it is easier to counsel them than 
when you are negative. This is because if you are not afraid about talking 
about your status, you are able to be more open with the patient; like most 
of my clients are able to accept their status quickly because I don’t hide my 
status. I tell them, ‘I was like this and this but now I am like this and that.’ 
” —C003 158 
Patients also take roles as community advocates and 
role models:
“But when I joined this clinic, I found that there were many more people 
like me and this gave me some strength. Back in the village I still live with 
many more like me and I now talk to them about disclosure and how to 
live positively. Nowadays I don’t even think about my illness.” —P003 156
“This made me resolve that even when am back in the village, I will be 
telling parents to take their children to be tested.” —P001 156 
“Yes. And at some point, I even used to come here even though not for 
treatment but just to encourage others who are like me. We used to have 
our sessions here… Let me now tell you that I have become of great 
assistance to them; even when they need any psychosocial counselling, 
you find that they just call on me… I have now become like the family 
reconciliator.” —P003 156 
“I come to work as a peer educator as a role model to other patients so that 
they can see that even if you are sick, one can still work” —P005 155
“I share with them my status, my family background, and my work in 
general. I make them feel comfortable. Since I am also HIV positive, I don’t 
let them feel like it’s the end of the world for them. I give my self as an 
example to them and show them that they can still live. For those who 
want to have children, I encourage them to access treatment and they can 
still get children like any other person.” —S003 158 
7.7—Access to Care
7.7.1—Health Seeking Hehaviour
Patients described what motivated them to access HIV 
care, which was usually because they had unexplained 
symptoms and poor health that were suggestive of HIV 
infection and advanced disease 
“I had some complications on the body then it became a bit serious so 
I forwarded myself voluntarily to come and know my situation. When I 
came it was confirmed that I was positive.” —P001 155
“When I came here, I was feeling very bad. I did not have any appetite. I 
was feeling dizzy, I was experiencing diarrhoea, I developed some ulcers in 
the mouth, my skin changed and I developed something similar to cracks. 
That’s when I decided to come.” —P003 158
“I learnt about it, when I suffered from small illnesses such as headaches, 
coughing; and then I got that disease with a burning sensation… Herpes 
Zoster. That is when I made up my mind to come to the hospital and be 
tested. After that, they asked me whether I would like to join a group so 
that I can get treatment.” —P001 159
Another patient described how they were guided to 
access care by their spirit:
“My spirit told me that I needed to go to the VCT centre to be tested and 
know my status.” —P004 156
Interestingly, a patient described attending for care 
having previously defaulted on treatment due to their 
improved health status:
“Yes, I am using but there was a time I thought I was well and I stopped 
about a year ago but then I fell sick again. So I have returned to the hospi-
tal so that I can continue with the ARVs.” —P002 156
7.7.2—Process of Choosing a Facility 
The two principle reasons for selecting a facility were 
proximity to home and personal recommendation:
“When I checked, I found out that I was positive. I couldn’t believe it. I later 
on came to this facility because it is nearer to my home.” —P001 157
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“I have known about [name]. I have heard people saying that it is a good 
hospital, so we decided to come because of its fame.” —P001 160
“I knew about it through hearing from people from my area how good it 
is.” —P006 156 
The third reason was a direct referral from within the 
health system:
“I had come for ante natal clinic. I was counselled and then sent to have 
my blood tested; and after that I have continued here until now. I was 
referred here.” —P002 159
“This facility is near. The other reason why I came is because I was pregnant 
and I had to come to the clinic.” —P005 155
7.7.3 Eligibility Criteria
All sites said that they accept any HIV positive patient, 
although caution is exercised for patients wishing to ac-
cess care far from their home district to reduce double 
counting and perceived patient stealth:
“But other patients who have been seen in other hospitals like [name], 
[name] or [name], if this patient has already been started somewhere else, 
and he wants to come here, we advice, in fact it’s a must that they should 
come with a referral letter. Without a referral letter we may not accept 
them because other patients may end up being double registered and he 
may use the other lot of the drugs to may be sell or something else. You 
never know.” —S002 158
“Maybe there are some conditions for people who have been going on 
care elsewhere or people who are enrolled in other centres; they have to 
produce a referral letter that is the condition, some previous history or 
some previous medical notes.” —S003 155
Also, facilities expressed concern about being able to 
provide home follow-up:
“It depends on the coverage area [facility name] has been given a working 
area currently, so if the patient that has come is within the coverage area, 
then we will work with them, but… we can not reach some areas, so we 
may not accept the people who come from far… [place names]… those 
are places that we cannot reach.” —S005 160 
“Not everyone, because like now we have a boundary. We have the 
catchments areas. There are people who come from [place], they come 
from the VCT and they are referred here. They come from [places]. We refer 
the [area] people to [same area], [area] people to [same area], and [area] 
to [area]. But they prefer [this facility] because of the proper care that we 
have. Some of them think it is good for them to be here but now we have 
a catchments area because it would be hard for the outreach workers to 
reach some of these people because of the catchment’s area boundary.” 
—S002 160
It was also recognised that patients may struggle 
to afford the transport fees to travel from afar and then 
may default- this reflects the problems reported by 
patients in finding transport costs for care:
“If they are from [district] and its environs, we readily accept them into our 
program. But if a client is coming from [far districts] we kindly ask them 
to try and access same services from [facilities] close to where they are 
coming from. This is because we also have to look at the issue of finances-
maybe one has to come to the clinic monthly and thus we must assess 
whether they have money for that. These are factors that we have to look 
into.” —S003 156
However, there were circumstances in which a 
patient from a further district would be accepted, and 
patients were permitted to enrol if they wished:
“We always take them but since the clinic has been congested, we take 
those who are staying within [place]. But those coming from far, say 
[place] or [place], we counsel them, advice them and then refer them to 
their nearest clinic. But if someone has a good reason of wanting to come 
here we accept them. Let’s say he is in [place] but he wants to move to 
[place] on transfer, its okay or the husband is staying in [place] and she is 
staying at home, so if she wants to move here she is allowed.” —S003 159
“However, this guidance on yes we accept all the HIV people who come to 
our clinic. Not unless somebody wants to be transferred out to the nearest 
CCC (comprehensive care clinic) they feel that they want to go to, may be 
they want to travel back home. If they want to be transferred, we do that. 
But we don’t chase clients away.” —S004 158
This awareness of the potential challenges to pa-
tients enrolled at a distance from their home were spelt 
out by staff:
“There are various factors that we usually look for: First of all is they want 
to be enrolled on care we usually check if they are able to keep their ap-
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pointments. We can’t enroll a patient who can benefit from another facility 
which is near his/her home. We do consider those things like cost, the 
distance, and then we refer them accordingly.” —S004 155
“We actually consider first of all the geographical factor. Yeah… we tend 
to get mostly patients who come from around for the reason that we 
do not want to take people from far who may be could default… you 
know… due to distance. Yes, at the moment actually we are operating 
on a kind of a divisional geographical area… Although we have people 
who come from far like from town which is 20 Kilometres away but we do 
accept because if they are able to come it is upon them.” —S004 160
A response to the patient desire to enrol at a dis-
tance while meeting facility concerns about defaulting 
on treatment has been the decentralisation of facilities:
“At the moment, one actually is the issue of defaulters that came in. We real-
ized that there are a lot more than we thought. So many patients who are 
coming from far could actually fail to attend clinic dates… he or she fails to 
come to collect the drugs the following month; the issue of transport comes 
in; they may lack transport money to come here and the issue of transport 
has come in i.e. lack of transport has come in terms of fare, we realized 
that we were going to have a problem in terms of the regimen failure. So it 
was actually decided that this was a top level issue; the medical personnel 
thought twice that in order for this program to succeed there is need to de-
centralize these services; so that now at the moment am telling you we have 
so many ART satellites… so that [facility name] is now being made like a 
referral. While actually, it is not denying access to those who may be stable 
financially; because somebody could be in [city] and he or she doesn’t want 
to be known that they are going for that kind of service.” S005 159 
Interestingly, it was acknowledged by staff that a 
patient’s confidentiality could be threatened by access-
ing local care:
“We are accepting them and we are asking them if it is possible and they 
are comfortable going to those nearer facilities because some people have 
this issue that from the nearer facilities where they come from, confidenti-
ality is not kept.” —S005 155
7.7.4 Retention and Shopping Around
The majority of respondents reported that they did not 
attend multiple care facilities, due to a combination of 
self-reported satisfaction with care and a request from 
their facility that they do not “shop around”:
“I don’t think it is bad because if it was, I wouldn’t have come back; I would 
just have stayed home… They tell us that we should not go looking 
for medical care from other sources once one has been registered at this 
HAART clinic.” —C001 159
The primary reason for attending elsewhere was the 
(earlier identified) drug stockouts:
Respondent: “Yes, septrin. I get it from the health centre; [name] health 
centre gives me septrin.”
Interviewer: “And why do you go there?”
Respondent: “I go and get septrin when they get finished.” —P003 159
Continuity of care was also identified as a reason 
for continued attendance at a single facility:
“No, after I started coming here I have never gone to other hospitals. Even 
when I fall sick or have any problem, I just come here. This is because they 
have my file which has all my records so it is important to come here.” 
—P007 157
The secure availability of free medications was 
reported as a strong motivation to remain in care:
“The other good thing is about medicine; she always gets her medicine. 
She actually gets most of the medicines and she is never asked to go and 
buy.” —C003 156
“The one thing that has really helped us here is the availability of 
medicines which are also given for free. You can never come here and lack 
medicine; you get it instantly… We do not pay for services at all and that 
includes counselling. I am very very grateful to this project.” —C003 159
The risks of non-availability of some components 
of treatment are sometimes not of patients then attend-
ing other facilities, but of patients not accessing appro-
priate care at all:
“For this test here, they were saying that the machines were not operating; 
so we had to go to Nairobi hospital-there is a branch from Nairobi Hospital 
here which is up town and they were costing about Kshs 1600. So many 
of the patients had no money and so they would just go back home.” —
P002 156 
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This lack of access may be applicable to both investiga-
tions and medications:
“They only pay if there is a particular drug that we don’t have but the pa-
tient needs. That is when we refer them. Notably we do not have acyclovir 
for the management of Herpes Zoster.” —S001 155
“They have been paying for some investigations and chest X-rays. But for 
the time being they are just paying for chest X-ray and not the other tests.” 
—S001 156
7.7.5—Costs to Patient
Staff generally reported that all interventions and drugs 
are free. For a small number of facilities specific drugs 
are charged but not for those who cannot afford to pay 
(although specific criteria were not given):
“But these ones we don’t charge them. The others are charged for septrin, 
but these ones we don’t charge them even for the multivitamin. That is 
what we can call special treatment.” —S001 157
A number of specific interventions were charged 
for in some instances:
“For instance if we suspect a patient has TB, they have to pay for the chest 
X-Ray. I f a patient has another condition say like hypertension and they 
need an ECG; lipid profile test, they have to pay for those tests on their 
own.” —S002 156
Facilities also try to dispense alternative drugs to 
those prescribed to avoid levying fees:
“Like some antibiotics since the doctor can prescribe different antibiotics 
that are not available and patients have to buy. But if we have alternatives; 
they don’t buy.” —S003 159
As reported previously, even transport costs are 
provided in some instances, again specific criteria were 
not stated apart from inability to pay:
“Transport, to and fro. And even if they come and tell us they don’t have 
transport back, we also give them. We want to assist them as much as we 
can.” —S004 158
7.8—Clinical Standards 
7.8.1—Process of Enrollment 
Patients generally reported facilities as being easy to 
find, and providing a welcome reception. As previously 
reported, long waiting was a problem. 
7.8.2—Frequency of Contact
Frequency of contact was fairly routine across sites, 
with most seeing clinical staff fortnightly when treat-
ment was initiated moving up to monthly for most and 
bi-monthly or quarterly for some who were responding 
well and stable on treatment or lived a long distance 
from the facility:
“I come for the service once per month; the service is good, only that today 
it is very sluggish or rather for the past one month. Initially we used to 
have several doctors but they have been withdrawn. We used to have this 
lady who is here, we had another one in the other room, and then we have 
the big gentleman. But now we only have one lady. In as much as she 
would want to please me, she will not be able to because I am spending a 
lot of time here. You feel demoralised by the services.” —C003 157
All offered a walk-in service for those with new 
emerging problems. For those with additional medical 
needs such as family planning, TB management as well 
as ART they reported frequent and repeated visits to 
the clinic as appointments did not coincide.
7.8.3—Monitoring and Documentation 
Community workers were employed as an original 
mechanism to follow up patients in the community and 
monitor their adherence:
“The clinic has hired these tracers [community health workers] who follow 
up on these patients who has delayed in collecting medicines. So for 
instance if there is a patient who has not been taking his or her medicines, 
the tracer has list of these patients and she does the follow ups… Some of 
them when you ask them why they haven’t been coming to the clinic they 
tell you that they didn’t have money, others may say that they didn’t have 
food; so you ask them, ‘aren’t you giving money for transport when you 
come to the clinic? Why can’t you borrow from someone and you will be 
refunded at the clinic?’ At times you may be forced to bring the patient to 
the clinic with you.” —C003 158
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Monitoring is strict and patients are sometimes 
expected to fulfil obligations if they are to receive treat-
ment:
“The requirement upon joining the group was that, I must attend clinic 
every month until one year is over. I even signed a form indicating that I 
will be attending the clinic every month for them to review my status. I 
have to do this to keep the promise.” —P001 156
Beyond adherence monitoring, a comprehensive set 
of monitoring forms were described:
“Adult follow-up forms, locater form, family information table, we have 
unscheduled form, we have adherence form, enrolment forms, there are 
many forms.” —S001 155
“Yes, we have a standard form but we are not very restricted to it. We have 
a standard form that checks basically on their weight, height, their use of 
contraception, we screen for TB during every visit and then we check for 
any new opportunistic infection. Then we check for any side effects on 
ARVs and then check on their adherence on any other drug they may have 
been using. Check on their CD4 count then fill in and then book them for 
the next appointment.” —S002 156
7.8.4 Referral Mechanisms
As described earlier, facilities attempted to refer pa-
tients to facilities closer to their homes which makes 
attendance more feasible:
“She has told us that ARVs have been sent to [town centre near where 
patient/carer comes from] as well but since [patient] is just being started 
on them since she was initially on septrin, she was asked to come here 
first; then come back after two weeks for review and after that she will be 
referred to [town centre near where patient/carer comes from] which is 
closer home so that we can save on bus fare.” —C003 156
Patients may be referred for convenience or for 
specific intervention unavailable at their main facility:
“If they want; because somebody is willing to be referred to a nearest 
health centre, is going to work there. He is being transferred; he will prefer 
to be transferred. That is the major reason; if they will because we would 
not force the person to be referred is that we have almost all the drugs 
that are provided in Kenya!… The patients we refer again are the patient 
of KS, Kaposi’s Sarcoma. Most of our patients with Kaposi’s sarcoma we 
refer to Homa Bay for the Cytotoxic drugs treatment because we don’t have 
Cytotoxics.” —S001 155
“We refer patients to Kenyatta National Hospital for cancer management. 
We also refer patients to nearer institutions; like if someone came here 
and we saw them and we discover that they come from [district] which 
is about 200 km from here; we start telling them that this is a life long 
treatment plan and so why would they want to spend 700 shillings every 
month to come and see us and there is an institution near home. And if 
they are willing, normally we refer them to those institutions.” —S001 159
Interviewer: “So sometimes a patient can ask for a transfer and for what?”
Respondent: “Yes. If they feel that this place is too far an expensive to ac-
cess due transport costs. Unless we have a case where a patient has cancer, 
we refer them to Kenyatta National Hospital for care.” —S001 156
Other reasons that patients request referral are so 
that they can die closer to home or because they have a 
job of work to attend that is far away:
“Some say that they are almost dying, and they don’t want to die far away 
from home. The others that we refer are those that get jobs somewhere like 
in Nairobi and there is a health centre there, we refer them there.” —S001 
157
Very interestingly, one staff member highlighted a 
further reason for referral to closer facilities- that the 
patient may benefit from community-based support:
“We do not just refer because of proximity concerns; we also refer because 
of social support. We realized that there are many organizations which are 
willing to support HIV/AIDS patients. We have for example the Constitu-
ency Aids Committees that supports patients through community-based 
organizations [CBOs].The fight against HIV/AIDS will only be won if all 
patients formed their own support networks- it’s not going to be won 
through hospital initiatives alone. It’s good to know that the social and 
therapy groups are the most important things and it’s something that 
seems to be working. The future of this fight against HIV/AIDS is when all 
these patients will be able to form support groups and we as the HCWs be 
in a position to support them. These groups should then be empowered to 
support each other, remind each other about clinic days, consult each other 
when they have problems and assist each other spiritually.” —S003 156
Additional stated reasons for referral were social/
financial needs such as food and income generation, 
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specific spiritual support (such as an Imam) and for an 
inpatient admission. If a patient is to be referred out, 
in order to ensure that there is continuity in adherence, 
one facility described a prescribing practice to ensure 
they have ART access whilst moving between facilities:
“Like if you want to leave [town] tomorrow, before they go there and get 
stranded, maybe they don’t know where to get the drugs from, and we 
don’t write exactly which hospital, of course when somebody wants to 
go to Nairobi we just give the photocopy and referral letter then they can 
choose for themselves which hospital they want to go to. We tell them 
to go and find out where they can get the drugs. We give them referral 
letters and a supply of ARVs so that they don’t go there and the following 
day they don’t have drugs. So what we normally do is, that we give them 
enough supply of drugs to last them a month or two weeks to help them 
prepare to enrol in the other CCC (comprehensive care clinic).” —S004 158
7.8.5—Staff Education and Training 
While clinical supervision was reported as routinely 
available for all sites if needed, in terms of advice on 
specific cases, there was often a lack of systematised 
supervision:
Interviewer: “What supervision do you receive?”
Respondent: “None. We only have a Medical Officer in charge but we only 
consult her when we have a difficult case.” —S001 156
“There is a Matron who is in charge of the place. She is our manager in this 
clinic. But as I do my work always, I need not be supervised. I normally do 
my work well but in any case, I contact her when I have something beyond 
my capabilities.” —S003 159
Interviewer: “Do you give some kind of supervision to workers?”
Respondent: “Before we used to but now it’s as if it has died. We used to in 
2006. But in 2008, we haven’t done.” —S001 157
There were individuals who took responsibility for 
supervising the entire facility staff:
“Everybody who works at the CCC reports to me. My work is to ensure that 
everything is running smoothly. I supervise for example the work of my 
data clerks, my data managers. At times I sit with them and see how they 
are collecting data and sometimes I even spend an hour or even half an 
hour with them when they are registering a patient and see what kind of 
problems they have and if they are collecting the right kind of information 
from the patients. Moving on to the triage nurses to see how the triaging is 
being done well, the vitals are being taken well. For the counsellors I have 
to sit with them when they are counselling a patient sometimes. Likewise I 
sit with the other clinicians. That’s what my job is.” —S001 158
Supervision for those who manage was not evident:
Respondent: “I don’t like to look at myself as a supervisor but since I am a 
team leader, I have no choice but sometimes just to find out how things 
are running on a daily basis at the clinic level and even just to find out from 
patients how they have been treated as they come in and out of the clinic; 
and to look at how many patients health workers saw in a day and see 
whether they have been strained and if there is a way to help them reduce 
their workload; so my supervision is at those levels. Then I report back to 
the institution and say these are the issues.”
Interviewer: “And yourself as a team leader, do you receive any form of 
supervision?”
Respondent: [Laughter] “I don’t know if I receive any supervision but I think 
the national team gets a chance once a year to walk round and see what is 
happening. So may be I am supervised at that level.” —S001 159
In terms of supervision, a commonly used term was 
that of teamwork, with all of the multidisciplinary team 
supporting and advising each other:
“…and we get to work as a team so we get to know what each one of 
us has been doing and really assessing if we have been doing our roles.” 
—S005 157
Staff reported using mechanisms to ensure that patients 
do not default and attend for appointments. This is 
challenged by the costs of repeat attendance and by the 
need to attend a number of facilities when drugs stock-
out. This was, interestingly, the only reason given for 
attending alternative clinics—that of non-availability of 
drugs. This was supported by staff data that also identi-
fied drug supply as a challenge.
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Results of the economic analysis for Kenya are pre-
sented below. Table 67 and Figure 25 show that there 
was wide variation in costs per patient per year, rang-
ing from $77 at Facility 157 to $1160 at Facility 159. 
Facilities 156 and 158 had per patient costs of $191 
and $170 respectively while the cost at Facility 155 was 
close to the median at $418 per patient.
There was also a wide variation in the components 
of the costs per patient as seen in Table 67 and Figure 
25. Per patient staff costs ranged from $5 at Facility 158 
to $440 at Facility 159. Similar variations existed for 
ARV costs per patient; Facility 156 was the lowest with 
$8 per patient with Facility 159 once again having the 
highest costs per patient at $514. In most cases other 
drug costs per patient were $6 or below, with the excep-
tion of Facility 156 which was $45. Laboratory costs 
ranged from $1 per patient at Facility 157 to $120 at 
Facility 159. Building and utility costs were below $100 
per patient per year at all facilities. All facilities had 
building and utility costs of between $5 and $18, except 
for Facility 159 at $84.
The staffing costs are shown in more detail in 
Figures 26 and 27. Clinical staff dominated the costs 
of staffing at all facilities in Kenya. At Facility 158 and 
Facility 160 clinical staff salaries constituted 70% and 
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Figure 25: Facility Cost per Patient
Figure 26: Cost distribution
Table 67: Total and Per-patient Cost of Care (US$ per Year)
Facility 155 156 157 158 159 160
Total
Per  
Patient
Total
Per
Patient
Total
Per  
Patient
Total
Per
Patient
Total
Per  
Patient
Total
Per  
Patient
Staff 251,097 46 895,838 91 98,282 17 45,808 5 813,046 440 212,614 31
ARVs 82,838 283 77,818 8 79,075 44 567,196 138 150,535 514 485,890 163
Other Drugs 13,305 2 445,820 45 34,583 6 193 0 4814 3 4941 1
Lab Cost 370,581 69 166,147 17 5275 1 421,680 44 221,630 120 243,534 36
Building/ 
Utilities/Rental
94,778 18 83,713 9 47,124 8 43,721 5 154,705 84 64,719 10
Total 812,599 418 1,669,336 170 264,338 77 1,078,598 191 1,344,730 1160 1,011,697 240
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60% of the total salary costs while at the other facilities 
the percentage was over 90% (Figure 27).
Patient loads varied widely also, for clinical and 
for non-clinical staff. Patient loads for clinical staff in 
general were lower than for non-clinical staff except in 
Facility 158, which also had the highest patient loads 
per clinical staff among the six sites in the study at 246 
patients per clinical staff member. Facility 160 had the 
next highest patient load for clinical staff at 148 while 
Facility 156 and Facility 157 were at 26 and 20 respec-
tively and Facility 159 and Facility 155 at 11 and 84 
respectively. Non-clinical staff loads ranged from a low 
of 103 at Facility 160 to a high of 375 at Facility 157.
It was hypothesised that there would be a relation-
ship between per patient staff costs and patient-staff 
ratios, i.e., facilities with high patient loads per staff 
should have lower staff costs. In Figure 28 a scatter plot 
of staff costs vs. patient-clinical staff ratios shows shows 
an inverse relationship, thus supporting the hypothesis.
8.1—Economies of Scale and Case Loads: Evidence 
from Uganda and Kenya
The relationship between size of the facilities as mea-
sured by number of patients and costs per patient per 
year was also examined. If there were economies of 
scale it would be expected that there would be a nega-
tive relationship between average costs per patient and 
patient numbers. This would be similar for staff costs 
per patient and patient loads for staff. Because there 
were only six facilities per country in this analysis the 
data for Uganda and Kenya were combined. In Figures 
29 and 30 costs per patient were plotted against total 
number of patients registered at a facility, and again 
against number of HIV patients. The figures show that 
for both number of HIV patients and total number of 
patients, the cost per patient is lower in facilities with 
more patients.
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of Patients
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9.1—Facility Characteristics, Participant and 
Interview Numbers
Over 100 patients at each of six PEPFAR-funded 
facilities, 696 participants in total, were recruited to 
participate in a longitudinal study to examine how 
patient health outcomes changed under care. Patients 
completed questionnaires at monthly intervals, and 
85.1% of participants completed all four timepoints.
Phase 1 data on staff resources and self-reported 
care provision clearly indicated that all six facili-
ties were strongest in clinical care while offering very 
limited social and spiritual care (1). As an example, 
each facility employed up to 294 nurses but none had 
more than two social workers. Only three facilities had 
community health workers, two employed counsellors, 
and the survey registered only two spiritual leaders. 
Self-reported care also indicated that social, psychologi-
cal and spiritual care elements were often not available, 
whereas the majority of clinical and symptom manage-
ment care components were reported at all facilities. An 
exception was severe pain control, where opioids were 
rarely reported. 
9.2—Participant Characteristics
9.2.1—Demography
Two-thirds of patients recruited to the study were 
female, and they tended to be younger than the male 
participants. This gender balance and age difference is 
similar to the findings of other studies of HIV preva-
lence in sub-Saharan Africa and Kenya (34–36). The 
ratio of HIV positive women to men in Kenya is ap-
proximately 1.8:1 (37) and among young adults aged 
under 25 the difference is much higher (34). One sug-
gested reason for this gender discrepancy in prevalence 
is the frequency of relationships between older men and 
younger women (38).
There was no maximum age limit for inclusion and 
participants were aged up to 69. The most commonly 
used indicator of HIV in countries with a generalized 
epidemic is the prevalence in the 15–49 age group, 
termed “adult” (39). Older people form a minority of 
people with HIV but their health problems are likely to 
be more severe; in this study, older age was associated 
with lowered physical health at recruitment. 
Almost all participants had attended primary 
school, and 43% had progressed to further education 
(high school or beyond). This level of education is bet-
ter than average for Kenyan adults, particularly consid-
ering the 2:1 ratio of women to men (36). 
9.2.2—HIV Diagnosis and Reason for Attending
The most common reason for attending at the facility 
was a new HIV diagnosis, and the median time from 
diagnosis to recruitment was 36 days. This may not 
be reflective of everyone cared for at the facility since 
the inclusion criteria stipulated that existing patients 
who did not have a new problem should not be ap-
proached for recruitment. Nonetheless, the implica-
tion is that services have to manage a constant intake 
of new people and a need for expanding services. One 
quarter of patients recruited were attending the facility 
to obtain medication or a laboratory test result, which 
suggests that the inclusion criteria may not have been 
rigorously applied.
9.2.3—Relative Wealth
Study participants were wealthier than the urban DHS 
sample population on indicators such as housing qual-
ity and water supply, although given that the DHS data 
were six years old the difference is likely to be slight 
(36).
The wealth quintiles were calculated using a pub-
lished method (14) and aimed to give a better represen-
tation of wealth using multiple measures appropriate to 
the developing country setting than a single measure 
of wealth could achieve. People in the poorest quintile 
lived in a thatch or mud and pole house with an earth 
floor, and burned firewood for fuel. The wealthiest 20% 
lived in homes with cement floors where someone 
9
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owned a radio, mobile phone and television. 
Surprisingly, the probability of using a shared or 
public latrine was similar across all five quintiles, and 
was not associated with a general improvement in 
conditions as were housing material and ownership of 
goods. This suggests either that sanitation is not a prior-
ity or that something other than cost inhibits improve-
ment. Having access only to a public or shared latrine, 
which was the situation for 42% of participants, is 
categorised as inadequate sanitation by the WHO (40) 
and is a major cause of ill health (41). Similarly, a third 
of participants relied on unsafe water sources with a risk 
of water-borne infections, which cause a high burden of 
morbidity and mortality in people with HIV (42). 
9.2.4—Illness Severity
There were several problems in collecting indicators of 
disease severity. Disease severity was measured in three 
ways and for two of the measures it was not possible to 
use the results in further analysis. The ECOG did not 
discern between patients—69.3% of patients were fully 
active according to the ECOG at T0. WHO staging 
was found to be used commonly in some facilities and 
rarely in others. The remaining measure, patient-report-
ed CD4 count at T1 was poorly completed and only 
through patient record review was the measure able to 
be completed satisfactorily (68 patients did not have a 
count at T1). 
Patients were generally physically able and had a 
mean CD4 count of over 300 at baseline. It is impor-
tant to remember that the study only recruited outpa-
tients, the great majority of whom attended the facility 
without an accompanying carer. They are likely to have 
better physical functioning than the entire population 
of people with HIV (some of whom are probably un-
able to attend for health care) and they do not include 
those who arrived for care and were admitted. 
Just over a third (35%) of participants had a CD4 
below 200, and 37.1% had a CD4 over 350. A CD4 
count over 350 cells/ml, before initiation of ART, is 
sometimes associated with the label ‘asymptomatic’, a 
confusion of the epidemiological disease surveillance 
concept of undiagnosable infection with the clini-
cal concept of no symptoms. The information on care 
received and on health outcomes clearly show that even 
participants with a relatively high CD4 count suffered 
from symptoms.
CD4 count increased by 52 cells/ml over time for 
those with 2 counts, but these individuals may not have 
been representative of the entire sample as people with 
closely repeated CD4 tests may have been more closely 
monitored because they were sicker. 
9.3—Care Participants Received
9.3.1—All Care Components
Participants received a mean of 11.9 components per 
month, showing little change over time. Altogether 
over three months the mean and median number of 
care components received per person was 20, with a 
maximum of 44 of a possible 52. The receipt of on aver-
age 20 care components in three months shows a high 
burden of care, including change in care regimes over 
time, and a complex set of multidimensional needs—no 
single care theme had as many as 20 items. 
The items received by over 75% of participants were 
all for prevention of infections or of HIV transmis-
sion, except for ART and non-opioids. It is entirely 
appropriate that preventive care components should be 
delivered to the majority of individuals and that this 
should not be necessary for most curative care. Over 
time, prevention components such as multivitamins and 
CTX increased in prevalence, while pre-and post-test 
counselling declined and most symptom care became 
less common, presumably as symptoms and infections 
were controlled. The care component with the fastest 
implementation was CTX which increased rapidly in 
provision between T0 and T1, probably because it is 
proven effective, easy to deliver and supported by policy 
(24).
A third of participants received malaria treatment 
in the month preceding T0. Frequently, anyone with 
fever-like symptoms is treated for malaria until tests 
confirm otherwise, so the treatment does not indicate 
that a third of the group actually suffered from malaria 
during the month. A study in Kenya found that the 
majority of adults experiencing acute symptoms first 
purchased drugs over the counter (without a prescrip-
tion), and then visited a health centre (43). It is possible 
that in some cases the symptoms which encouraged 
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people to seek healthcare were first treated as malaria 
and later led to an HIV test. This theory is further sup-
ported by the steep decline in the proportion of pa-
tients receiving malaria treatment from T0 to T1.
Counselling/advice, nutrition, prevention and 
CTX were the care themes with highest provision. The 
nutrition care theme was high because of the single 
care component of nutritional counselling, which could 
have been categorised as counselling or as a prevention 
component. 
9.3.2—Care Received Away from the Facility
Social and spiritual care components were most likely 
to be received from some other location than the study 
facility, in accordance with the Phase 1 results which 
found that these were the areas of care least commonly 
offered. These areas are often not seen as health issues 
and rather as the responsibility of others, although it 
is known that poverty is closely associated with nega-
tive health outcomes, and that spiritual and existential 
issues are common in severe disease (44, 45).
Clinical care components such as non-opioid 
analgesics which were available from facilities were 
also quite often received elsewhere. Phase 1 qualita-
tive interviews showed that some patients combined 
HIV care from a distant ART provider with day to day 
healthcare from a more accessible health centre. An-
other possibility is that participants were buying their 
own medication on advice from the facility. 
9.3.3—PEPFAR Care and Support Categories
Clinical and prevention care receipt were very high, as 
shown above by the receipt of individual components. 
Social care had a 60% prevalence but, as discussed 
above, much of this was provided from other sources, as 
with spiritual care. The lowest level of provision was for 
psychological care although the APCA African POS 
showed psychological problems were burdensome; for 
example 35% of participants had been unable to talk 
about how they felt in the three days prior to T0.
9.3.4—Care for the Newly Diagnosed
It is appropriate that receipt of post-test counselling 
should decline over time, although initial prevalence 
should have been higher than 83%. The care received 
suggests a programme of CTX, ART assessment, nu-
tritional advice and multivitamins being implemented. 
There was a short delay between facility registration and 
ART initiation. Anecdotal evidence from facility staff 
indicated that the usual policy was to put the patient 
onto CTX for three weeks, partly as a test of adherence, 
before beginning ART. The fact that the delay was rela-
tively short indicates that facilities were able to supply 
ART in good time, with sufficient stocks and a reliable 
supply chain. Twenty-nine percent of participants had 
received ART before recruitment to the study. Some of 
these could have been pregnant women taking a short 
course for PMTCT.
Symptom treatment was not greatly different in the 
newly diagnosed group from the entire sample, suggest-
ing a similar burden of infections. Treatment for anxiety 
and depression were very low although HIV diagnosis 
is thought to be a time of great distress (46). The only 
commonly delivered components of psychological care 
were post-test counselling and adherence counselling, 
both of which are often a means of information trans-
mission rather than a time to express feelings.
9.3.5—Preventive Care Package
Less than a quarter of participants in either group 
received all five elements during the study, but each 
component apart from an ITN was received by more 
than half. This pattern suggests that the elements were 
delivered separately rather than as a unit. It seems ap-
propriate that the PCP elements should be provided 
to everyone with HIV who would benefit from them 
rather than all elements being delivered to all patients 
regardless of need.
9.4—Care Themes
9.4.1—Spiritual
Almost half of participants prayed with staff, usually, 
as with all spiritual care, at somewhere other than the 
research facility. Over two thirds met with a religious 
leader and the proportion remained steady over time. 
Given that participants obtained spiritual care for 
themselves at another location, increasing their time 
commitments and transport costs, it is clear that spiri-
tual care was important to people in this setting. 
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Contact with traditional healers declined steeply 
after T0. Anthropological studies have shown that 
people combine different paradigms of health care 
pragmatically, incorporating theoretically irreconcil-
able concepts of health into a health-seeking strategy 
according to their perceived success(47). In this case, 
traditional healing and medicine appear to have been 
applied as sequential alternatives rather than comple-
mentary care. However, relations between traditional 
healing and medicine are poor in Kenya, and social 
desirability bias may have prevented participants telling 
healthcare workers that they continued to visit tradi-
tional healers. 
9.4.2—Counselling and Advice
Many different forms of counselling were provided to 
large numbers of patients, but there is also evidence 
that these services may not be adequate. Psychiatric 
therapy was very rarely provided and was not sus-
tained; at T3 only 0.2% of participants received it. Sixty 
percent of participants were in an HIV support group, 
and qualitative interviews at Phase 1 showed these were 
very highly valued. Support groups are a key element of 
care, yet 40% of participants did not benefit from them. 
The care theme was named “counselling and advice” 
because many counselling care components are more 
focused on the delivery of information, such as nutri-
tional counselling, which is an educational intervention 
to improve knowledge of food groups and vitamins. 
While beneficial, this kind of counselling may not ad-
dress psychological issues such as anxiety, loneliness or 
lack of peace, which the study outcomes showed to be a 
burden for participants.
9.4.3—Nursing
A high proportion of participants received wound care 
and the proportion increased over time. Wounds could 
have been caused by skin breakdown related to infec-
tions, bedsores, or other conditions, as well as injuries.
9.4.4—Pain Management
Every month, each participant had a 40% probability of 
taking non-opioid analgesics such as paracetamol.  Such 
common use of analgesics indicates a high prevalence of 
pain, but non-opioids were not followed up with other 
analgesics. HIV is associated with high pain prevalence 
and burden, particularly in the later stages (48), and 
prevalence remains high for patients on ART (49).
Barriers to opioid use include legal restrictions and 
a reluctance of health care staff to prescribe, based on 
fears of addiction and lethality. These opioid myths can 
be overcome through education and training, as advo-
cacy can lead to policy change (50).
9.4.5—Symptom Management
Every month over a quarter of participants received 
treatment for a symptom which was not listed as a 
care component, indicating that the CSRI did not 
adequately capture all important care delivery for this 
population. The CSRI was composed using existing 
knowledge of common infections and symptoms in 
HIV. The specific symptom burden in Kenya was not 
known and it appears that there are differences between 
the expected symptom needs and those found in Kenya. 
In the literature, receipt of ART is associated with 
more, not fewer, symptoms, and with greater physical 
and global distress (49). ART causes symptoms through 
toxicity and liver damage while reducing the risk of 
opportunistic infections. One possible consequence of 
beginning ART is immune reconstitution inflammation 
syndrome (IRIS), symptoms such as fever arising from 
the restored immune system’s response to a pre-existing 
infection (51), also causing the “unmasking” of TB. 
Half the study population received malaria treat-
ment at some point during the study, although, as 
explained above, it is not likely that all of them had ma-
laria infection as malaria is often diagnosed presump-
tively. People with HIV are at greater risk of malaria 
and show more severe symptoms if they get it(52), but 
CTX dramatically reduces the risk of malaria.
9.4.6—Nutrition
One of the main reasons for low adherence to ART 
is lack of food (53) making the drugs very difficult to 
take. Although multivitamins were far more commonly 
received than food, in a population where 9.5% required 
therapeutic feeding in a three month period, the preva-
lence of hunger and inadequate nutrition is likely to be 
higher than is reflected by the level of food provision in 
the study. Improved water source was relevant for care 
Phase 2 Kenya 87
discussion of longitudinal Quantitative study 87
because water-borne infections are a common cause of 
morbidity and mortality for people with HIV (42), so 
the common receipt of water treatment at home was a 
positive finding.
9.4.7—Social
Over three months, 12% of participants obtained 
legal advice and 20% received home help, indicating 
that these services are needed in the population. Even 
though physical function was generally high, partici-
pants required help in social care. Memory work took 
place at all facilities, most commonly at Facilities 157 
and 159. The original project was a scrapbook or box in 
which people with terminal illness would make a record 
to leave to their children. The term now encompasses 
a range of methods, often used with children but also 
with adults, to improve communication within families 
(54). 
9.4.8—Prevention
Prevention with positives (PWP) was one of the most 
common components in the study. Also known as 
secondary prevention, it is a package of interventions 
aimed at preventing further transmission of HIV and 
protecting the HIV positive individual from coinfection 
with further strains of HIV (33). Isoniazid for TB pro-
phylaxis was rarely used and anecdotal evidence from 
facility staff suggested it was not popular because it was 
too expensive to maintain for the large numbers of peo-
ple potentially at risk of TB. Infection control training 
decreased over time, suggesting it was a single delivery 
of education rather than a sustained programme.
9.4.9—ART
Throughout the three months of follow-up the propor-
tion of participants who received ART steadily in-
creased. There was rapid initiation into therapy; the me-
dian time from diagnosis to study recruitment was just 
over a month but 75% of participants had received at 
least one dose of ART by T3. This speed suggests that 
people were diagnosed late in the disease trajectory and 
would have benefited from earlier diagnosis before the 
need for ART. Participants did not all show complete 
adherence to ART, which could have several possible 
explanations. Some participants might have received a 
brief course of ART for prevention of mother to child 
transmission. In other cases, the recording may be at 
fault, for example if participants received two months’ 
supply of ART and then did not record receiving it the 
following month. During the civil unrest and violence 
in early 2008, several facilities operated this policy to 
reduce the number of journeys patients needed to make. 
Support and monitoring services were usually provided 
but there was still a gap between ART and support, 
which is worrying given the burden of symptoms expe-
rienced by people on ART.
9.4.10—CTX
As well as its use in daily prophylaxis, CTX is also 
prescribed as a course of antibiotics to treat infection. 
Participants who reported taking CTX the previous day 
but not having it for prophylaxis were probably in this 
group. Daily CTX has been shown to reduce morbidity 
and mortality in people with HIV in Uganda (55). 
9.4.11—TB
The proportion of participants who received TB treat-
ment was 12.4% at T0 and changed very little over 
time, although the proportion to have ever received it 
was higher (19.5%), showing that these were not all the 
same group of people receiving a course of TB treat-
ment over the whole period of the study. TB is a very 
common cause of death in HIV (56) and HIV is the 
biggest risk factor for activating latent TB (57) which is 
the reason why many participants were referred to the 
HIV centre from chest clinics. 
9.5—Health at the Beginning of the Study
The APCA African POS and MOS-HIV used to col-
lect longitudinal data have both been validated for use 
with HIV positive patients in sub-Saharan Africa (5, 
58) and have been used longitudinally (5, 59), demon-
strating their suitability for use in this study. The MOS-
HIV and APCA African POS were well completed at 
all time points. Missing responses for all MOS items 
was less than 0.5% at all timepoints. Missing responses 
for all APCA African POS items ranged from 0.43% 
of participants at T0 to 2.70% of responses at T3.
The MOS-HIV physical and mental health sum-
mary scores of the population at baseline were com-
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parable to those found in other studies of HIV disease 
in the sub-Saharan African setting (8, 11). There is a 
strange pattern to the distribution of scores. They are 
designed to be Normally distributed around a mean 
of 50 with a standard deviation of ten (12) but in this 
population the upper part of the curve drops away very 
steeply, as though cut off. The reason for this is not 
known. 
The APCA African POS measures multidimen-
sional problems: pain and symptoms (physical); worry 
and being able to share feelings (psychological); find-
ing life worthwhile and being at peace (spiritual); and 
having enough help and advice fro the family to cope 
(social). Each question is representative of clinical need 
and the items were not designed to be united into 
domains.
9.5.1—Problems Facing Caregivers
The findings relating to carers can only be interpreted 
with caution as only a small proportion of participants 
were accompanied by their carer to the health facility. 
The proportion of participants attending the facil-
ity with a carer fell from 12% at T0 to 3.4% at T3. 
Of those who came and completed the APCA Afri-
can POS questions, carers reported receiving a lot of 
information, although not as much as wanted, and were 
not very worried but not completely confident. The 
low proportion of patients attending with a carer may 
reflect the relatively high physical wellbeing of patients, 
but at the same time, 35% of participants at T0 report-
ed they had been unable to share how they felt in the 
previous three days. The feeling of isolation and loneli-
ness reported by a third of participants was emphasised 
by the majority coming for care alone.
9.6—How Participants Differ by Facility
9.6.1—Patient Characteristics at Different 
Facilities
There was no marked difference between age, gender 
and education distributions of study participants at the 
different facilities, suggesting that the demographic 
characteristics of the sample are representative of the 
wider population and were not skewed by abnormal 
results from any facility.
9.6.2—Illness Severity at Different Facilities
Mean CD4 count varied from 266 at facility 158 to 354 
at facility 159. CD4 counts in this range are well below 
the normal level, indicating immunosuppression and 
a risk of opportunistic infections. CD4 count can vary 
extensively within and between individuals, meaning 
that although CD4 count is the best way to monitor 
a person’s disease trajectory over time it is of limited 
use to compare the health of large groups. Also, in 
interpreting the mean CD4 count change at different 
facilities it must be remembered that the time period 
over which the change was examined was different for 
every participant with a possible range of periods from 
one month to 21 months.
9.6.3—Care Received at Different Facilities
The mean number of care components received on-
site varied from 7.1 at facility 157 to 13.5 at facility 
155. In general the proportion of individuals receiving 
symptom management care components did not differ 
greatly over time, although the receipt of some compo-
nents which were less directly relevant to clinical need 
did vary. For example, 91% of participants at facility 
155 received condoms, but only 40% at facility 160. The 
proportion of participants who received malaria treat-
ment varied from 19% at facility 156 to a very high 
70% at facility 155. 
Most care themes contained one component which 
was the most commonly received at every facility and 
which largely governed the prevalence of that care 
theme; nutritional counselling for nutrition, pain as-
sessment for pain, visit from a faith leader for spiritual 
care, etc. The care theme with the widest variation 
in provision at T1-T3 by facility was nursing, which 
ranged from 5.2% at facility 157 to 79.9% at facility 
158. Facility 157 employed almost ten times as many 
nurses as facility 158 and it is not clear why this dif-
ference in care receipt should have occurred. The result 
may be due to participants having different interpreta-
tions of the term ‘nursing care’.
9.6.4—Health at Baseline at Different Facilities
At baseline Facility 160 had the lowest mean scores 
for both physical and mental health, and Facility 156 
had the highest. The difference in mean scores between 
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facilities was statistically significant for both outcomes. 
Facility 156 took the largest proportion of participants 
whose stated reason for attending at T0 was to col-
lect medication or a lab test result. It is possible that 
this facility did not implement the inclusion criteria 
properly and recruited patients who did not have a new 
presenting problem. Thus their health outcomes would 
be higher at baseline. Meanwhile, Facility 160 recorded 
that the largest fraction of its participants had been 
referred because of an HIV test result or were newly 
diagnosed.
9.7—Participant Characteristics and Health
9.7.1—Gender, Age, Education
Men and women had the same health outcomes, which 
is in some ways surprising. Women are more vulnerable 
to HIV infection and might be expected to show fewer 
symptoms because antenatal testing is routine and both 
men and women are equally likely to attend for VCT 
(60). Thus, women should have a higher probability of 
finding out their diagnosis before sickness develops and 
they seek healthcare because of it, yet outcomes were 
the same for both genders.
Older age was associated with worsened physical 
health but had no association with mental health. As 
well as the general expectation of decreasing physi-
cal health with age, there is some evidence that HIV 
progresses more rapidly in older people (61).
9.7.2—Relative Wealth
The positive association between socioeconomic status 
and health outcomes is well known. In this study, 
participants with great relative wealth (defined using 
poverty quintiles after the DHS method) reported 
significantly higher physical and mental health at 
baseline. It is important to remember that though this 
study showed the poorest people to have worse health, 
there is evidence that greater proportionate wealth is a 
risk factor for HIV infection (62). The wealth quintiles 
used in this study were generated from the dataset and 
can only be used to describe individuals relative to each 
other, not in absolute terms, thus it is not possible to 
link wealth to probability of recruitment, as it is with 
gender.
9.7.3—Illness Severity
According to CD4 group (under 50, 50–200, 201–350 
and over 350), higher physical health score was sig-
nificantly associated with higher CD4 count, but the 
association with mental health was only weakly signifi-
cant and there was no association at all between APCA 
African POS total score and CD4 group. The results of 
linear regression in Appendix I show that the appar-
ent association between mental health and CD4 was 
completely confounded by physical health which was 
related to both. Conversely, adjusting for mental health 
did not eliminate the association between physical 
health and CD4, proving that the former result was not 
caused simply by overadjusting. These results show that 
people with HIV have similar multidimensional prob-
lems and levels of mental health at all stages of disease, 
after accounting for the decline in physical health.
Analysis of carer presence and outcomes in Appen-
dix I showed that apparently carers were present to pro-
vide practical support for patients with physical needs, 
not psychological support for patients with mental 
needs. This is interesting in the light of evidence from 
the APCA African POS that a substantial proportion 
of patient need was from the psychological dimension.
9.7.4—Individual Care Components
TB is a major killer of people with HIV in sub-Saharan 
Africa and the combination of HIV and TB is known 
as a dual epidemic. In the study, people taking TB 
treatment before recruitment had lower physical health 
than those who had not. It is not known whether 
this difference is caused by the symptoms of TB (e.g., 
coughing, night sweats, weight loss, fatigue), or whether 
TB is a proxy for more advanced HIV disease, as results 
showed TB treatment was associated with lower CD4 
count. However, those receiving TB treatment also had 
lower mental health, which is not closely associated 
with CD4 count, suggesting some other connection.
9.7.5—Association of Outcomes with Loss to 
Follow-Up
Unlike traditional techniques for analysing longitudi-
nal data, multilevel modelling can make efficient use 
of data with missing timepoints. The limitation is that 
at least two points must be present in order to calcu-
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late change. In this study participants with fewer than 
four data points showed worse physical and mental 
health than participants who completed all four. This 
is unsurprising, and many studies of health over time 
suffer from the problem that those who are most sick 
are least likely to have the time and ability to complete 
questionnaires. Traditional techniques would have re-
moved these non-responders from analysis and created 
a bias towards better health. On the other hand, there 
were no differences in health outcomes between those 
who completed only the first interview and those who 
completed more than one. Therefore, excluding the 60 
participants who completed only T0 for longitudinal 
analysis did not bias the population.
9.8—Changes in Health Over Time
The use of the MOS-HIV in longitudinal studies has 
been demonstrated in Uganda (11) and internationally 
(59, 63, 64). Some studies have been analysed using tra-
ditional methods and others using longitudinal analysis 
similar to that presented here. Unusually, this study was 
multicentred and the analysis included an adjustment 
for clustering by facility.
The results show that study participants, who were 
newly diagnosed with HIV or had developed a new 
problem and were attending PEPFAR-funded HIV 
care and treatment clinics, showed statistically and 
clinically significant improvements in their self-report-
ed physical and mental health during the first three 
months of care. It is not possible to determine within 
this PHE whether the improvement was caused by the 
care they received or whether it would have happened 
in any case. However, improvement in health outcomes 
over time is contrary to the progressive trend of HIV 
disease.
In the APCA African POS, any change in score is 
considered clinically significant, but a reduction in the 
proportion of people with severe or moderate problems 
is of more clinical interest than an overall shift from 
mild problems to none. The results showed that preva-
lence of severe problems did decline swiftly from T0 to 
T1 and then often plateaued, as the sustained improve-
ment in mean scores was made up by improvements 
at the milder end of the spectrum. Improvement in 
median score was largest for the items with the low-
est baseline score. This is to be expected, as the ceiling 
effect of the tool limited the potential for improvement 
of items such as symptom burden which did not begin 
at a particularly low level.
9.8.1—Changes in Health Over Time for Those 
in Most Need 
Some people suffer from intractable pain or complex 
symptoms which are not responsive to treatment and a 
general increase in health outcomes may mask the small 
group who do not improve. In this study population, 
there was no evidence of such an effect, although it is 
important to remember that only outpatients were in-
cluded and that people who left the study after T1 had 
lower baseline health scores than those who remained. 
An additional note is the phenomenon of convergence 
to the mean, which would give those with low scores 
at baseline an increased probability of showing im-
provement compared to the population as a whole. The 
association between mental health score at baseline and 
over time was weaker than for physical health, suggest-
ing that outcome is more difficult to predict for those 
with low mental health scores.
9.8.2—Change in Health Over Time at 
Different Facilities
Facility 156 showed a very different mean physical 
health score change over time compared to the other 
five. Physical health score gain was not maintained 
after T1, with the result that Facility 156, which had 
the highest mean physical health at T0, had the low-
est at T3. The same pattern was observed for mental 
health but to a lesser extent. This finding is particularly 
surprising given that better baseline health score was 
predictive of further improvement.
At Facility 156 over 60% of participants recorded 
their reason for attending the facility at T0 to be receiv-
ing medication or the results of a lab test. As described 
earlier, this reason for attending was not one of the 
inclusion criteria. It seems probable that participants 
attending for this reason were less likely to have a new 
problem which required particular care, which may 
explain why participants at Facility 156 reported better 
physical health at the beginning but showed less im-
provement in outcomes compared to other facilities.
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9.9—Changes in Health Over Time in Detail 
9.9.1—Participant Characteristics
Improvements in self-reported well-being were sig-
nificant even after accounting for patients’ background 
characteristics: baseline well-being, individual wealth, 
education, and CD4 count. The association of other 
potential confounders had been found to be insignifi-
cant in univariate analysis. The improvement was also 
not an artifact of increased loss to follow-up in those 
with lower health. Cross-sectional analysis showed that 
higher relative wealth was associated with better physi-
cal and mental health at baseline. Longitudinal analysis 
demonstrated that participants with greater relative 
wealth also showed significantly greater improvement 
in self-reported physical and mental health over time, 
even after accounting for the fact that a higher baseline 
score was itself a predictor of greater improvement.
Possible mechanisms for this effect include; better-
off people may seek healthcare earlier in the trajectory 
of worsening symptoms, may be better able to afford 
medication, transport costs and food, may be better 
nourished and more likely to have health-promoting 
infrastructure such as a clean water source, reducing the 
risk of water-borne infections. Even when ART is free, 
there are considerable cost barriers to HIV care such 
as the cost of lost work time, food and transport to the 
care facility (65).
9.9.2—ART and TB Treatment
In the study, after accounting for CD4 count, knowing 
whether a patient was receiving ART did not help to 
predict physical health or the rate at which their physi-
cal health would improve. The finding was not lost in 
overadjustment for CD4 count, since most participants 
only had one CD4 count, dating from before initiation 
of therapy. In interpreting these results it is important 
to remember that the study was observational and was 
not designed to measure the effectiveness of ART. The 
participants receiving ART would have differed sys-
tematically from non-recipients, with more advanced 
HIV disease and in many cases a longer history of care. 
The results show that ART users and non-users both 
benefited from multidimensional care and support over 
a three-month period.
Change in mental health was definitely not as-
sociated with ART, TB treatment or CD4 count. The 
implication appears to be that mental health is complex, 
individual and does not rely on physical state. In the 
study, the majority of improvement in mental health 
occurred between T0 and T1.
9.9.3—Care Availability
Health outcomes were not statistically associated with 
the prevalence of any care themes by facility over time. 
This could be a true reflection of events, but there were 
also several factors which increased the probability of a 
Type II error. 
The six facilities were quite similar to each other 
in the care they delivered. Clinical and preventive care 
were available to many participants, social and psycho-
logical care to fewer. Four of the six facilities were HIV 
clinics in public hospitals administered by the Ministry 
of Health. Possibly as a consequence, the variance in 
participant health outcome between facilities was about 
one twentieth the size of the variance between indi-
viduals. The models relied on variance between facilities 
in order to determine the association with facility-level 
care availability, but too little variance occurred at this 
level to enable useful predictions to be made (results in 
Appendix I). If the sample had included facilities which 
were very different from each other in resources and 
care delivery, there would have been more variance.
The analysis acknowledged that repeated measures 
from individuals, and measures of individuals from 
facilities should not be treated independently (66). In 
other words, the observations from participants from 
one facility were likely to be more similar than patients 
from different facilities, and repeated measures from 
one individual were likely to be more similar than mea-
sures from different individuals were accounted for by 
using multi-level modelling. However, the study design 
and analysis could not account for or detect differences 
in modes or frequency of care provision, staff attitude 
or the capability of the care providers that are likely to 
influence patient outcomes.
9.10—Strengths
The facilities involved in the study were selected at 
random (1), thus reducing response bias (facilities con-
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fident in the outcomes of their care being more likely to 
respond to an invitation to participate than others). No 
facilities refused to participate. The longitudinal nature 
of the study design enabled the change in patient out-
comes to be monitored over time, thus overcoming the 
limitation of a before and after study design (30).
Eligible patients were those who were new to the 
facility or who were presenting with a new problem. 
These criteria were applied to maximise the potential of 
detecting any influences of care on patient outcomes in 
the short follow up time available for this study. Given 
the chronic illnesses associated with HIV infection, it 
seemed there was a high possibility of recruiting a great 
proportion of patients to the study who had had the 
same illness for a long time, were stable on ART, and so 
were unlikely to change their health outcomes in three 
months. There was a high response rate (95.6%) and 
low level of patients leaving the study over the three 
months (104 patients missed one or more interviews).
Subsequent patients were asked to participate if 
they met the inclusion criteria, until the desired num-
ber had been recruited. This minimised the possibility 
of healthcare workers recruiting patients who they 
thought likely to have favourable outcomes. There were 
no facilities which struggled to recruit sufficient num-
bers. The concise and multi-dimensional nature of the 
APCA African POS means this study provides valuable 
data on the multi-dimensional wellbeing of HIV posi-
tive patients accessing outpatient clinics in sub-Saharan 
Africa, and this has potential for future clinical and 
research uses.
9.11—Limitations
The random selection in Phase 1 was originally based 
on patient numbers only, and so the facilities involved 
in Phase 2 do not necessarily represent the diversity 
of geography, relative wealth of the facility catchment 
areas, facility funders, service provision or other aspects 
that may affect service provision, quality of care, facility 
attendance or response to treatment. Some of these fac-
tors (e.g., relative wealth of the patients, care received at 
the facility) were measured for individuals and so were 
accounted for in the analysis. Additionally, the Phase 
2 facilities were selected purposively by a prreviously 
decided method (size).
The APCA African POS summary score has not 
previously been calculated and the tool was not de-
signed to be so summarised, although the separate 
items have been assessed in a validation study of reli-
ability and sensitivity (13).
A large number of statistical tests increases the 
probability of falsely identifying connections. In this 
study, five demographic covariates plus eight care 
themes were each modelled separately with two out-
come variables, making 26 models. Stepwise downward 
regression was later used to rule out any covariates 
which might have been included due to Type II error.
The CSRI recorded the receipt of 52 items of care. 
It is possible that the tool excluded some items of 
care, the receipt of which could potentially have been 
influencing health outcomes. The act of undertaking the 
study may have influenced the care given, and thus af-
fecting participant outcomes in a way that normal care 
would not have shown. Furthermore, even the process 
of asking a series of questions about how patients feel 
could be viewed as a form of care in itself, or it could 
have revealed health problems to the health provider 
that a normal consultation would not have detected. 
The fact that almost a quarter of participants 
recorded their reason for coming to the facility was to 
obtain medication or a test result does not fit with the 
inclusion criteria. Possibly these participants attended 
to collect medication and were then discovered to have 
a new problem; alternatively, they may not have had a 
diagnosed new problem and might have been recruited 
anyway. The inclusion criteria were set to avoid the 
situation of having long-term patients with managed 
problems showing no change in health outcomes over 
three months. In the study, mean outcomes did improve 
over three months, and this effect could only have been 
weakened by the inclusion of participants who did not 
have new problems.
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The qualitative interviews with patients, their carers, 
and staff revealed greater understanding about care 
delivery and receipt in PEPFAR-funded HIV care and 
treatment facilities in Kenya. Patients and carers usu-
ally reported positive experiences of care and appreci-
ated the receipt of symptom management, ART and 
counselling/information services. Patients gave each 
other social support and were encouraged to advocate 
for HIV care, and both carers and staff were likely to 
be HIV positive, indicating the multiple roles enacted 
in the health facility community. Challenges to care 
were long waiting times, unaffordable costs (even when 
treatment was free), and unreliable drug supplies. Staff 
reported overburden with large numbers of patients and 
attempts to meet costs themselves. 
Anxiety was found to be a common problem 
amongst those living with HIV infection as well as 
their families. The prevalence and intensity of anxiety, 
it appears in the data, is compounded by poverty and 
stigma. It is understandable that facilities cannot always 
meet social needs, but these should be discussed (which 
they are often not) where possible to identify appropri-
ate providers. Further, a number of patients reported 
that they are not asked about their emotional wellbeing 
during clinical encounters. 
Drug availability is a systemic issue that clearly 
needs attention. Although ART availability did not 
seem to be a major problem, the provision of simple 
medications such as analgesics and antibiotics were 
problematic and led to suboptimal care as patients 
could not afford to purchase elsewhere. These prob-
lems were commonly reported across staff and patient/
family data. Palliative care drugs were also identified 
as a need, with the (erroneous) expectation in one case 
that they would be expensive. For facilities, difficulty 
procuring drugs seemed to be less a problem of cost 
and more about unstable supply, inadequate stock and 
legal restrictions. Staff reported (anecdotally) that the 
amount of any drug that a public health facility can 
order per month is tightly controlled. Staff at two facili-
ties wanted to prescribe morphine, which is difficult to 
access and prescribe in Kenya. 
The main problem carers experienced was lack 
of money to pay for food, transport and school fees. 
Patients repeated the same three priorities for pay-
ment. For at least some patients and carers, poverty was 
intense. They could not afford to pay the small costs of 
home-based care such as disposable gloves and soap, 
which staff ended up providing from their own pocket. 
Patients in most need were refunded travel costs or giv-
en extra but there seemed to be no clear guidelines as to 
who was entitled, leaving the system based on charity. 
Staff wanted to give more than they could, and felt that 
they were not doing enough. Being forced to deliver 
inadequate care causes moral distress to staff as well as 
physical distress to patients (67). Thus the discrepancy 
between needs and resources, without the protection 
of a written policy and exacerbated by overwhelming 
patient numbers, puts staff at risk of burnout. 
The data give useful insight into the value of com-
munity support and the role of community health 
workers. It should be noted that family carers are 
(unpaid) resources who enable patients to be cared for 
at home. They often reported not being asked about 
their own needs and experiences, and they should be 
given at least recognition that they may have needs to 
be expressed. 
Patients were highly appreciative of the care and 
support they received, and particularly appreciated be-
ing treated courteously by staff, as was also stressed in 
Phase 1. The reputation of a clinic appeared to be major 
factor in the choice of care provider, a good reputa-
tion being highly attractive. However, while staff were 
caring and attentive, a few patients did note that staff 
attitude was occasionally not as they would hope. The 
expectation of confidentiality, proximity, and holistic 
and reliable provision of treatment and care appear to 
be maintained.
The staff request for paediatric counselling train-
ing which had been identified in Phase 1 was repeated. 
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HIV-positive children entering adolescence constitute 
a new, emerging group of patients who would not 
have lived so long before the rollout of ART, and they 
require specific counselling to understand and manage 
their condition (68). 
Staff identified a need for more space to be able 
to offer counselling and confidential medical care as 
needed, to meet patient stated needs of guaranteed con-
fidentiality. Patients also objected to the long waiting 
times, a result of overburdened staff. Time spent in the 
waiting bay, talking to other patients, gaining support, 
sometimes singing and praying together, was valuable 
for patients, but at the same time they did not wish to 
spend all day there and they felt at risk of picking up 
infections.
The interlinked roles of carers who were also pa-
tients, staff who were HIV positive, and patients who 
were community advocates illustrated the comments of 
some Phase 1 interviewees about the facility staff and 
patients as a family. Research in several countries has 
found that people with HIV respond best to counsel-
ling from others with HIV, and greater involvement of 
people with HIV/AIDS (GIPA) is a principle of HIV 
care and prevention. One staff member revealed their 
vision of HIV care:
“The future of this fight against HIV/AIDS is when all these patients will 
be able to form support groups and we as the HCWs be in a position to 
support them. These groups should then be empowered to support each 
other, remind each other about clinic days, consult each other when they 
have problems and assist each other spiritually.”
The same theme was echoed in patients’ encouragement 
to remain active, attend weddings and celebrations, 
and be part of community life. By advising patients to 
discipline their minds not to think of themselves as 
isolated, staff appeared to be warding off self-imposed 
stigma. Having HIV seems to damage self-efficacy, and 
in Phase 1 the restoration of dignity and self-respect 
was as much an aim of microfinance programmes as 
was increased income. At the same time, the risk of 
the ‘facility as family’ model is that an entirely separate 
community of people with HIV is created, centred on 
their disease. This is an alternative way of life, rather 
than normalisation. 
Staff put considerable effort into maintaining ART 
adherence. Techniques included referring patients to 
their nearest facility, deterrence of those who lived 
too far away, reimbursement of transport costs, asking 
patients to sign a pledge to attend, regular adherence 
counselling, and employing ‘tracers’ to hunt down and 
bring in defaulters.
The standard form for patient assessment included 
weight and height, TB screening, presence of OIs, ART 
adherence and side effects, use of other drugs and CD4 
count, but no assessment of pain, symptom experience, 
emotional situation or psychosocial need. 
10.1—Strengths and Limitations
There are several strengths and limitations to the 
qualitative data. Firstly, although the views of patients, 
carers and staff were captured in this study, which gave 
views from the key individuals involved in patient 
care, respondents were identified by the participating 
facilities, which may have introduced bias. Second, as 
the interviews were conducted in a range of languages 
they had to be analysed in the common language of 
English. Although this raised issues of translation and 
interpretation it allowed respondents to express them-
selves freely without the constraints of translating their 
thoughts to a less familiar language. Furthermore, the 
protocol ensured that interpretation of the local mean-
ing was established. The interviews were coded twice 
by independent researchers in the UK and Kenya. This 
process gave rigour to the coding process by reducing 
individual bias in interpretation. In addition, the cross-
country coding allowed the possibility of culturally 
different interpretations to arise and be discussed.
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Discussion of Costing Study
There was considerable variation in the facility cost of 
providing care and support, with the main cost drivers 
being salaries for clinical staff, ARVs and other drugs, 
and lab costs. There were economies of scale, with larger 
facilities having lower costs per patient per year.
Providing care and support for HIV positive 
patients constitutes a significant part of national HIV 
programmes in general, and care and support is a focus 
of PEPFAR with its commitment to reach 12 million 
people with care and support services. In considering 
scale up and expansion of care and support services it is 
helpful to know the costs of such services. With almost 
40 million people testing positive for HIV and nearly 
three million people already on ART (39), the financial 
sustainability of maintaining and expanding care and 
support is a challenge for the public health community.
The cost of providing comprehensive HIV care and 
support may vary significantly across country settings 
and program delivery approaches. Calculating care 
and support costs in a range of settings will provide 
estimates of annual per-patient care costs that are 
representative of Emergency Plan-supported programs. 
Understanding the contextual factors that affect the 
cost of providing comprehensive HIV care and support 
is important in interpreting comparative costs analysis 
across country and program settings.
The overall purpose of the costing component of 
this study was to estimate the average costs of provid-
ing care and support to a patient over a one year period. 
This could then be used to calculate life time care for 
patients as a function of their life expectancy, or be 
used to estimate scale-up requirements of program 
expansion. However, such modeling was not part of the 
present study.
11.1—Strengths and Limitations
Care and support is the aggregate of many services, 
(psychological support, ART, pain management, etc.) 
The average cost of care for patients will therefore be 
the aggregate of the costs of providing these individual 
components. Although this study examined drug, staff, 
laboratory and facility running costs, the costs per 
patient for individual components of care could not 
be calculated. The cost of drugs other than ARVs was 
a particularly difficult area. A small selection of drugs 
relevant to HIV care were identified, but the propor-
tion of total drug costs spent on these would depend 
partly on the extent of the range of drugs offered by the 
facility. For other components of care where the cost 
drivers were higher for staff time than for drugs, such 
as counseling services, it was not possible to allocate 
proportional staff time to the specific components of 
care sufficiently well.
The facilities received funding from the Ministry of 
Health and in some cases from other donors as well as 
PEPFAR funding which came through partner organi-
sations. The amount of funding received from PEPFAR 
and the proportion of its budget that this represented is 
not known, thus costs at the facility, rather than direct 
costs to PEPFAR, are the aim of analysis.
Care and support is provided not only at facilities 
but also in many cases by communities, at the family or 
household level or by FBOs/NGOs all of which incur 
costs and contribute to the overall costs of care for a pa-
tient. Individual patients may also incur costs in terms 
of time off of work (lost income) or the opportunity 
costs of their time in productive work and for trans-
portation. Due to funding limitations, this study only 
looked at facility-based costs. Other areas of cost which 
were not represented include those incurred by program 
managers at the donor level, administration of donor-
funded programmes, and training of specialized care 
and support for HIV positive patients. Lastly, the study 
did not take account of cost savings associated with 
averted illnesses or reduced in-patient costs as a result 
of effective care and support.
11
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Integration and Conclusions
This study has shown that patients who are newly 
diagnosed as HIV positive or have experienced a new 
health problem and who are attending PEPFAR-
funded HIV care and support services show statistically 
and clinically significant improvements in physical and 
mental health over the course of three months under 
care. Such improvements were seen even in patients 
with the poorest physical and mental health.
Although it was not possible to determine which 
care components were associated with the greatest 
health improvements (because the sickest patients were 
more likely to receive more care components and not 
receiving care does not mean the care was not needed), 
a summary of the greatest patient needs and most com-
mon care components received, as well as the notable 
gaps in care, can indicate the care that might be most 
beneficial to patient health and wellbeing. The most 
common care components received related to preven-
tion of infections and maintenance of patients’ physical 
wellbeing (e.g., CTX, nutritional advice and pre and 
post test counselling), ART, and pain management (as-
sessment of pain and non-opioid analgesics). The rela-
tively low pain, symptom and worry burden in the study 
population compared to other problems, as indicated by 
the APCA African POS, suggests that the wide provi-
sion of these care components is beneficial to patients. 
The APCA African POS revealed that at the start 
of the study patients’ lowest scores related to being un-
able to share their feelings with others and feeling that 
they and their family were not getting enough help to 
plan for the future. Patients reported little improvement 
in these concerns over the course of the study even 
though counselling care components were commonly 
received. Patient and staff interviews revealed that such 
care comprised mainly information transmission rather 
than an opportunity to discuss concerns. Furthermore, 
social care components were received by a minority of 
study participants, possibly in part because of insuf-
ficient social workers and high patient loads for non-
clinical staff. These findings suggest that these impor-
tant problems of patients attending care and support 
services are not being adequately addressed. Facilities 
with higher proportions of non-clinical staff did not 
have the highest per patient costs, suggesting that staff 
cost is not the reason for not providing care in this area. 
The costing component of the study revealed that 
the major cost drivers were not consistent across the six 
facilities and there were large variations in the cost per 
patient of providing care and support. These costs were 
not connected to the level of health improvement expe-
rienced by patients. There are lessons to be learned from 
the more efficient facilities, but this must not reduce 
quality of care. 
The longitudinal quantitative study showed that the 
majority of participants received some form of counsel-
ling, but qualitative evidence revealed that counselling 
can consist merely of information transmission from 
counsellor to patient, without addressing emotional 
issues. Anxiety and worry were shown to be severe 
patient problems in both qualitative and quantitative 
studies, and the costing study showed that the patient 
load for non-clinical staff (such as counsellor and social 
workers) is frequently unmanageable. In the qualitative 
interviews, staff reported insufficient social workers, and 
patients and carers stated that high quality care would 
involve being visited in their homes by someone who 
knew their situation.
The interviews showed that patients sometimes 
had to buy the drugs which were prescribed to them 
at a pharmacy outside the facility. Thus the distinction 
between “care received at the facility” and “care received 
elsewhere” is not as clear-cut as it appeared to be in the 
quantitative longitudinal study. 
Facility 159 had much higher costs than any other 
facility. The proportion of costs to area was not greatly 
different from other facilities, with staff making up the 
largest fraction of costs. Facility 159 recruited partici-
pants with the highest health outcomes at baseline and 
they showed the least improvement over time. Partici-
pants at this facility made less gain because they began 
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from a higher point. 
Ceiling effects (the upper limit of outcome mea-
sures), regression to the mean (the increased prob-
ability of central values through random chance) , and 
the behaviour of disease and health in populations all 
mean that people with better health will gain less from 
care. In HIV the result is that a facility which receives 
patients whose HIV disease is more advanced could ap-
pear to gain more in health scores by offering care and 
support to manage symptoms, infections, psychological 
problems etc. Meanwhile a facility which recruited peo-
ple at an early stage would not be able to do as much 
to help them. This effect would be more pronounced 
in physical than mental health because physical health 
is more closely linked to disease progression. Facility 
159 appears to have done less for its patients in terms 
of health gain while costing more than twice as much 
per patient, but this could be the result of its offering 
prompt care so that patients never experience the de-
cline and recovery of health measured at other facilities. 
The main reason why qualitative interview patients 
attended for care was because of symptom burden. 
The quantitative evidence showed that participants 
with lower relative wealth presented with worse health 
outcomes, suggesting that they bore with symptoms 
for longer before accepting the expense of travel to the 
facility. The most common symptoms in qualitative 
interviews were pain and lack of energy, which are both 
invisible and often underdiagnosed or not recognised as 
a real problem. The multidimensional scores indicated 
unacceptable levels of pain, and the MOS-HIV results 
showed that only 23% of participants said they always 
had enough energy to do the things they wanted to do. 
Talking about death was seen as “brave” and as 
something of which only a few patients (or staff ) would 
be capable. All the facilities were predominantly for 
outpatients and care of the dying was not a major part, 
although the nine deaths during the quantitative study 
equate to a mortality rate of 5% per year. Care included 
memory work with very practical help such as taking 
photographs of the patient for families to keep, and 
legal services including will-writing. These two com-
ponents of care were rarely received in the quantitative 
study and the interviews helped to reveal their impor-
tance in the context.
Staff reported that patients would normally have 
a carer with them only if they were incapable or not 
adhering; this was supported by evidence from the 
quantitative study that patients with a carer had worse 
physical health. Patients’ lowest scores in the multi-
dimensional questionnaire were for lack of someone 
to share their feelings with and of help and advice for 
their family. At the same time, in qualitative interviews 
the staff stressed the importance of patients support-
ing each other and patients expressed the benefit they 
gained from such support. Carers were themselves 
often HIV positive. More patients would benefit from 
the emotional, social and practical support of having a 
carer, which should not be seen as necessary only for 
the physically incapable 
One carer made a very good point: “the patient 
cannot eat alone while the child is just watching.” It 
is not possible to provide adequate food for a single 
member of a family if the others do not have enough. 
The carer described sharing out an orange between all 
members of the family, each person receiving a tiny 
piece. Staff reported that some patients were unable to 
have even one meal a day, and that the most in need 
were old people looking after their HIV positive or-
phaned grandchildren. Over 90% of quantitative study 
participants were given nutritional counselling. If lack 
of knowledge was the problem causing malnutrition, 
it has been adequately addressed, but the qualitative 
interviews show that the main reported problem was 
poverty.
Carers worked hard to find fruit and green veg-
etables for the patients. Telling patients they should eat 
healthily without providing them with the means to 
do so imposed a financial and psychological burden on 
families, and it is not certain that this was outweighed 
by any gain in health. When patients did receive a food 
handout (17% of the longitudinal cohort) it was usually 
flour for porridge delivered to those who were severely 
underweight. At the same time, 9.5% of participants, 
all outpatients, received therapeutic feeding for severe 
malnutrition. All the signs indicate chronic, systemic 
hunger as the reason for malnutrition.
Patients found benefit from time in the waiting bay, 
gaining social and spiritual support from other patients. 
However, the quantitative study showed that a lack of 
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someone to talk to and lack of help and advice were 
still major problems for patients, suggesting that the 
communal support is not adequate to meet everyone’s 
needs. These services need to be developed further, ei-
ther by empowering patients to do more for themselves 
or by direct delivery of care. 
The costing study showed that it was cost-effective 
for a facility to have a large number of patients, but 
staff reported that the quality of care declined in these 
circumstances. As the quantitative study showed that a 
high proportion of patients were newly diagnosed, but 
loss of patients was very low, the problem of patient 
numbers is likely to increase. The high patient-staff 
ratios increase waiting times, which are an impediment 
to satisfactory care, and raise the pressure on staff. The 
lack of space is also likely to become even more of a 
problem, which again inhibits quality care by threaten-
ing confidentiality.
Small costs to a facility, such as a shortage of lab 
reagents or drug stocks, impact heavily on patients 
as they are sometimes unable to make up these costs 
themselves by transport to another facility or buying 
the drugs at a pharmacy.  Since transport cost was the 
largest inhibitor to attendance, the poorest patients 
would be most likely not to return, as was reported 
by staff. In the quantitative study transport costs were 
generously reimbursed which might have shifted the 
priorities, so this hypothesis could not be tested.
12.1—Strengths and Limitations
The mixed-methods design was a strength of the evalu-
ation, allowing triangulation between the different 
elements. The quantitative interviews illuminated what 
was meant by care and support, longitudinal quantita-
tive study showed the number of people to receive it, 
and the costing study showed the various ways in which 
it could be delivered. Far more data were collected than 
can be explored here and the dataset will continue to 
reveal insights into the experience of people receiving 
HIV care in Kenya.
Use of two well-validated tools, a multidimensional 
outcome measure as well as the more traditional quality 
of life questionnaire, allowed more understanding of 
the issues causing most concern to patients. Qualitative 
interviews supported this evidence that psychological 
problems such as loneliness and anxiety were a cause of 
distress in the population. The longitudinal study design 
was appropriate to the study, allowing observation of 
how quickly problems were managed over time and 
whether care was sporadic or maintained.
The tightly controlled methods of data collection, 
management and validation ensured a high quality of 
data in the longitudinal quantitative study. Completion 
was very high at all facilities and over time. Qualitative 
interviews were conducted by external researchers but 
they often took place on facility property and partici-
pants may have felt constrained in speaking negatively 
about the facility, even though they were assured that 
the recording would be confidential. 
The longitudinal quantitative study was observa-
tional, not randomised. It was not a comparison be-
tween those in and out of care, nor was it designed to 
measure the effectiveness of ART, which as a covariate 
was inextricably associated with disease progression. 
Given the circumstances of the evaluation, a compari-
son group was not available and so it is not possible to 
determine what fraction of the findings demonstrated 
in this study were the result of PEPFAR funding and 
what would have happened without it. No data exist 
from before the beginning of the PEPFAR investment 
which could be used as a baseline. 
The facilities were selected purposively from a 
randomly selected sample, and thus are not representa-
tive of all PEPFAR-funded programmes. An evaluation 
of this kind, which required resources in terms of staff 
time, space and basic infrastructure from its facili-
ties could not have been carried out in a truly random 
sample as the majority of PEPFAR-funded Care and 
Support facilities are very small. 
The six facilities were quite similar, which has both 
strengths and limitations. Equality in funding source, 
structure and philosophy of care prevented undue bias 
between the facilities as all received a similar patient 
population. On the other hand, the homogeneity of 
care delivery precluded comparison between facilities to 
link care to outcomes. 
The study measured care received, not care needed. 
There is no certainty that all the care components a pa-
tient received were necessary, nor that patients received 
all the care they required. 
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Recommendations
13.1—For Health Professionals
 » People with HIV have physical and mental health 
needs throughout the trajectory of illness, and 
mental health in particular is not related to HIV 
progression but can be a problem at any stage. All 
patients referred with HIV should be assessed for 
psychological need on a regular basis. Emotional 
wellbeing should be a core component of patient 
assessment in HIV monitoring upon registration 
and throughout patient care.
 » The needs of carers should be included in the 
patient care encounter. Including carers early on 
the care trajectory would demonstrate the value of 
the carer role in the eyes of facilities, improve social 
care for patients and could help to identify patient 
needs that are not acknowledged by the patients 
themselves. 
 » Participants established on ART were able to fur-
ther improve their physical and mental health over 
three months.  Care and support, complementary 
to ART, can help to optimise health. 
 » All patients should be assessed for pain, which 
should be managed according to the WHO Pain 
Ladder.
13.2—For Health Facility Managers
 » Health facilities should have a clear policy regard-
ing delivery of social care, food support and finan-
cial refunds, so that the burden of decision making 
and payment does not fall on health delivery staff.
 » Staff need to be supported and protected from risk 
of burnout to maintain valuable skills in health care 
and reduce turnover.
 » There should be sufficient numbers of non-clinical 
staff to ensure a manageable patient load for coun-
sellors, nutritionists, social workers and community 
health workers, and high quality patient care. The 
areas addressed by these professions are a severe 
cause of need for people with HIV. 
 » Sufficient space is essential to providing confiden-
tial counselling services and meeting patient needs. 
13
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13.3—For Policymakers
 » Many participants were initiated onto ART within 
weeks of their HIV diagnosis, showing that they 
could have benefited from treatment at an earlier 
stage. Testing needs further encouragement so that 
people with HIV are identified as early as possible 
in the disease trajectory and gain the maximum 
benefit from care and support services including 
ART.
 » No problems were reported with the supply of 
ARVs but supplies of other drugs were frequently 
unreliable, causing expense to patients and delays 
to care. Supply chain systems should adopt the best 
practices of the ART delivery system. 
 » Chronic hunger is not adequately managed by 
short-term interventions. Food shortage caused 
by poverty is a significant problem which inhibits 
delivery of HIV care. Health facilities should work 
towards sustainable, adequate food supply for all 
patients to help maintain health and adherence.
 » Policymakers should advocate for increased use of 
appropriate analgesics, including opioids, to man-
age chronic pain.
13.4—For Researchers
 » The evaluation model used here could be replicated 
in other countries.
 » Facility staff who had hosted research projects for 
years expressed a wish to learn skills and conduct 
their own research. Future research programmes 
should include building of knowledge and capacity 
in host settings.
 » A study of care and outcomes for children should 
be undertaken to explore the multidimensional 
problems of this important population, particularly 
the expanding group of HIV positive older children 
for whom optimal care is still being developed.
 » Shortage of non-ART drugs delayed patient care 
and was a common complaint, but the cause of 
these shortages is unclear. Examination of the bar-
riers to drug delivery and a more detailed investiga-
tion of how drugs are supplied would be beneficial 
in terms of care delivery and patient satisfaction. 
 » The APCA African POS summary score provided 
a useful indication of multi-dimensional problems 
in this study population. Further evaluation studies 
should measure multidimensional outcomes using 
mixed methods to triangulate findings.
 » A study of the how different staff working in care 
and support of HIV patients spend their working 
hours would enable an examination of how care 
costs relate to patient outcomes.
 » Further study of referral networks from individual 
facilities would help understand where, as well as 
why, patients obtain care that is not provided at the 
principal facility of study.
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A Demography
Demography questionnaire
P1 Please indicate the patient's gender male=1, female=2
I would like to ask you a few questions about your background:
P2 How old are you (years)?
P3 What is the highest level none=1
of education you attended? attended primary=2
attended secondary=3
diploma=4
degree or higher=5
P4 What is the main material natural earth, mud, sand=1
used to make the floors finished cement=2
of your house? linoleum=3
parquet/polished wood=4
tile=5
carpet=6
stone=7
P5 What is the main material natural thatched/straw=1
used to make the  walls rudimentary mud and poles=2
of your house? un-burnt bricks=3
burnt bricks with mud=4
finished cement blocks=5
stone=6
Wood timber=7
burnt bricks with cement=8
P6 What is the main material used natural thatched=1
to make the roof of your house? finished wood/planks=2
corrugated iron sheets=3
asbestos=4
tiles=5
tin=6
cement/concrete=7
P7 What type of toilet do you use at home? private flush=1
private VIP latrine =2
private traditional pit (covered)=3
private traditional pit (uncovered)=4
public/shared=5
bush/field/other=6
P8 How far from the facility do you 
live? (kilometres) If not known, don't know=888 km
 ask for means of travel and  time taken to estimate distance.
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P9 What is the main source of safe bottled=0
drinking water for your house? piped inside house=1
piped outside house (yard, public tap)=2
protected well=3
borehole=4
spring/rain water=5
unsafe unprotected well=6
river/stream/pond=7
tanker truck=8
P10 What type of fuel does your electricity=01, lpg/natural gas=02
household mainly use biogas=03, paraffin/kerosene=04
for cooking? coal=05, charcoal from wood=06
firewood=07, straw/shrubs/grass=08
dung=10, no food cooked in household=11
P11.1 Does anyone in the car yes = 1, no = 2
P11.2 household own a …? bicycle
P11.3 refrigerator
P11.4 television
P11.5 mobile phone
P11.6 radio
Now I would like to ask you a few questions about your HIV diagnosis:
P12 What date did you enrol into this facility? dd/mm/yy
unknown day= 15, unknown month= 06, unknown year =888888
P13 why did you visit this facility today? new illness/well-being issue = 1
referred = 2 (from where)
obtain medication = 3 Place from which referred (2), 
HIV test result = 4 or other reason for attending (5):
other = 5 (specify) ________________
P14 date diagnosed HIV+ dd/mm/yy
unknown day= 15, unknown month= 06, unknown year =888888
P15 date started on ARV treatment dd/mm/yy
unknown day= 15, unknown month= 06, unknown year =888888
777777=not on ARV
P16 Current WHO clinical stage (1-4) 8=don't know
P17 Most recent CD4 count don't know=8888
P18 date of most recent CD4 count dd/mm/yy
unknown day= 15, unknown month= 06, unknown year =888888
P19 How many dependants do you have?
(family members who are dependent on you including children)
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        date
.
The APCA African POS & ECOG 
Question
number
ASK THE PATIENT
Questions 1-7
POSSIBLE RESPONSES ANSWER
Q1
Please rate your pain 
(from 0 = no pain to 5 = 
worst/overwhelming
pain) during the last 3 
days
0 = No pain at all 
1 = Slight pain 
2 = Moderate pain 
3 = Severe pain (interferes with activities of daily 
life)
4 = Very severe pain 
5 = Overwhelming. The worst pain you can 
imagine

Q2
Have any other 
symptoms (e.g. nausea, 
coughing or constipation) 
been affecting how you 
feel in the last 3 days? 
0 = no, not at all 
1 = slightly 
2 = moderately 
3 = severely 
4 = very severely 
5 = overwhelmingly 

Q3
Have you been feeling 
worried about your 
illness in the past 3 
days?
0 = Not at all worried 
1 = Worried very occasionally 
2 = Worried some of time 
3 = Worried a lot of the time 
4 = Worried most of the time 
5 = Worried all of the time 

Q4
Over the past 3 days, 
have you been able to 
share how you are 
feeling with your family or 
friends?
0 = Not at all 
1 = Only once 
2 = Occasionally 
3 = Fairly frequently 
4 = Often 
5 = Yes, I’ve talked freely 

Q5
Over the past 3 days 
have you felt that life was 
worthwhile?
0 = Not at all 
1 = Not very often 
2 = Occasionally 
3 = Some of the time 
4 = Most of the time 
5 = Yes, all the time 

Q6
Over the past 3 days, 
have you felt at peace? 
0 = Not at all 
1 = Not very often 
2 = Occasionally 
3 = Some of the time 
4 = Most of the time 
5 = Yes, all the time 

Q7
Have you had enough 
help and advice for your 
family to plan for the 
future?
0 = None 
1 = Very little 
2 = For a few things 
3 = For several things 
4 = For most things 
5 = As much as wanted 

Thank the patient 
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ASK THE CARER Questions 8, 9 and 10 ONLY if consent 
given by patient and carer
Q8
How much information 
have you and your family 
been given? 
0 = None 
1 = Very little 
2 = Some 
3 = Quite a lot 
4 = A great deal 
5 = As much as wanted 
7 = N/A, no carer/consent not given 
8 = carer not present at time of interview 

Q9
How confident does the 
family feel caring for 
____?
0 = Not at all 
1 = Not confident about many things 
2 = Confident about a few things 
3 = Confident about some things 
4 = Confident about most things 
5 = Very confident 
7 = N/A, no carer/consent not given 
8 = carer not present at time of interview 

Q10
Has the family been 
feeling worried about the 
patient over the last 3 
days?
0 = Not at all worried 
1 = Worried very occasionally 
2 = Worried some of time 
3 = Worried a lot of the time 
4 = Worried most of the time 
5 = Worried all of the time 
7 = N/A, no carer/consent not given 
8 = carer not present at time of interview

ECOG (rated by the 
interviewer) 
Q11
Physical function of 
patient
0= fully active, able to carry on all pre-disease 
performance without restriction 
1=Restricted in physically strenuous activity but 
ambulatory and able to carry out light work, 
e.g., light house work, office work 
2=Ambulatory and capable of all selfcare but 
unable to carry out any work activities. Up and 
about more than 50% of waking hours 
3=Capable of only limited selfcare, confined to 
bed or chair more than 50% of waking hours 
4=Completely disabled. Cannot carry on any 
selfcare. Totally confined to bed or chair 

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The MOS-HIV 
Question
number
QUESTION POSSIBLE
RESPONSES 
ANSWER
I would like to ask you a few questions about your health.   
Q1 In general would you say your health is: Excellent=1 
Very good=2 
good=3 
fair=4
poor=5 

Q2 How much bodily pain have you generally 
had during the past thirty days? 
None=1 
Very mild=2 
Mild=3
Moderate=4 
Severe=5 
Very severe=6 

Q3 During the past thirty days, how much did 
pain interfere with your normal work, 
including both work outside the home and 
housework?
Not at all=1 
A little bit=2 
Moderately=3 
Quite a bit=4 
Extremely=5 

The following questions are about activities that a person might do during a typical day. Does your
health now limit you in the following activities? And if so, how much?
Yes, limited a lot=1 
Yes, limited a little=2 
No, not limited at all=3
Q4.1 The kinds or amounts of vigorous activities 
you can do like digging, fetching water from 
a well, carrying a load, splitting firewood, 
running, lifting heavy objects or engaging in 
strenuous sports

Q4.2 The kinds of moderate activities you can do 
like washing clothes, moving a jerrican of 
water or cleaning the house 

Q4.3 Walking up hill, climbing stairs  
Q4.4 Bending, lifting light objects or kneeling  
Q4.5 Walking a moderate distance, like the length 
of a football pitch or taking a village walk 
Q4.6 Feeding, dressing or bathing yourself or 
ability to use the latrine 
MOS-HIV
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The following questions are about work. Does your health now restrict you in doing the following 
kinds of work?
Q5 Does your health keep you from working at a 
job, doing work around the house or 
attending school? 
Yes=1 
No=2 
Q6 Have you been unable to do certain kinds or 
amounts of work, housework, schoolwork, 
because of your health? 
Yes=1 
No=2 
For each of the following questions, please tell me the answer that comes closest to the way you 
have been feeling. 
(Interviewer must begin by reading this 
introductory question to the patient) 
How much of the time during the past 30 
days:
All of the time=1 
Most of the time=2 
A good bit of the time=3 
Some of the time=4 
A little of the time=5 
None of the time=6 
Q7 Has your health limited your social activities, 
like visiting with friends or family? 
Q8.1 Have you been a very nervous person?  
Q8.2 Have you felt calm and peaceful?  
Q8.3 Have you felt depressed? 
Q8.4 Have you been a happy person?  
Q8.5 Have you felt so depressed that nothing 
could cheer you up? 
Q9.1 Did you feel full of life and energy?  
Q9.2 Did you feel totally without energy?  
Q9.3 Did you feel tired?  
Q9.4 Did you have enough energy to do the things 
you wanted to do? 
Q9.5 Did you feel weighed down by your health 
problems? 
Q9.6 Were you discouraged by your health 
problems? 
Q9.7 Did you feel despair over your health 
problems? 
Q9.8 Were you afraid because of your health?  
(Interviewer must begin by reading this 
introductory question to the patient) 
How much of the time during the past 30 
days:
All of the time=1 
Most of the time=2 
A good bit of the time=3 
Some of the time=4 
A little of the time=5 
None of the time=6 
Q10.1 Did you have difficulty reasoning and making 
decisions, for example, making plans or 
learning new things?

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Q10.2 Did you forget things that happened recently, 
for example, where you put things or when 
you had appointments?

Q10.3 Did you have trouble keeping your attention 
on any activity for long? 
Q10.4 Did you have difficulty doing activities 
involving concentration and thinking? 
Please tell me the answer that comes 
closest to describing whether the 
following statement is true or false for 
you.
Definitely true=1 
Mostly true=2 
Don’t know=3 
Mostly false=4 
Definitely false=5
Q11.1 You are somewhat ill 
Q11.2 You are as healthy as any other person you 
know 
Q11.3 Your health is excellent 
Q11.4 You have been feeling bad recently 
Q12 How has the quality of your life been during 
the past thirty days? That is, how have things 
been going for you? 
Very well, could hardly 
be better=1 
Pretty good=2 
Good and bad parts 
about equal=3 
Pretty bad=4 
Very bad, could hardly 
be worse=5 

Q13 How would you rate your physical health and 
emotional condition now compared to thirty 
days ago? 
Much better=1 
A little better=2 
About the same=3 
A little worse=4 
Much worse=5 

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CSRI date
Ask the patient if they have received the following care in the last 30 days
Category Component of care have you received this If yes, where?
of care care from any facility this facility=1
in the last month? elsewhere=2
1=yes, 2=no, 8=don't know If A=2 or 8, B=7
Question number Question section: A B
C1 Spiritual visit by pastor etc
C2 prayer with staff
C3 contact with traditional healer
C4 Psychological pre and post test counselling
C5 adherence counselling
C6 family planning counselling
C7 patient HIV support groups
C8 family counselling
C9 psychiatric therapy
Clinical Prevention
C10 prevention with positives
General
C11 wound care
C12 other nursing care
C13 ART/ARV
C14 assess ART treatment
Pain
C15 assessment of pain
C16 strong opioids eg morphine
C17 weak opioids eg codeine
C18 non-opioids eg paracetemol
C19 treatment for neuropathic pain
Symptom management
C20 anxiety/depression treatment
C21 treatment for nausea/vomiting
C22 treatment for skin rash/itching
C23
C24 treatment for constipation/laxatives
C25 treatment for genital thrush
C26 treatment for oral thrush/candidiasis
C27 treatment for cryptococcal meningitis
treatment for diarrhoea, including ORS or drip
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Category Component of care have you received this If yes, where?
of care care from any facility this facility=1
in the last month? elsewhere=2
1=yes, 2=no, 8=don't know If A=2 or 8, B=7
Question number Question section: A B
C28 treatment for other fungal infections
C29 treatment for herpes (e.g. acyclovir)
C30 treatment for malaria
C31 TB testing
C32 TB treatment
C33
C34
C35 management of cancer
C36
Prophylaxis
C37 food
C38 multivitamins
C39 nutritional advice
C40 provided access to safe drinking water at home
C41 septrin/cotrimoxazole to take every day
C42 isoniazid (INH) to prevent TB
C43 condoms
C44 mosquito bednets
C45 Social provide household items
C46
C47 employment training/IGA
C48 transport/money for bus to care centre
C49 legal services
C50 memory book work
C51 loans/microfinance
C52 infection control training
C53 Did you sleep under a bednet last night? 1=yes, 2=no
C54 Did you take cotrimoxazole yesterday? 1=yes, 2=no
How much have you spent on your care in past month (inclu transport to facility and drugs)
C55 at this facility? shillings
C56 anywhere else? shillings
 treatment for other opportunistic 
infections
home help e.g. help with bathing, housework, 
cooking
therapeutic feeding for severe malnutrition, i.e. 
drip
physiotherapy i.e. excercises to help improve 
movement
End of interview
Thank patient
Complete front cover
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Patient Qualitative Interview  
Schedule
E
 » Introduce self and background
 » Introduce project
 » Explain how patient selected 
 » What we will talk about
 » How long it will last 
 » Consent & confidentiality
 » Collect consent now
 » Tape recording & destruction
 » What will happen with data
 » Who to speak to if they have any questions 
 » Complete basic demographic information about patient
•	 Age
•	 Gender
•	 Household size
•	 Household location (urban, peri-urban, rural)
•	 Currently using ART (yes/no)
•	 History
 - How did you come to find/access the facility? 
 - Why did you come to this facility? 
 - How easy/difficult was it to become a patient here? 
•	 Contact
 - How often do you come to this service? 
 - What do you attend the service for? 
 - How satisfied are you with the service you receive?
* What is good about it?
* What is not so good about it?
 - (If the patient receives medicines) What problems, if any, have you had getting medicines? 
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•	 Need
 - What would you say are your biggest problems in relation to your HIV diagnosis?
* (Suggestions to help patient: These could be anything, such as getting to the facility, pain or other symptoms, 
childcare, anxiety, etc.) 
 - Do you have any other pressing problems that may not be obviously related to HIV?
* (Suggestions to help patient: Again, these could be anything such as family relationships, food, etc.) 
 - How does the facility help you with these problems, if it does? 
 - What help do you currently receive (including medications) from this facility? 
 - When you see the health worker, what do you talk about with them? 
 - Do they ever talk with you about:
* Spiritual care? – what specifically do they ask/do?
* Clinical care? – what specifically do they ask/do?
* Ways to prevent infecting others with HIV? – what specifically do they ask/do?
* Emotional/psychological wellbeing? – what specifically do they ask/do?
* Social or financial issues? – what specifically do they ask/do?
* General advice and communication skills for you? – what specifically do they ask/do?
 - Are there ever any things you need or problems you have that you don’t talk about? 
 - What else does the health worker do for you? 
 - Do you feel that staff ever treat you differently from other patients because you have HIV?
•	 What would you like an HIV care service to do for you, what things would you need? 
•	 Which other health services do you go to? 
 - Why do you go there? 
 - What things do you get there? 
•	 We are coming to the end of the interview. Is there anything we haven’t asked about that is important to you? 
Do you have any questions?
Thank the patient.
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 » Complete basic demographic information about carer: 
•	 Age 
•	 Gender 
•	 Household size 
•	 Household location (urban, peri-urban, rural) 
•	 Relationship to patient
•	 Contact
 - How often does your relative see the service? 
 - What do they attend the service for? 
 - How satisfied are you with the service they receive?
* What is good about it?
* What is not so good about it? 
 - Do you collect any medicines from the facility for them? 
* If so, what problems, if any, have you had getting medicines for the patient? 
•	 Need
 - What would you say are your biggest problems in relation to the patient’s HIV diagnosis? 
* Are there any other pressing problems you have that may not be obviously related to HIV? 
 - How does the facility help you with these problems, if it does? 
 - Do you ever see a health worker?
* If you see the health worker, what do you talk about with them?
* Do they ever ask you about any problems/questions you have as a carer/relative of the patient with HIV (try to 
use the patient’s name)? 
 - Does the health worker talk to you or your relative about:
* Spiritual care?
* Clinical care?
* How to prevent infecting others with HIV?
* Emotional/psychological wellbeing?
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* Social or financial issues?
* General advice and communication skills? 
 - What else does the health worker do?
 - What would you like an HIV care service to do? (i.e., what things would you, the patient, or your family 
need? 
 - We are coming to the end of the interview. Is there anything we haven’t asked about that is important to 
you? Do you have any questions?
Thank the carer.
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 » Introduce self and background
 » Introduce project
 » Explain how staff member selected
 » What we will talk about
 » How long it will last 
 » Consent and confidentiality
 » Collect written consent
 » Tape recording and destruction
 » What will happen with data
 » Who to speak to if they have any questions 
•	 About you
 - What is your job title? 
 - How long have you worked at this facility?
•	 Access
 - What criteria, if any, do you have for patients who want to access your service? 
 - Are you able to accept all the patients that wish to access your service?
* If not how do you choose them? 
 - Are there any costs to patients? 
•	 Contact
 - How often/where do you see patients? (i.e. regularity of appointments) 
 - Do you ever see their families?
* If so are you expected to offer support to them also? 
* In what ways?
* Do you? 
 - How do patients get in touch with you? 
 - Can you describe the average patient encounter:
* What standard forms/reporting, if any, do you have?
* What do you ask/record?
 - What sorts of things do you to talk with the patient about? (For the following areas of care include the 
following areas of enquiry: do you talk about it? What do you ask? What do you do? Is it part of your job? 
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If not, whose? Do you refer them on in these cases? Are you confident/do you feel able to offer this care?) 
Prompt:
* Spiritual care 
* Clinical care
* Ways to prevent HIV transmission
* Emotional/psychological wellbeing
* Social/economic wellbeing
* Bereavement 
 - What do you give them?
•	 Care and referrals
 - What is the difference between caring for early and advanced disease patients with HIV? 
 - What happens with dying patients? 
 - Do you ever refer HIV patients on to other facilities?
* For what?
•	 Multiprofessionalism and training 
 - Do you work with other health care workers in your facility, and if so, how? 
 - What sort of problems do you not ask patients about as it someone else’s work? 
 - What supervision do you receive/give to workers? 
 - What training have you had? 
 - What extra training would you like? 
 - What do you consider to be your own personal skills and strengths in caring for HIV patients? 
 - Where do you feel you could do better?
•	 Components of care
 - What problems, if any, do you find with supplying medicines to patients?
* Which ones do you use most/least?
* What medicines don’t you have that you’d like to have? 
 - If you could add extra services to your facility what would you like to provide? 
 - Are there any problems relating to HIV that you can’t manage in your facility (e.g. severe pain, depression, 
poverty)?
* Is there anything you do for patients in these situations? 
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 - Do you refer patients to any other services?
* What for?
* Please can you describe the process of referring a patient (i.e. details of any written information, patient follow-
up, communication with the other facility)
•	 Evaluation
 - What are the strengths of your facility? 
 - What are the weaknesses of your facility? 
 - What main challenges do you face in terms of sustainability for your facility?
•	 We are coming to the end of the interview. Is there anything else important to you that you would like to say?
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H Costing Instrument
facility number Date
Completed by : Names of those interviewed
Accountant:
Pharmacist:
Clinician (drugs, lab tests etc):
(1) Patient numbers
1 total # individuals cared for in past year (2007):
2 # individuals provided with any HIV care in past year (2007), including ART and non-ART:
3 of those, # individuals provided with ART in past year (2007):
NB: all following questions refer to HIV care only and in the context of patients being HIV positive
(2) staff
ask a range of staff (doctor, nurse, counsellor, CHW)
staff type number of HIV patients # hours spent hours worked
you see in a typical day with HIV patients per week per week
4.1.1 doctor 1
4.1.2 doctor 2
4.2.1 nurse 1
4.2.2 nurse 2
4.3.1 counsellor 1
4.3.2 counsellor 2
4.4.1 community health worker 1
4.4.2 community health worker 2
4.5 clinical officer
4.6 pharmacist
4.7 lab staff member
4.8 nutritionist
4.9 social worker
4.10 physiotherapist
Mackuline Atieno
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facility number Date
(3) medicines ask pharmacist Option A OR ask clinician/pharmacist option B
medicine Actual quantity dispensed Estimated quantity used by typical pt in 3 mths (tabs)
in Feb-April 2008(tabs) on ART pre-ART
5 Abacavir (ABC)
6 Didanosine (ddI)
7 Efavirenz (EFV)
8 Indinavir (IDV)
9 Lamivudine (3TC)
10 Lopinavir (LPV)  + Ritonavir (RTV)
11 Nelfinavir (NFV)
12 Nevirapine (NVP)
13 Stavudine (d4T)
14 Stavudine + Lamivudine
15 Stavudine + Lamivudine + Nevirapine
16 Tenofovir (TDF)
17 Tenofovir + Emtricitabine (FTC)
18 Zidovudine (ZDV)
19 Zidovudine + Lamivudine
20 Zidovudine + Lamivudine + Nevirapine
21 strong opioids eg morphine
22 Septrin/cotrimoxazole
23 weak opioids eg codeine
non-opioid painkillers (name 3 most common)
24.1 1
24.2 2
24.3 3
25                                TB Treatment
600mg
400mg
200/50mg
150mg
300mg
Aspirin
300mg
Brufen
300/150mg
200mg
30+40mg
Paracetamol
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facility number Date
(3) medicines continued ask pharmacist Option A OR ask clinician/pharmacist option B
medicine Actual quantity dispensed Estimated quantity used by typical pt in 3 mths (tabs)
in Feb-April2008 (tabs) on ART pre-ART
other antibiotics for opportunistic infections (name 3 most common)
26.1 1 0
26.2 2 0
26.3 3 0
Name 2 most common first line ART regimens: Estimated number of patients on this regimen
27.1 1.___
27.2 2.___
Name 2 most common second line ART regimens:
28.1 1.___Zidovudine+lamivudine+lopinavir/ritonavir
28.2 2.___
(4) lab tests
ask lab staff and doctor Option A or Option B
Actual number of tests this facility Estimated number of tests a typical patient
test conducted in Feb-April 2008 receives in 3 months
on ART pre-ART
29 liver function test (LFT)
30 AFB smear (TB)
31 CD4 count
32 haemotology test (FHG)
33 viral load
Abacavir+didnosine+lopinavir/ritonavir
Amoxil (500mg+250mg)
Doxycycline
Stavudine+lamivudine+nevirapine
Zidovudine+lamivudine+nevirapine
Cefzil (500mg)
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(5) building infrastructure and utilities (all, not only HIV) ask accountant/manager
34 Utility costs per month (shillings)
Include water, electricity, generator fuel, 0
 communications, waste disposal etc
35 Transport costs, fuel, drivers, maintenance (shillings) 0
36 Clinical consumable costs per month (shillings)
Include gloves, syringes, cotton wool 0
swabs, plasters, soap, sterilising solution etc
37 amount spent on volunteer staff (inclu training, 0
travel reimbursements, payment in kind) in past 3 months (shillings)
(6) capital costs ask accountant
38 approximate total facility space (sq m)
39 approximate facility space for HIV care (sq m)
40 rent per month, or estimated rental value
41 number of four-wheeled vehicles
42 number of two-wheeled vehicles
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Loadings onto Wealth Factor
Table 68 shows the contribution of each variable to the 
single factor measuring socioeconomic status, with the 
exception of six variables which did not contribute at 
all. The variables loading most heavily onto the factor 
were a negative loading on having an earth floor, and 
positive loadings on using paraffin/kerosene/coal or 
charcoal as cooking fuel, and having piped water either 
inside or outside the house. 
Association of Mental Health Score with Physical 
Health Score
Linear regression was used, with CD4 count as a con-
tinuous variable, to explore the effect of CD4 on mental 
health score adjusting for physical health score. The 
hypothesis was that the observed association of mental 
health score and CD4 count was explained by the effect 
of CD4 on physical health score. 
It was also hypothesised that participants with 
lower physical health would be more likely to be ac-
companied by a carer, but the same would not be true 
of mental health. To test this hypothesis, linear regres-
sion was used to separate the associations of carer pres-
ence with physical and mental summary scores at T0. 
Table 69 shows that after adjusting for mental 
Table 68: Loadings onto Wealth Factor
Variable Loading
Earth floor -0.308
Paraffin/kerosene/coal cooking fuel 0.187
Piped water outside house 0.181
Charcoal for cooking fuel 0.180
Piped water inside house 0.178
Tiled/cement/asbestos/tin roof 0.168
Corrugated iron roof 0.147
Private flush toilet 0.141
Natural gas/LPG for cooking fuel 0.136
Mud and poles/unburnt brick/brick with mud walls -0.133
Own a television 0.126
Own a refrigerator 0.105
Own a mobile phone 0.079
Own a car 0.066
Protected well/borehole/rain water 0.048
Public/shared/bush latrine 0.025
Own a radio 0.017
Polished wood/tile/carpet floor -0.009
Own a bicycle -0.006
Table 69: Linear Regression at T0 with Physical Health Score as an Outcome
Model Covariate Coefficient Standard Error T P 95% CI
A CD4 count 0.011 0.002 6.34 <0.001 0.008–0.015
B Mental health score 0.690 0.038 18.29 <0.001 0.616–0.764
B CD4 count 0.008 0.001 5.25 <0.001 0.005–0.010
Table 70: Linear Regression at T0 with Mental Health Score as an Outcome
Model Covariate Coefficient Standard Error T P 95% CI
C CD4 count 0.005 0.002 3.49 0.001 0.002 to 0.008
D physical health score 0.507 0.028 18.29 <0.001 0.453 to 0.561
D CD4 count -0.001 0.001 -0.31 0.754 -0.001 to 0.002
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health score, physical health score was still closely as-
sociated with CD4 count (p<0.001). However, when 
mental health score was the outcome in Table 70, there 
was no association between mental health and CD4 
after adjusting for physical health (p=0.754). The appar-
ent association between mental health and CD4 count 
in the top half of Table 70 was completely confounded 
by physical health score. The fact that the association 
did not disappear in Table 69 shows that this was not 
simply a product of overadjusting. 
Table 71 shows that patients with a carer present 
at T0 had an average physical health score five points 
lower than those without a carer, and the difference was 
highly significant (p<0.001). After adjusting for mental 
health, the association with carer presence was reduced 
(because of the close correlation between physical 
health and mental health) but still significant (p=0.01). 
Conversely, Table 72 shows that although patients with 
carers had a mean mental health three points lower 
than those who came alone, this difference was com-
pletely confounded by physical health.
Details of Longitudinal Analysis Method
Multilevel modelling was carried out using the Stata 
xtmixed command function. Outcomes were physical 
health score and mental health score, measured up to 
three times at monthly intervals. Baseline score was 
incorporated as a covariate and not as an outcome. 
Models included levels for facility and individual. The 
only random effects was timepoint (interview number, 
rather than actual time interval), which was allowed to 
have a random coefficient at the individual level. Other 
covariates were fixed. Demographic and care theme 
covariates were constant over time, receipt of ART and 
TB treatment varied. The default independent covari-
ance structure was used. Variance and standard error of 
variance were reported for random-effects parameter 
estimates. 
Exploring the Variance at Different Levels
Multi-level modelling consists of attempting to sepa-
rate the variation in scores into variance at different 
levels; in this case, variance within individuals over 
time, between individuals, and between facilities. Two 
techniques were used to identify the extent of the vari-
ance between facilities. Multilevel models of care relied 
on between-facility variances in order to function.
Table 73 shows the results of ANOVA tests com-
paring baseline health scores between the six facilities. 
The results show that facility accounted for a propor-
tion of the variation, reducing the value of R squared. 
Physical health varied more between facilities than 
mental health did.
Additionally, a multilevel model without covariates 
was developed to ascertain the contribution of the facil-
ity level to change over time. In Table 74 it is clear that 
the great majority of variance was between individuals, 
rather than between facilities.
Table 71: Linear Regression at T0 with Physical Health Score as an Outcome
Model Covariate Coefficient Standard Error T P 95% CI
A Carer present -5.097 1.309 -3.89 <0.001 -7.668 to -2.527
B Carer present -2.724 1.054 -2.58 0.010 -4.794 to -0.655
B mental health score 0.716 0.036 19.75 <0.001 0.644 to 0.787
Table 72: Linear Regression at T0 with Mental Health Score as an Outcome
Model Covariate Coefficient Standard Error T P 95% CI
C Carer present -3.316 1.100 -3.01 0.003 -5.476 to -1.157
D Carer present -0.742 0.889 -0.83 0.404 -2.488 to 1.004
D physical health score 0.505 0.026 19.75 <0.001 0455 to 0.555
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Table 73: Results of ANOVA Using Facility at T0
n R squared Adjusted r squared F p
Physical health score 692 0.045 0.038 6.47 <0.001
Mental health score 692 0.017 0.009 2.30 0.044
Table 74: Results of Multilevel Model with Random Intercept 
Facility Level Individual Level
Variance Standard Error Variance Standard Error
Physical health score 3.376 2.540 53.325 4.045
Mental health score 0.476 0.547 31.871 2.455
Phase 2 Kenya 124
PEPFAR Categories of CareJ
Table 75: PEPFAR Categories of Care
Area of Care and Support Care Components included from CSRI Area of Care and Support Care Components included from CSRI
Clinical Pre and post test counselling
Adherence counselling
Nursing care
Adult diagnostic HIV testing
Weighing
Assessment of pain
Strong opioids
Weak opioids
Non-opioid analgesics
Treatment for neuropathic pain
Treatment for nausea/vomiting
Treatment for skin rash/itching
Treatment for diarrhoea
Laxatives
Treatment for thrush
Treatment for oral candidiasis
Treatment for cryptococcus
Treatment for other fungal infections
Treatment for herpes
Treatment for malaria
TB detection and treatment
Therapeutic feeding for malnutrition
Treatment for other opportunistic infections
Management of cancer
Multivitamins
Nutritional advice
Access to safe drinking water at home
CTX
Isoniazid to prevent TB
ITNs
Wound care
Physiotherapy
Psychological Family counselling
Psychiatric therapy
Anxiety/depression treatment
Spiritual Visit by faith leader
Staff prayer with patients
Contact with traditional healer/herbalist
Memory book work
Social Home help
Employment training
Legal services
Loans/microfinance
Prevention Family planning counselling
Patient HIV support groups
Support for family testing
Prevention with positives
Condoms
Phase 2 Kenya 125
Country-Level Coding FramesK
Coding Frame Developed by APCA
 » Components of care/care provision
•	 Curative, preventive and on going monitoring 
•	 VCT, RCT and Diagnostic counselling
•	 Adherence counselling
•	 Spiritual care
•	 Bereavement care 
•	 Socio-economic support
•	 Laboratory services 
•	 Psychological/emotional care 
 » Health seeking behaviour
•	 Associated with self initiation into care
 - Sickly
 - Suggestive symptoms 
 - Community advice 
•	 Reasons for choice of facility
 - Proximity
 - Available services 
 - Affordability
 » Patient and carer needs
•	 Clinical 
•	 Preventive
•	 Social and financial
•	 Emotional/psychological
 » Structure of HIV/AIDS care services
•	 Criteria for accessing care
•	 Enrollment process
•	 Frequency of care
•	 Documentation in care
•	 Differences in care needs for patients at different 
stages of disease
•	 Referrals 
•	 Costs to patients
•	 Education and training
•	 Supervision
 » Strengths, challenges, and service gaps
•	 Services facilities /patients would like to have 
•	 Challenges faced
•	 Patients’ perceptions of services received
Coding Frame Developed by KCL
 » Carer Roles, Relationship to Patient and Facility
•	 Patient as care provider and educator
 » Content of service receipt
•	 Advanced and bereavement care
•	 Carer
•	 Clinical and medicine
•	 Monitoring and process
•	 Preventive
•	 Psychological, counselling and advice
•	 Referral
•	 Social
•	 Spiritual
 » Experiences of Care Provision and Receipt
•	 Negative experiences
•	 Positive experiences
•	 Facility self-reported strengths
•	 Patient and carer self report
•	 Suggested improvements
•	 Clinical and facility challenges
 » Initiating Care
•	 Criteria for service entry and care
•	 Patient choice of facility
•	 Process of enrollment
•	 Retention and shopping around
•	 Service identification of needs
 » Needs
•	 Carers
•	 Clinical
•	 Preventive
•	 Psychological
•	 Social
•	 Staff
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Table 76: MOS-HIV Responses at T0
Subscale No. Question Responses
poor fair good very good excellent
Health perception
Q1 Health is 14.4 41.7 33.3 7.5 3.2
true mostly true don’t know mostly false false
Q11.1 Somewhat ill 48.0 30.3 2.0 10.1 9.7
Q11.4 Feeling bad recently 42.9 35.3 0.1 10.4 11.2
false mostly false don’t know mostly true true
Q11.2 As healthy as anyone 
you know
24.1 20.3 5.6 25.4 24.6
Q11.3 Health is excellent 33.3 29.4 2.3 21.2 13.8
very severe severe moderate mild very mild none
Pain
Q2 Bodily pain 5.2 14.8 29.7 22.7 11.4 16.2
extremely quite a bit moderately a little bit not at all
Q3 Pain interfering with 
daily life
10.9 16.7 14.7 23.1 34.6
limited a lot
limited a 
little
not limited 
at all
Physical function
Q4.1 Vigorous activities 26.0 37,2 36.8
Q4.2 Moderate activities 9.6 29.5 60.9
Q4.3 Walking up hill 15.4 33.1 51.6
Q4.4 Bending, kneeling 7.8 27.4 64.8
Q4.5 Walking 5.2 18.7 76.2
Q4.6 Self care 2.3 9.8 87.9
Yes No
Role function
Q5 Cannot work 23.3 76.7
Q6 Cannot do some work 27.2 72.8
Proportion of Time
all most a good bit some a little none
Social function
Q7 Limited social activi-
ties
8.5 7.2 5.2 11.1 10.3 57.8
Mental health
Q8.1 Nervous 3.0 6.8 5.5 20.0 21.1 43.7
Q8.3 Depressed 2.0 7.6 6.0 19.7 25.9 38.8
Q8.5 Very depressed 1.9 4.7 4.6 13.9 22.8 52.0
L MOS-HIV Responses at T0
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Table 76: MOS-HIV Responses at T0
Subscale No. Question Responses
Vitality
Q9.2 Without energy 3.6 6.8 7.3 16.2 26.7 39.4
Q9.3 Tired 4.6 10.2 8.6 28.4 30.1 18.1
Health distress
Q9.5 Weighed down 3.9 8.5 6.8 22.0 26.6 32.2
Q9.6 Discouraged 3.5 7.5 5.0 16.6 26.0 41.4
Q9.7 Despair 1.9 5.2 4.9 14.8 18.4 54.8
Q9.8 Afraid 3.3 7.6 3.6 15.4 23.0 47.1
none a little some a good bit most all
Mental health
Q8.2 Calm and peaceful 10.1 11.8 22.4 6.3 24.4 25.0
Q8.4 Happy 6.8 9.3 21.1 8.6 29.3 24.9
Vitality
Q9.1 Full of life 8.2 14.9 21.0 11.6 25.4 18.7
Q9.4 Enough energy 9.2 15.5 22.2 9.8 20.7 22.6
all most a good bit some a little none
Cognitive function
Q10.1 Difficulty reasoning 3.2 6.6 5.2 15.4 17.7 51.9
Q10.2 Forgetful 2.0 7.5 3.9 16.9 16.3 53.5
Q10.3 Attention problem 1.7 5.5 4.2 14.7 18.9 55.0
Q10.4 Concentration 
problem
2.6 5.3 4.2 13.4 16.7 57.6
very bad pretty bad about equal pretty good very good
QoL Q12 Quality of life 4.3 15.1 51.3 25.2 4.0
much worse a little worse the same
a little 
better
much  
better
Health transition
Q13 Compared to 30 days 
ago
4.5 17.3 27.2 35.0 16.0
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Feedback from DisseminationM
Introduction
Part of the objective of this evaluation is, in conjunction 
with MEASURE Evaluation, to build commitment to 
utilising the findings and lessons learnt from the study. 
As a step towards meeting this objective a meeting was 
held in Nairobi in July 2009 with the research team and 
participating facilities. The purposes of this meeting 
were (a) to share the results of Phase 2 with partici-
pants; (b) to gain insight into the findings from those 
involved in service delivery to improve the presentation 
of the findings in the report; (c) to discuss the recom-
mendations made, with the option of facilities making 
additional recommendations if desired.
Representatives from all six facilities, the country 
team and the Ministry of Health attended the work-
shop.
Meeting Outline
Participants were given a summary of the findings. 
Presentations from the research team explained (a) the 
parties involved and the aims, objectives and design of 
the evaluation; (b) methods and data collection experi-
ences; (c) results 
Participants were then divided into five groups in 
order to explore key themes that arose from the data in 
more detail. In addition to the summary report already 
received, each group was given relevant supplementary 
data (i.e., report tables and excerpts from qualitative 
interviews) to aid discussions. Group participants were 
asked to discuss the main findings relating to the theme 
allocated. Prompts to aid discussion included: Were any 
findings surprising? What are the areas where things 
are doing well or are on track and why? What areas 
need improvement and why? Participants were then 
asked to review and discuss the recommendations con-
tained in the summary report, and finally to draft their 
own set of recommendations for action in this thematic 
area using the attached format. Discussion summaries 
were shared with all.
Meeting Feedback—General
Participants expressed their appreciation at being 
informed of the findings. In general participants found 
that the findings were borne out by their own experi-
ence, and agreed that there were many unmet psycho-
social needs for their patients. Mental health score was 
consistently lower than physical health score, and it is 
known that mental health problems, particularly de-
pression, are major contributors to non-adherence. The 
issue, participants agreed, was how to manage mental 
health appropriately. 
There was great interest in the finding that physical 
and mental health scores were not significantly associ-
ated with ART use. It was emphasised that these are 
self-reported outcomes, and that the findings should 
absolutely not be interpreted to mean that ART is inef-
fective, rather that some problems in patient experience 
persist after ART. Participants would have liked to see 
what happened to outcomes over a longer period of 
time.
Some additional questions for analysis were raised 
in discussion. Facility staff reported they had expected 
that women would report better health scores than 
men, both because they were less likely to mention 
problems and because, anecdotally, men only come for 
testing when symptoms are severe. The results showed 
that in fact outcomes were not associated with gender. 
Staff were interested to know whether the presence 
of a carer was associated with relative wealth or gen-
der. The probability of having a carer did not differ by 
wealth quintile on an ANOVA test. If all observations 
were included, men were accompanied by a carer on 
8.4% of visits and women on 5.9%, which was signifi-
cant on a t-test (p=0.02). This contradicted the group’s 
expectation, which was that women, believed to be 
more likely to disclose their status, would be accompa-
nied more often.
Facility staff attributed the low use of morphine to 
regulatory restrictions but Dr Zipporah Ali, the execu-
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tive director of KEHPCA, pointed out that Kenya was 
allowed to import 15kg of morphine per year and only 
made use of 5kg. She argued that use of morphine was 
limited by clinicians’ reluctance to prescribe it, due to 
fears of addiction and inadequate training.
It was suggested that the civil unrest in Kenya fol-
lowing the 2008 presidential election, which is known 
to have disrupted access to care, should be considered as 
a contributor to mental health problems.
Meeting Feedback—Groups
ART, PCP, Pain Management, Symptom and 
Infection Management, Prevention
This group was surprised by the finding that self-
reported outcomes were not significantly affected by 
ART. They suggested that pain may have been under-
reported, as pain is not taken seriously as a health 
concern, so that patients reporting pain may be viewed 
as complaining. 
Nutrition, Social Care, Psychological Care, 
Spiritual Care
This group debated whether the finding that therapeu-
tic feeding declined over time represented a reduction 
in need or in provision. This is a limitation of the data 
which could only have been overcome through inde-
pendent clinical observation of patients. It was partici-
pants’ experience that over 80% of HIV patients would 
benefit from extra food support. Receipt of nutritional 
counselling was high but it was suggested that deliver-
ing this care in a group setting, alongside individual 
counselling, might enforce the message and take receipt 
to 100%.
The group reported that in their opinion pre-and 
post-test counselling at VCT services was not always of 
good quality, and therefore although over 90% of par-
ticipants received it, there could still have been unmet 
need. Again, the evaluation was unable to determine 
the quality of care delivered except by change in out-
comes over time. 
Facility Strengths and Weaknesses
The group highlighted strengths of the six facilities 
including provision of counselling, ART, PWP, CTX, 
treatment for OIs, and streamlined referral. Adherence 
counselling was considered a cornerstone of patient 
management and the key to lifelong care. The goal was 
for patients to be able to attend regularly and take their 
medication.
Several challenges that facilities faced were identi-
fied by the group. Lack of psychosocial and spiritual 
care was attributed to lack of skilled staff and space. 
Drugs for opportunistic infections might be unavail-
able or too expensive. The group reported that routine 
medication was well supplied but second line therapies, 
or strong antibiotics, could be more difficult to access. 
Another challenge was that patients became attached 
to the CCC (Comprehensive Care Centre, where all 
HIV care is delivered) and were reluctant to transfer 
elsewhere. When the CCC was closed over the week-
end, patients in need of care would wait rather than 
visit another health centre. Staff at other health centres 
encouraged this by refusing to treat CCC patients. The 
group encouraged integration of services and training 
so any staff could meet the needs of patients irrespec-
tive of HIV status or disease stage.
Patient Issues and Perspectives
The group reported that food was a major problem. 
Patients were in need but the facility did not want to 
encourage dependence on short-term aid by providing 
food in an unsustainable manner. Patients who received 
food became reluctant to transfer to another care centre 
which did not offer it. The group felt that the most 
effective approach would be skills training and IGA to 
enable families to be self-supporting.
Group participants encouraged the provision of 
spiritual care within facilities, in part so that patients 
would not visit faith healers to meet their spiritual 
needs. In some settings, patients would be told they 
had been cured and cease to take ART. Use of herbal 
medicines could also be a problem, as it was often not 
reported to health workers and could lead to side effects 
or reduce the effectiveness of treatment.
Carer Issues and Perspectives
The group found that there was a lack of focus on carer 
wellbeing, with carers complaining about long waiting 
times, few home visits, and severe financial restraints 
Phase 2 Kenya 130
feedBacK from dissemination 130
resulting in lack of food. The group were surprised that 
carers were more likely to accompany the patients in 
the earlier visits than later, and also that, despite the 
difficulties they reported, carers scored low worry on 
the POS. 
The group endorsed the evaluation findings relating 
to the multiple roles of people with HIV who might 
be patients, carers, and peer counsellors on different 
occasions. They found that peer counselling was very 
popular and that having HIV positive staff in core 
areas, such as outreach, was an asset to a facility.
Each group produced recommendations, which are 
presented together in the table below, with the relevant 
data supporting them and the principle beneficiaries. 
Some recommendations were common to more than 
one group and have been merged together.
Table 77
Recommended Actions Data Supporting Recommendation Beneficiaries
Longitudinal Qualitative Cost/survey
Improve access to PCP components, except CTX which 
is well delivered. 
•	 Low receipt of BCP 
components
•	 Patients 
Improve pain assessment and management, and 
medical education regarding pain. Increase opioid 
prescription. Develop protocols and clinical training to 
encourage and control use
•	 Persistent pain over three 
months
•	 Use of non-opioids very high 
but opioids very low
•	 Patient reports of pain •	 Phase 1: 
opioids only 
found in 
injectable form
•	 Patients
•	 Staff
Support and monitoring needed for ART clients, 
including monitoring of treatment failure and drug 
resistance. Conduct CD4 tests more regularly, improve 
use of second and third line treatments
•	 Patients without CD4 count
•	 Self-reported health on ART 
no higher than ART-naïve 
patients, problems persist 
after treatment
•	 Staff report low knowledge 
of second line therapies
•	 Patients
Develop IGA, prevent dependence on food aid and 
make families independent. Skills training e.g. farm-
ing methods to improve yield, fishing, grants to start 
funds.  
•	 High proportion receiving 
therapeutic feeding indicates 
poor nutrition. Social care is 
the weakest area.
•	 Need for food, but also 
dignity and sense of 
competence
•	 Patients
•	 Families
Need more family counselling—might be related to 
disclosure at home, focus on this is needed
•	 Proportion of participants 
without a carer
•	 Anxiety related to disclosure •	 Families
Incorporate psychiatric therapy fully into counselling, 
refer where necessary
•	 Low provision of psychiatric 
therapy
•	 Psychiatric problems 
impairing ability to work 
and care for family
•	 Phase 1: 
weak referral 
networks
•	 Patients
Patients should be encouraged to seek spiritual care 
alongside medical care, medical institutions should 
have spiritual leader. Staff will also benefit, and 
patients less likely to go to faith healers.
•	 Spiritual care delivery to 
under 80% of participants
•	 Patients report benefit 
from spiritual care, 
encouragement, sense of 
hope, community support
•	 Patients
•	 Staff
Recruitment of more nutritionists, counsellors  and 
social workers
•	 Low delivery of social care
•	 Psychological and social 
problems more severe than 
physical
•	 Counsellors report overwork. 
Patient numbers, long 
waiting time. 
•	 High 
patient:staff 
ratio, especially 
non-clinical
•	 Patients
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Table 77
Recommended Actions Data Supporting Recommendation Beneficiaries
Longitudinal Qualitative Cost/survey
Decentralise to smaller and mobile services. Equip the 
smaller sites to provide more care components and 
also do outreach. 
•	 Loss to follow-up over time, 
especially for patients with 
poorer health scores
•	 Transport costs
•	 Desire to get all care from 
one place
•	 Patients
Triage patients and reduce waiting times. Allow fast-
track route to pharmacy for stable patients.
•	 Big range in care 
components received, one 
path not suitable for all
•	 Waiting times, opportunity 
cost
•	 Staff time a 
major expense, 
to be used 
efficiently
•	 Patients
Mental health worker attached to the CCC. Identify 
and treat anxiety and depression.
•	 Mental health scores lower 
than physical. High levels of 
psychological problems
•	 Anxiety reported •	 Patients
Prioritise motivation of health workers •	 High turnover, burnout. 
Difficulty maintaining 
quality care with ever 
increasing numbers
•	 Staff
Increase supply of OI drugs and make them free for 
those who can’t pay
•	 High prevalence of OI 
treatment, including many 
unspecified, possibly rare 
conditions 
•	 Patients unable to afford 
prescriptions, problems 
intensify due to lack of 
treatment
•	 Patients
Encourage and expand support groups •	 Prevalence not 100%
•	 Needing to share feelings a 
big problem
•	 Benefits of support groups, 
emotional, practical
•	 Patients
Involve more CHWs and encourage them to do home 
visits to improve psychosocial care. Work with chiefs 
and village elders.
•	 Social care and integration 
into daily living (e.g. home 
help, provision of household 
items) are poorly provided
•	 Interviews – carers lack time 
to see HCWs. Patients lonely, 
like home visits. Transport 
costs.
•	 Patients
•	 Families
Focus on carers’ wellbeing. Carers should be included 
in treatment plans
•	 Complex care regimes, 
difficult to manage alone
•	 Carers want to be included, 
value information to improve 
care
•	 Carers
Employ more HIV positive peer counsellors •	 Lack of someone to share 
feelings with a major 
problem
•	 Patients appreciate peer 
support - social, spiritual 
and psychological gains
•	 Patients
Find more space; facility encourages multidisciplinary 
family meetings and psychosocial meetings but lacks 
space to host them
•	 Patients report benefits of 
support groups. Family care 
a neglected issue
•	 Phase 1: 
space a very 
common 
issue in staff 
interviews
•	 Families
•	 Patients
Research active clinical services are essential for 
improving care. Facilities need resources and skills to 
conduct research and find answers to their questions
•	 Staff want to do research 
themselves not only host it
•	 Staff
•	 Patients
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